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1. Abbreviations
Units were abbreviated using the International System of Units (SI). The single letter code
was used for amino acids and nucleotides and abbreviations according to common words the
dictionary was used.
Table 1.1. Abbreviations
aa amino acid(s)
Abi-1 Abl interacting protein-1
Abl Abelson
ACSF artificial cerebrospinal fluid
ADAM A-Disintegrin-And-Metalloprotease
AF-6 Acute myeloid leukemia-1/chromosome 6 fusion protein/afadin-6
Amp ampicillin
AMP adenosine 5’-monophosphate
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
AP alkaline phosphatase
APS ammonium persulfate
APV 2-amino-5-phosphonovaleric acid
Arg Abelson-related gene
Arp2/3 actin-related protein 2/3
ATP adenosine 5’-triphosphate
Borax sodium tetraborate
BBS BES buffered saline
BCIP 5-bromo-4-chloro-3-indolyphosphate
BES N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid
bp base pairs
BSA bovine serum albumin
1
1. Abbreviations
CA Cornu ammonis
CAM cell-adhesion protein
CamKII Ca2+/Calmodulin-dependent kinase II
cAMP cyclic AMP
CAP c-Cbl associated protein
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate
cDNA complementary DNA
CMV cytomegalovirus
CNS central nervous system
CREB Ca2+/cAMP-responsive element binding protein
C-terminus carboxy terminus
CXCR chemokine receptor of CXCR-family
Da Dalton (g/mol)
DG dentate gyrus
DIG digoxigenin
DIV days in vitro
DMEM Dulbecco’s modified Eagle’s medium
DMSO dimethylsulfoxide
DNA desoxyribonucleic acid
dNTPs deoxyribonucleoside triphosphates
dsDNA double strand DNA
DTT 1,4-Dithio-DL-threitol
E embryonic day
ECFP enhanced cyan/blue fluorescent protein
ECL enhanced chemoluminescence
E. coli Escherichia coli
EDTA ethylenediaminetetraacetic acid
Eph erythropoietin-producing hepatocellular
ephrin Eph receptor interacting
EGF epidermal growth factor
EGFP enhanced green fluorescent protein
EGFR epidermal growth factor receptor
EPSP excitatory postsynaptic potential
Erk extracellular-signal regulated kinase
2
EtOH ethanol
ExFP ECFP, EGFP or EYFP
EYFP enhanced yellow fluorescent protein
FAK focal adhesion kinase
FBS fetal bovine serum
fEPSP field EPSP
fig. figure
FNIII fibronectin type III
G protein GTP-binding protein
GAP GTPase-activating protein
GDP guanosine diphosphate
GEF guanine nucleotide exchange factor
GluR glutamate receptor subunit
GPI glycosylphosphatidylinositol
Grb growth-factor receptor bound
GRIP glutamate receptor interacting protein
GTP guanosine trisphosphate
HEPES N-2-hydroxyethylpiperanzine-N’-2-ethanesulfonic acid
HEK human embryonic kidney
HeLa Henrietta Lacks
HBSS Hank’s balanced salt solution
HC heavy chain
HRPO horseradish peroxidase
HS horse serum
HUVEC human umbilical cord venous endothelial cell
IF immunofluorescence
Ig immunoglobin
IHC immunohistochemistry
IP immunoprecipitation
IPTG isopropyl β-D-thiogalactopyranoside
KA kainate receptor subunit
Kan kanamycin monosulfate
kb kilo bases
KD kinase dead
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Kuz Kuzbanian
lacZ gene encoding β-galactosidase
LB Luria-Bertani
LC light chain
LMW-PTP low molecular weight phosphotyrosine phosphatase
LTD long-term depression
LTP long-term potentiation
MAP mitogen-activated protein
MAP2 microtubule-associated protein 2
MAPK mitogen-activated protein kinase
MB mushroom body
MEM minimal essential medium
mGluR metabotropic glutamate receptor
MOPS 3-(N-Morpholino)propanesulfonic acid, 4-Morpholinepropanesulfonic acid
NBT nitroblue tetrazolium
Nck noncatalytic region of tyrosine kinase
NGF nerve growth factor
NMDA N-methyl-D-aspartate
NMJ neuromuscular junction
NP-40 Nonidet P-40
NR NMDA receptor subunit
N-terminus amino terminus
N-WASP neural Wiskott-Aldrich syndrome protein
OD optical density
O/N over night
P postnatal day
p.a. per analysis
PAGE polyacrylamide-gel-electrophoresis
Pak p21 activated kinase
PBS phosphate-buffered saline
PBST PBS with Tween
PCR polymerase chain reaction
PDZ postsynaptic density-95/discs-large/zona occludens 1
PDZ-RGS PDZ-regulator of heterotrimeric G-protein signalling
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PFA paraformaldehyde
pH potentium hydrogenii
PHIP pleckstrin-homology-domain interacting protein/ ephrin interacting protein
PI3K phosphatidylinositol 3-kinase
PICK protein interacting with C kinase
PKA protein kinase A
PKC protein kinase C
PMSF phenylmethylsulfonyl fluoride
PP protein phosphatase
PPF paired-pulse facilitation
PSD postsynaptic density
PSD-95 postsynaptic density protein 95
PTP post tetanic potentiation
PTP1B protein tyrosine phosphatase-1B
PTP-BL protein tyrosine phosphatase-basophil-like
pY phospho-tyrosine
RasGAP Ras-GTPase activation protein
Ref. reference
RNA ribonucleic acid
rpm rounds per minute
RT room temperature
RTK receptor tyrosine kinase
Ryk receptor-like tyrosine kinase
SAM sterile α-motif
SDF-1 stromal-cell-derived factor-1
SDS sodium dodecyl sulfate
SEM standard error of the mean
SFK src family kinase
SH src homology
SHEP SH2 domain-containing Eph receptor-binding protein
SLAP Src-like adaptor protein
SSC sodium salt citrate
src sarcoma virus transforming gene product
TAE Tris-acetate EDTA
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TBS thetaburst stimulation
TE Tris-EDTA
TEMED N,N,N’,N’-Tetramethylethylenediamine
tet Tetracycline
TK tyrosine kinase
TNF-α tumour necrosis factor-α
Tris Tris[hydroxymethyl]aminomethane
TX-100 Triton X-100
U unit(s)
UV ultra-violet
WB western blot
wt wild type
X-gal 5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside
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2. Publication from the work presented in
this dissertation
Zimmer M., Palmer A., Köhler J., and Klein R.
EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact me-
diated repulsion.
Nature Cell Biology (2003) 5(10):869-878
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3. Summary
The Eph receptors comprise the largest subfamily of receptor tyrosine kinases (RTKs) with
important roles during neuronal development. Unlike other RTKs, these receptors can be ac-
tivated by their membrane bound ligands, the ephrins. Recent evidence strongly suggests that
Eph receptors and their ligands also contribute to synapse formation and synaptic plasticity
in the postnatal brain. However, the details of the mechanisms still remain unclear.
In order to better understand the role of EphB2 receptors during these processes in living
cells, EphB2 receptors were visualized. Therefore, one variant of the enhanced blue, green,
or yellow fluorescent protein (E(C/G/Y)FP) was fused to the receptor. For this, ExFP was
inserted in one of three different positions of EphB2: the N-terminus (EphB2-N), a site close
to the juxtamembrane region (EphB2-C1) and between two functional relevant domains of
the cytoplasmic tail (EphB2-C2). The different EphB2-ExFP receptors, EphB2-N, EphB2-C1
and EphB2-C2, were exogenously expressed in cell lines and showed intense fluorescence at
the plasma membrane, comparable to other described transmembrane ExFP fusion proteins.
Biochemical methods were used to test functionality of the different EphB2-ExFP proteins
concerning tyrosine phosphorylation and interaction with known proteins, such as NR1 and
GRIP2, and showed no obvious impairment. Surprisingly, however, the cluster behaviour
of the EphB2-ExFP variants transiently expressed in neurons was different, only the EphB2-
C1 proteins revealed a proper cluster formation after ephrinB stimulation, indicating that the
ExFP insertion at the N- and C-terminus impaired the clustering.
In order to study the dynamics of trafficking, insertion and cluster behaviour of fluorescently
tagged EphB2 receptors in living neurons, hippocampal cultures were transfected with these
constructs. EphB2-C1 expressing neurons revealed two pools of fluorescent clusters, one pool
was static, representing EphB2 receptors at the plasma membrane, whereas the other pool was
trafficking along neurites, presumably reflecting EphB2 proteins in transport vesicles. In ad-
dition, the subcellular distribution of these receptors was analyzed, revealing that e.g. EphB2
clusters are present at the tips of filopodia and in growth cones. Filopodia are highly dynamic
structures, which explore the environment and therefore have to extend and retract a lot. Our
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group recently described a new mechanism of how an adhesive Eph-ephrin interaction be-
tween filopodia of immature growth cones and EphB2-expressing cell lines can be turned into
a retraction response by bi-directional EphB/ephrinB-triggered trans-endocytosis. Intrigued
by these findings, we were interested whether bi-directional transcytosis also exists in mature
hippocampal cultures, presumably being involved in the dynamics of filopodia. The present
thesis could show that after contact of mature neurons with cells, most-likely glial cells, the ex-
ogenous expression of fluorescently tagged EphB2 receptors in neurons induces a retrograde
transcytosis into the interacting neighbouring cell. This reverse transcytosis of EphB2-C1 pro-
teins was often followed by persistent retraction of the neuronal protrusion. This could have
a potential role in axon pruning or in morphological plasticity in mature neurons, thereby ad-
justing the proper connectivity.
In a second approach, thy1-EphB2-C1-EYFP transgenic mice were generated to gain insights
into the in vivo behaviour of these fluorescently tagged proteins and to have a closer look in
the dynamics and cluster behaviour of EphB2 receptors during synaptogenesis and in spines
of more mature neurons. Contrary to our expectations, both the fluorescent intensities and
the distribution of the EphB2-C1-EYFP proteins in these transgenic mice were not bright nor
sparse enough for conclusive imaging experiments.
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The human brain is a complex structure. It consists of trillions of cells, about roughly 1012
cells are nerve cells (neurons) and at least 1013 cells are glial cells (Haydon, 2001). These cells
are interconnected and build up the complex brain architecture. The neuronal network is su-
perbly organized in brain areas that construct our perceptions of the external world, fix our
attention and control the machinery of our actions. These brain structures and regions have
to develop a correct cellular organization and synaptic connectivity. During embryonic de-
velopment of the nervous system, precursor cells produce through extensive cell proliferation
postmitotic neurons and glial progenitor cells. These cells then migrate to build the different
brain structures. An important next step is the correct wiring and the establishment of proper
interconnections of these neurons among and within different brain areas. To archieve this,
neurons extend axons tipped with growth cones that explore the enviroment, navigate along
specific pathways, recognize their appropriate targets and then form synaptic connections by
elaborating terminal arbors. Growth cone navigation is controlled by long- and short-range
attractive and repulsive guidance cues. Upon arrival at the target region, functional synaptic
contacts are rapidely formed. However, this initial connectivity is not rigid, but needs to be
refined throughout early development and also later during adult life.
During our lifetime we experience and learn continuously to adapt to our environment. The
basis behind this is the functional and anatomical modifiability of neuronal connections due
to activity-dependent plasticity. How exactly these cellular events are regulated and which
molecules contribute to it, will be the focus of this study with particular emphasis on the
Eph/ephrin system.
I will first introduce some of the morphological structures and molecular components respon-
sible for synaptic plasticity. I will then describe the Eph receptors and the ephrin ligands and
their bi-directional signalling. Finally, a description of transcytosis and the resulting cell de-
tachment as a possible mechanismen for axon guidance in early development, e.g. through
axon repulsion will be presented.
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4.1. The synapse
Densely packed neuronal and glial cells are interconnected in systems and form a net: the cen-
tral nervous system (CNS) - with over 1015 synaptic and even more extrasynaptic connections.
The CNS is an active assembly of cells that continously receives information, analyzes it, per-
ceives it and makes decisions. In the brain, information is communicated between neurons in
the form of electrical signals. This communication occurs at highly specialized sites of contact
between a presynaptic nerve terminal and a postsynaptic neuron – the synapse.
A typical neuron has four morphologically defined regions: the dendrites, the cell body, the
axon and the presynaptic terminals. The branched dendrites are the main apparatus for re-
ceiving incoming signals from other cells. In contrast, the usually long axon is the main
conducting unit for carrying signals to other neurons or target organs. The information is
transmitted in the form of chemical transmitters released from synaptic vesicles in the presy-
naptic terminal of the axon into the synaptic cleft (v25 nm wide). After rapid diffusion across
the synaptic cleft, the neurotransmitters bind to their specific receptors (transmitter-gated ion
channels) in the postsynaptic membrane of the dendrite, where the message is processed, inte-
grated and propagated. Depending on the kind of transmitter and the ion channel, an electric
signal can cause an inhibitory or excitatory synaptic input in the target cell. The postsynaptic
site of many synapses is specialized in a thorny-like protrusion called a spine (Cajal, 1888).
4.1.1. Glutamate receptors
The amino acid glutamate is the most important and prevalent excitatory neurotransmitter
in the mammalian brain and spinal cord and acts through the binding on different types of
glutamate receptors: the ionotropic receptors and the metabotropic receptors. Ionotropic re-
ceptors form ion channels (glutamate-gated cation channels) and are the most common of all
transmitter-gated channels in the brain. According to their different sensitivities to glutamate
analogues and sequence similarities, they can be divided into three functionally distinct sub-
classes: N-methly-D-aspartate (NMDA) receptors, α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA) receptors and kainate receptors (Hollmann and Heinemann, 1994;
Dingledine et al., 1999). The channels are multimeric complexes composed of a combinatorial
assembly of two to four subunits. These subunits NR1 and NR2A through NR2D are involved
in the formation of NMDA receptors. AMPA receptors are assembled from another set: GluR1
through GluR4 (GluRA-GluRD) and kainate receptors are combinations of the subunits KA1-
KA2 and GluR5-GluR7 (Wisden and Seeburg, 1993; Bettler and Mulle, 1995). The subunit com-
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position of glutamate receptors varies, creating great structural and functional heterogeneity.
This heterogeneity is further increased by alternative splicing and RNA editing. AMPA re-
ceptors in the adult hippocampus are composed of mainly GluR2 with either GluR1 or GluR3
(Wenthold et al., 1996). During postnatal development, NMDA receptor subunit composi-
tion changes from mainly NR1/NR2B to mainly NR1/NR2A, which has a significant effect on
the time course of the NMDA-mediated excitatory postsynaptic potential (EPSC) (Flint et al.,
1997).
Postsynaptic AMPA receptors mediate the majority of the fast excitatory synaptic transmis-
sion in the CNS. Kainate receptors contribute to the postsynaptic responses at some excitatory
synapses (Castillo et al., 1997; Vignes et al., 1998) and can also modulate presynaptic neuro-
transmitter release (Chittajallu et al., 1996; Contractor et al., 2000). These non-NMDA recep-
tors open for Na+ or K+ influx. The postsynaptic NMDA receptors are unique among the
ionotropic channels in that they are in addition voltage-dependent. At resting membrane po-
tentials, NMDA receptors are blocked by extracellular magnesium-ions and are only relieved
from this Mg2+ block when the membrane is depolarized. Thus, both membrane depolariza-
tion and glutamate binding are needed to open the NMDA receptors for Ca2+ influx (= coin-
cidence receptors), which contributes only to the late component of the EPSP. These inflow-
ing calcium-ions can activate downstream calcium-dependent signal transduction processes,
thereby modulating the excitatory synaptic transmission of the neuron. The metabotropic
glutamate receptors link glutamate release to GTP-binding (G) protein-mediated signalling
cascades in the postsynaptic membrane (Pin and Duvoisin, 1995).
4.1.2. The postsynaptic density
Glutamate receptors are an essential component of the postsynaptic density (PSD). Ultrastruc-
tural studies of this disk-shaped postsynaptic membrane undercoat in excitatory synapses
have revealed an electron-dense thickening that marshals more than seventy proteins (Husi
et al., 2000; Walikonis et al., 2000). The PSD has been proposed to be a protein lattice that
localizes and organizes the various ion channels, receptors, scaffold and adaptor proteins, cy-
toskeleton proteins, kinases, phosphatases and other signalling proteins (Pawson and Scott,
1997; Ziff, 1997; Kennedy, 1998). Many of these proteins contain postsynaptic density-95/discs-
large/zona occludens 1 (PDZ)-domains, which are protein-interaction domains that bind to
the PDZ-binding motif usually at the cytoplasmic carboxyl (C-)termini of membrane proteins,
including ionotropic glutamate receptors, Eph receptors, neuroligins, stargazin, thereby clus-
13
4. Introduction
tering and anchoring proteins at high density in the PSD (Doyle et al., 1996; Songyang et al.,
1997; Scannevin and Huganir, 2000; Sheng, 2001). Structurally, proteins in the PSD are in close
proximity to glutamate receptors and other signalling proteins, which allow rapid responses
of the synapse once glutamate has been released (Kennedy, 1998). The PDZ scaffold proteins
are well-positioned to link the postsynaptic membrane with the underlying actin cytoskeleton
and couple spine morphology and actin dynamics to postsynaptic receptor activation (Figure
4.1).
Figure 4.1. Ultrastructure of the synapse. (A) The PSDs (red asterisks) of chemical synapses are darkly
stained and are in contrast with all other, much lighter structures in the mouse neocortex. Scale bar =
1 µm. (Ref. http://synapses.mcg.edu/atlas/1_6_1.stm) (B) Electron micrograph of a synapse between an
axon terminal (AR) and a dendritic spine (D) with polyribosomes (red arrow) and microtubules (blue arrows)
present in the subsynaptic cytoplasm. The presynapse contains numerous synaptic vesicles. The PSD is vis-
ible as a thick membrane undercoat postsynaptically in the rat hippocampus. Scale bar = 200 nm. (Ref.
http://synapses.mcg.edu/atlas/1_6_37.stm)
The best characterized of the PDZ scaffold proteins is postsynaptic density-95 (PSD-95) pro-
tein, an abundant component of the PSD. This multidomaine scaffold protein is capable of
forming a macromolecular signalling complex by binding to subunits of the NMDA receptor
and other molecules (Scannevin and Huganir, 2000; Sheng, 2001). Overexpression of PSD-95
promotes spine growth in cultures (El-Husseini et al., 2000) and potentiates AMPA receptor-
mediated EPSCs in brain slices (Béïque and Andrade, 2003; Stein et al., 2003; Ehrlich and
Malinow, 2004). The synaptic potentiation induced by the ectopical expression of PSD-95 in
brain slices seems to mimic long-term potentiation (LTP), in that it converts silent synapses
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into functional synapses, drives GluR1 into synapses, occludes LTP and enhances long-term
depression (LTD) (Béïque and Andrade, 2003; Stein et al., 2003; Ehrlich and Malinow, 2004).
Another class of proteins included in the postsynaptic membrane are the cell-adhesion pro-
teins (CAMs), such as cadherins, syndecans and neuroligins. The transmembrane CAMs are
needed for the formation and maintenance of the synaptic junction through interaction with
their presynaptically expressed partners via their extracellular domains.
4.2. Synaptic plasticity
Certain excitatory synapses in the brain can dynamically regulate their strength and structure
in response to afferent activity. This property, also called synaptic plasticity, is believed to
underlie a variety of neuronal processes, such as brain development, learning and memory
(Bliss and Collingridge, 1993). The most widely studied examples of synaptic plasticity are
LTP and LTD in the hippocampus.
The hippocampus has three major afferent pathways: The perforant fiber pathway from the
entorhinal cortex forms connections with the granule cells of the dentate gyrus (DG). The
granule cells send axons that form the mossy fiber pathway, which synapse on the pyramidal
cells in the Cornu ammonis 3 (CA3) region of the hippocampus. The pyramidal cells of the
Figure 4.2. Long-term potentiation in the hippocampus. (A) Schematic view of a hippocampal slice showing
the perforant fibers from the subiculum, which forms excitatory connections with the granule cells of the dentate
gyrus. The mossy fiber axons synapse on pyramidal cells in area CA3 of the hippocampus. The Schaffer collateral
fiber pathway connects the pyramidal cells of the CA3 region with the pyramidal cells in the CA1 region. LTP
occurs at each of the three major synaptic pathways in the hippocampus. (B) Thetaburst stimulation (TBS) of the
Schaffer collateral pathway causes an increase in the amplitude of the synaptic response recorded in CA1 neurons,
lasting for up to several hours in vitro.
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CA3 regions send excitatory Schaffer collaterals to the pyramidal neurons in the CA1 region
of the hippocampus (Freund and Buzsáki, 1996). LTP has been studied most extensively at
the Schaffer collateral pathway to the CA1 region in hippocampal slices, which was also the
focus for the experiments in this work (Figure 4.2A).
The first description of LTP was in 1973, when Bliss and Lømo (Bliss and Lomo, 1973) showed
that brief repetitive activation of hippocampal excitatory synapses causes a persistent en-
hancement in synaptic strength for several hours or, under some circumstances, for days or
weeks. They called this facilitation LTP. LTP in the Schaffer collateral and perforant pathway
is associative and requires simultaneous firing in postsynaptic and presynaptic neurons, sup-
porting Hebb’s theory: In 1949, the psychologist Donald O. Hebb proposed that synapses are
strengthened when pre- and postsynaptic elements are synchronously active (Hebb, 1949).
LTP can be subdivided temporally in early LTP (E-LTP), lasting for 1-3 hours and late LTP
(L-LTP) that lasts for at least 6-8 hours. E-LTP does not involve de novo protein synthesis, in
contrast to the L-LTP, for which protein synthesis is an important component (Figure 4.2B)
(Kandel, 2001).
At most central synapses, activation of NMDA receptor and subsequent Ca2+ influx into the
postsynaptic cell are critical for the induction of synaptic plasticity. The NMDA receptor an-
tagonist 2-amino-5-phosphonovaleric acid (APV) can block LTP and LTD of the CA1 region
of the hippocampus (Collingridge et al., 1983; Fujii et al., 1991; Mulkey and Malenka, 1992).
Interestingly, following LTP induction most studies demonstrate a selective increase in the
AMPA receptor EPSPs and little change in NMDA receptor EPSPs (Kauer et al., 1988; Muller
and Lynch, 1988). In addition, AMPA receptors can be inserted into the postsynaptic site in
an activity-dependent manner (Shi et al., 2001). Taken together, these data show that poten-
tiation or strengthening of excitatory synapses is associated with the specific recruitment and
insertion of AMPA receptors from intracellular pools into the postsynaptic membrane (Lledo
et al., 1998; Shi et al., 1999). Similarly, frequent activation that causes synaptic depression or
weakening of synaptic strength is correlated with AMPA receptor endocytosis from the post-
synaptic membrane (Daw et al., 2000; Man et al., 2000). In most cases, the insertion and re-
moval of AMPA receptors (= trafficking) is triggered by Ca2+ influx through NMDA receptors.
Therefore, AMPA receptors are suggested to be responsible for mediating synaptic plasticity,
whereas NMDA receptors are controlling plasticity (Montgomery and Madison, 2004).
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4.3. Glial cells
Glial cells are divided into two major classes: microglia, which are phagocytes and macroglia
composed of oligodendrocytes, Schwann cells and astrocytes. Oligodendrocytes and Schwann
cells are responsible for the myelination in the central and peripheral nervous system, respec-
tively. Astrocytes are the most numerous glial cell type and account for nearly one-half of the
cells in a human brain (Peters et al., 1991; Laming et al., 1998). Morphologically, astrocytes are
in close association with neurons and have extensive contacts with endothelial cells (Simard
et al., 2003). Each hippocampal astrocyte in the mouse brain defines a territory that is free of
processes from neighbouring astrocytes and only the most peripheral processes overlap with
one another (less then 5%) (Ogata and Kosaka, 2002). Originally, these little cells were thought
to be passive glue that connects and supports neurons. During the last decade, however, there
has been mounting evidence that neuroglial cells are important modulators of synaptic trans-
mission (Nedergaard et al., 2003).
Figure 4.3. Astrocytes as regulators of synaptic activity, synaptogenesis and neurogenesis. Astrocytes transmit
signals to neurons that can directly modulate synaptic strength in the CNS by releasing glutamine, for instance
(illustrated here by an increase in spontaneous excitatory postsynaptic currents). Moreover, astrocytes are potent
inducers of synaptogenesis and crucial for maturation of synapses. In addition, astrocytes are involved in the
regulation of neurogenesis from endogenous progenitor populations, at least in the dentate gyrus of adult rats
(scheme taken from Nedergaard et al. (2003)).
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4.3.1. Properties and functions of neuroglial cells
Astrocytic processes intimately associate with synapses, the ideal place to synchronize neu-
ronal network activity. Many synapses in the brain are ensheathed by astrocytes and it has
been estimated that an individual astrocyte in the adult rodent brain may surround and inter-
act with as many as 10,000 synapses (Bushong et al., 2003, 2004).
One of the functions of the ensheating glial cell is to clear neuronal waste, including metabolic
byproducts and released neurotransmitters (e.g. glutamate) during synaptic transmission.
Most synapses lack extracellular enzymes for glutamate inactivation and therefore the rapid
reuptake of this transmitter from the synaptic cleft via glutamate transporters with fast kinet-
ics is very important (Bergles et al., 1999; Danbolt, 2001). The fast uptake by perisynaptic glia
is crucial to terminate the postsynaptic response and prevent excitotoxicity by excess gluta-
mate. It also enhances spatial specificity of signalling and partially shields synapses from each
other by preventing glutamate spillover.
In the absence of glia, neurons in culture form few and functionally immature synapses. Co-
cultures with astrocytes or glia-conditioned medium, increase the number of synapses and en-
hance synaptic efficacy (Pfrieger and Barres, 1997; Ullian et al., 2001). Glia secrete molecules,
such as cholesterol and tumour necrosis factor-α (TNF-α) that are crucial for synaptogenesis
and maturation of synapses. Cholesterol is a component of lipid rafts, which are important
for the formation and stability of neuronal synapses (Hering et al., 2003) and TNF-α enhances
synaptic efficacy by increasing the surface expression of AMPA receptors in neurons (Beattie
et al., 2002).
Recent studies demonstrated that there is a dynamic bi-directional communication between
glia and neurons at this tripartite synapse. Release of neurotransmitter from the presynaptic
terminal also stimulates the perisynaptic glial cell via metabotropic glutamate receptors. The
activated glial cell, in turn releases gliotransmitter (e.g. glutamine) from vesicles by a calcium-
dependent mechanism that can directly stimulate the postsynaptic neuron and can feed back
to the presynaptic terminal to either enhance or depress further release of neurotransmitters
(Volterra et al., 2002). Thus, surrounding astrocytes function as active partners by transmitting
signals to neurons, through which synaptic strength in the hippocampus, cortex and thalamus
is directly modulated (Kang et al., 1998; Haydon, 2001; Newman, 2003). In addition, astrocytes
return the released glutamate in the form of glutamine to neurons. Neuronal reuptake of glu-
tamine seems to be important because continued release of glutamate depends on astrocytic
glutamine synthetase activity (Norenberg and Martinez-Hernandez, 1979; Pow and Robinson,
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1994; Laake et al., 1995). In contrast to astrocytes, neurons lack the enzyme pyruvate carboxy-
lase and therefore cannot perform net synthesis of glutamate from glucose but can hydrolyze
glutamine to form glutamate (Yu et al., 1983; Shank et al., 1985; Waagepetersen et al., 2001).
Interestingly, recent work in the larvae brain of Drosophila melanogaster demonstrated that
neuron-glia signalling triggered by the steroid hormone ecdysone is required to actively re-
cruit glia to the appropriate axonal segments for the selective pruning process. Processes of
the surrounding glia first infiltrate bundles of larval axon branches and then engulf clusters
of axonal varicosities – interpreted to be synaptic boutons – prior to their degeneration. At
the time of axonal pruning, glial cells remove axon branches by phagocytosis and accumulate
acidic degenerative organelles (Awasaki and Ito, 2004; Watts et al., 2004).
In addition, astrocytes are involved in the maintenance of the blood-brain barrier, as well as in
the regulation of neurogenesis from endogenous progenitor populations (Horner and Palmer,
2003). Thus, the multitask functions of astrocytes are essential for higher brain function (Fig-
ure 4.3).
4.4. Eph receptors and their ephrin ligands
Eph receptors and their ligands are found in a wide variety of cell types in developing and ma-
ture tissue with reciprocal or overlapping expression patterns. In case of the complementary
expression of interacting Eph receptors and ephrins, the activation occurs at the interface of
their expression domains (Gale et al., 1996). Due to the nature of the membrane-anchored lig-
ands, the interactions between Eph receptors and ephrins activate a bi-directional signalling
cascade transducing the signal in the Eph-receptor expressing cell as well as in the ephrin-
expressing cell. Therefore, the Eph/ephrin interaction mediates a cell-to-cell communication
that has important roles in the establishment of neuronal and vascular networks during em-
bryonic development, which involves diverse processes like (neuronal) cell migration, axon
guidance, (neo-)angiogenesis and tissue patterning (e.g. topographic mapping, segmental
patterning) (Palmer and Klein, 2003).
The findings from the last years are changing the conventional view of these proteins to func-
tion predominantly in a developmental context (Dalva et al., 2000; Ethell et al., 2001; Grun-
wald et al., 2001; Henderson et al., 2001; Contractor et al., 2002; Takasu et al., 2002; Henke-
meyer et al., 2003; Penzes et al., 2003; Grunwald et al., 2004). The new essential function of
these molecules lies in the regulation of structural and physiological functions of excitatory
synapses through multiple mechanisms in the adult brain. Besides, they have been found
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to be involved in nerve generation, cancer progression and pathological angiogenesis in the
adult (Palmer and Klein, 2003).
Figure 4.4. The Eph class of receptor tyrosine kinases and their ligands. Eph receptors can be subdivided accord-
ing to their binding affinities to their ephrin ligands and to sequence similarities. The B-subclass (in mammals:
EphB1-B4, EphB6) binds preferentially to ephrinB1-B3, whereas EphA receptors bind promiscuously to ephrinA1-
A5. There are two exceptions to this subclass discrimination: (i) EphA4 receptors can bind to ephrinAs as well as
to ephrinB2 and -B3 and (ii) EphB2 can also interact with ephrinA5.
4.4.1. The Eph class of receptor tyrosine kinases
In 1987, the first member of the Eph receptors, EphA1, was identified in a screen for tyro-
sine kinases involved in cancer (Hirai et al., 1987). This new receptor was named Eph, after
“erythropoietin-producing human hepatocellular” carcinoma cell line from which its cDNA
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was isolated. The Eph receptors form the largest known subfamily of receptor tyrosine kinases
(RTKs) (Orioli and Klein, 1997; Flanagan and Vanderhaeghen, 1998). Today, it is known that
vertebrates have at least 14 members (van der Geer et al., 1994; Murai and Pasquale, 2004)
that are related to Eph receptors by sequence and by general characteristics of their kinase
and extracellular domain (Holder and Klein, 1999). Invertebrates like the fruitfly Drosophila
melanogaster and the nematode Caenorhabditis elegans have only a single Eph receptor: Vab-
1 and Dek, respectively (George et al., 1998; Scully et al., 1999). Thus, the diversity in this
subfamily of RTKs among vertebrates must have arisen through more recent gene duplica-
tions and this might also explain the high degree of functional overlap between family mem-
bers and interspecies homologous from quite distantly related organisms, like humans and
zebrafish (Oates et al., 1999; Kullander and Klein, 2002). Based on sequence similarity and lig-
and affinity mammalian Eph receptors can be divided into an A-subclass, which contains eight
members (EphA1-A8) and a B-subclass, which consists of five members (EphB1-B4, EphB6).
Chicken expresses an additional EphB receptor, EphB5 (Wilkinson, 2001). Binding specificity
within a subclass is low. There are two preferred binding specificity subclasses: EphA recep-
tors (EphA1-A8) bind promiscuously to the glycosylphosphatidlylinositol(GPI)-linked A-type
ephrins (ephrinA1-A5), whereas EphB1 to EphB3 receptors bind to the transmembrane B-type
ephrins (ephrinB1-B3). In contrast to this A- or B-subclass discrimination: EphA4 receptor has
also been found to bind ephrinB2 (Flanagan and Vanderhaeghen, 1998) and ephrinB3 (Gale
et al., 1996). Additionally, a recent study showed EphB2 receptors to interact with ephrinA5
(Figure 4.4)(Himanen et al., 2004). In addition, there are also Eph receptors with less or no
binding specificity: EphB5 does not bind any of the known ephrins. Suggesting that there
might be other ligands for the Eph receptors. Finally, EphB4 can be only activated by ephrinB2
binding (Brambilla et al., 1995; Gerety et al., 1999).
4.4.2. Ephrin ligands
Identification of the ligands lagged several years behind that of the receptors. In 1994, soluble
receptor affinity methods were used to identify the first Eph ligands, namely the ephrins (eph-
rinA1) (Bartley et al., 1994). The name ephrin derived from Eph receptor interacting protein
or from the ancient Greek word ephoros, meaning an overseer or controller (Eph Nomenclature
Committee, 1997). Homologues of ephrin ligands have been identified in vertebrate and inver-
tebrate. The nine ephrins in vertebrates have been subdivided into an A-subclass (ephrinA1-
A5) and B-subclass (ephrinB1-B3), according to their affinities for each other, sequence con-
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servation and the mode of ephrin membrane attachment (Gale et al., 1996; Eph Nomenclature
Committee, 1997).
EphrinA ligands are tethered to the cell surface by a GPI-anchor, whereas ephrinB ligands
are single pass transmembrane proteins, which possess a short cytoplasmic region. In in-
vertebrates the nematode Caenorhabditis elegans has four GPI-anchored ephrin genes (EFN1-
4)(Chin-Sang et al., 1999; Wang et al., 1999), whereas the fruitfly Drosophila melanogaster has
only one gene encoding for ephrin (Dephrin) (Dai, 1999; Bossing and Brand, 2002). Dephrin
has unusual structural features compared to other ephrins. Although the amino (N-)terminal
part of the ligand shares similarities with vertebrate ephrins, the Dephrin encoding sequence
instead predicts three transmembrane domains and a cytoplasmic part with some sequence
similarity to vertebrate ephrinBs (Bossing and Brand, 2002).
4.4.3. Structure of Eph RTKs and ephrin ligands
4.4.3.1. Receptor structure
The extracellular region of the transmembrane Eph receptors consists of a N-terminal ligand-
binding globular domain (v180 amino acids (aa)), adjacent to a cysteine-rich epidermal growth
factor(EGF)-like region, which is followed by two fibronectin type III (FNIII) repeats (Figure
4.5). One FNIII repeat (v90 aa) is a long stretch that is repeated 15-17 times in the fibronectin
protein. It is a common motif in many cell-surface proteins.
The single transmembrane spanning region is followed by the cytoplasmic part, which can
be divided into four functional units: the juxtamembrane region that contains two conserved
tyrosine (Y) residues, a classical protein tyrosine kinase (TK) domain, a sterile α-motif (SAM)
and a postsynaptic PDZ-domain binding motif. The TK domain catalyses phosphoryl trans-
fer from adenosine 5’-triphosphate (ATP) to tyrosine residues in protein substrates. The aa
of the SAM domain are roughly conserved and are thought to participate in protein-protein
interactions forming dimers or oligomers. Another protein-protein interaction motif – the
PDZ-binding motif – are the C-terminal 4-5 aa residues containing a consensus binding se-
quence that includes a hydrophobic residue (usually valine or isoleucine) at the very carboxyl
terminus. This C-terminal PDZ-domain target site might bind scaffolding proteins.
4.4.3.2. Ligand structure
Ephrins are characterized by the presence of a unique N-terminal receptor-binding domain,
which is separated from the membrane via a linker of v40 aa. EphrinA ligands are attached
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to the exoplasmic leaflet of the cell membrane by a GPI-anchor, whereas B-subclass ephrins
possess a single-pass transmembrane helix, followed by a short but highly conserved 83-90 aa
cytoplasmic region containing 5-6 conserved tyrosine residues and a C-terminal PDZ-binding
motif (Figure 4.5).
Figure 4.5. Domain structure of Eph receptor and ephrin ligands. The transmembrane EphA/B receptors are mul-
tidomain RTKs and consist of an N-terminal ephrin-binding domain, followed by two fibronectin-type III repeats
and a transmembrane region (TM). Intracellularly, the juxtamembrane region, containing two important tyrosine
residues (Y), is followed by a tyrosine kinase domain, a SAM domain and a PDZ-domain binding site. The GPI-
anchored ephrinAs are composed only of a N-terminal receptor-binding domain, whereas the transmembrane
ephrinB ligands have a cytoplasmic domain with conserved tyrosine phosphorylation sites (Y) and a C-terminal
PDZ-domain binding motif.
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4.4.4. Bi-directional signalling between Eph receptor and ephrin ligands
Unlike most RTKs that bind their cognate soluble ligands, the Eph receptor family mem-
bers are activated through the binding of membrane-bound proteins. Therefore, interac-
tion between receptor and ligand requires cell-to-cell contact (trans-interaction), which makes
Eph/ephrin ideal signalling molecules in developmental processes, such as boundary forma-
tion and axon guidance (Holland 1998). This trans-interaction leads to multimerization of both
receptor and ligand to distinct clusters in their respective plasma membrane. This initiates a
so-called bi-directional signalling cascade where the Eph receptor TK domain transduces the
forward signal into the Eph-expressing cell and the ephrin transduces the reverse signal into
the other cell, acting each as both “receptor” and “ligand” simultaneously (Figure 4.6A-B).
The outcome of the activation of the bi-directional signal-transduction cascade can differ de-
pending on the subclass-expression of Eph/ephrin and from the cell types. As an example, a
repulsion of neighbouring cells or growth cones can follow. In a few cases, the activation lead
to an increased attraction. In molecular terms, many signalling pathways that are downstream
of Eph/ephrin converge to regulate the cytoskeleton.
4.4.4.1. Binding and activation of Eph/ephrins
Prior to cell-to-cell contact, unbound ephrins and Eph receptors may form low-affinity ho-
modimers at the surface (Toth et al., 2001; Himanen and Nikolov, 2003), probably in lipid rafts
(Brückner et al., 1999). It is thought that cell-to-cell contact leads to a repositioning of these
homodimers so that ligands and receptors bind each other with a 1:1 stoichiometry in large
aggregates known as patches (Figure 4.6D-E).
So far, the clustering mechanism has been revealed by structural studies of the complex formed
between the ligand-binding globular domain of EphB2 and the complete extracellular part of
ephrinB2 (Himanen et al., 2001). Structural information on the ephrin-binding globular do-
main obtained from the EphB2-ephrinB2 complex reveals two distinct ephrin-binding sites
located on opposite sides of the domain. These sites interact with separate regions of dis-
tinct ephrinB2 molecules with different affinities. Biophysical studies in solution indicate that
EphB2 interacts with EphrinB2 in a two-step process: in the first step, one receptor and one
ligand bind with high affinity and specificity to form a heterodimer dominated by the inser-
tion of an extended ephrin loop into a channel of the globular domain. In the next step, these
heterodimers interact with each other through a lower affinity interaction to form ring-like
tetramers, in which each receptor interacts with two ephrins and vice versa (Figure 4.6D). In
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these complexes the Eph/ephrin proteins are precisely positioned and orientated, promot-
ing higher-order aggregates that are believed to initiate the bi-directional signalling cascade
(Figure 4.6C, E)(Kullander and Klein, 2002; Murai and Pasquale, 2003). In the high-order clus-
tering, other Eph/ephrin domains are probably involved, like the SAM domain (Stapleton
et al., 1999; Thanos et al., 1999) and the cysteine-rich region of the receptors (Lackmann et al.,
1998), as well as the C-terminal PDZ-domain binding site from Eph receptors and ephrinB
ligands (Hock et al., 1998b; Torres et al., 1998; Brückner et al., 1999; Buchert et al., 1999; Lin
et al., 1999; Cowan et al., 2000).
Figure 4.6. Mechanism of Eph receptor activation and the initiation of bi-directional signalling. A Prior to
cell contact, Eph receptors and ephrins are inactive. The unbound Eph receptor is in a close conformation held
by a fold in the juxtamembrane region. (B) Cell-to-cell contact induces dimerization of receptor and ligand. The
cytoplasmic tails of the Eph receptors are now juxtaposed, which facilitates trans-phosphorylation by basal activity
of tyrosine residues (grey circles). Phosphorylation of the activation loop within the kinase domain stimulates
kinase activity. Phosphorylated tyrosines (pYs) causes changes in the structure of the ephrinB cytoplasmic tail and
the Eph receptor juxtamembrane domain, thus relieving inhibitory constraints on the kinase domain. (C) Eph-
ephrin binding results in high-order clustering by the lateral aggregation of multiple Eph-ephrin complexes. The
pYs provide binding sites for many signalling and adaptor proteins, thereby inducing (i) forward (F) signalling
into the Eph-expressing cell or (ii) reverse (R) signalling into the ephrin-expressing cell or bi-directional signalling
into both cells. (D) Dimerization and tetramerization interfaces of the tetrameric complex of ephrins (blue) and
Eph receptors (red). One ephrin-binding domain of a receptor and one Eph-binding domain of a ligand initially
form a high-affinity heterodimer dominated by the insertion of an extended ephrin loop into a channel of the
globular domain (black arrows). Two heterodimers then join to form a tetramer through a lower affinity interaction
(grey arrows), in which each ligand interacts with two receptors. (E) Possible high-order side-by-side clustering
of the ring-like tetrameric Eph/ephrin complexes might occur via the SAM domains in the receptors and the
C-terminal PDZ-domain binding-sites in ephrins (grey arrows) and Ephs (black arrows).
25
4. Introduction
4.4.4.2. Mechanisms of Eph receptor forward signalling
The catalytic activity of RTKs is tightly regulated by several mechanisms because it controls
crucial cellular events, including growth, differentiation, migration, metabolism and survival
(Himanen and Nikolov, 2003; Hubbard, 2004). In the absence of ligand binding, Eph recep-
tors, like all RTKs, are either monomeric or dimeric on the cell surface and in an inactive state.
Binding of ephrin induces stabilization and clustering of Eph receptors, thereby allowing the
receptor kinase domain to trans-phosphorylate the tyrosine residues in the cytoplasmatic tail
of the neighbouring receptor through the spacial proximity (Figure 4.6A-B)(Schlessinger, 2000;
Ullrich and Schlessinger, 1990). Cis-phosphorylation might occur, but it is believed to be also a
downstream event of the ligand-binding. The activation of Eph receptors leads to phosphory-
lation of ten or more specific tyrosine residues in the cytoplasmic domain (Kalo and Pasquale,
1999), several of which are involved in the upregulation of TK activity (Choi and Park, 1999;
Binns et al., 2000; Zisch et al., 2000).
The most general mechanism for stimulating kinase activity involves the phosphorylation of
the so-called activation loop within the kinase domain, which in its non-phosphorylated form
blocks the kinase active site (Johnson et al., 1996). In addition, for a subset of RTKs like Eph,
the highly conserved juxtamembrane region is known to negatively regulate the catalytic ac-
tivity of the TK. The EphB2 crystal structure of the intracellular region reveals that the kinase
domain is auto-inhibited by the non-phosphorylated juxtamembrane region (Wybenga-Groot
et al., 2001). Trans-phosphorylation of the two juxtamembrane tyrosine residues is thought to
destabilize the autoinhibitory conformation of the juxtamembrane region because steric and
electrostatic forces push the phosphorylated juxtamembrane region away from the kinase do-
main, leading to upregulation of TK activity (Figure 4.6) (Wybenga-Groot et al., 2001). The
exposed phosphorylated juxtamembrane tyrosine residues now become available for the re-
cruitment to the cell membrane of many different downstream signalling proteins bearing src
homology-2 (SH2) domains, resulting in the assembly of signalling complexes, which initi-
ate intracellular signal transduction cascades (Figure 4.6-7). At least four phosphotyrosines
in the Eph receptor serve as docking sites for a number of SH2-domain containing proteins,
including Ras-GTPase activation protein (RasGAP), the src family kinases (SFKs) Src and Fyn,
non-receptor TKs Abl-related gene (Arg) and Abelson (Abl), low molecular weight phospho-
tyrosine phosphatase (LMW-PTP), phospholipase Cγ, phosphatidylinositol 3-kinase (PI3K),
SH2 domain-containing Eph receptor-binding protein 1 (SHEP1) and adaptor proteins Src-like
adaptor protein (SLAP), growth-factor receptor bound 2 (Grb2), Grb10, Crk and noncatalytic
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region of tyrosine kinase (Nck) (Krull et al., 1997; Zisch and Pasquale, 1997; Gao et al., 1998a).
Furthermore, PDZ binding motifs at the C-terminus of the Eph receptors bind to PDZ-domain
containing proteins such as Acute myeloid leukemia-1/chromosome 6 fusion protein/afadin-
6 (AF6), a receptor-like tyrosine kinase (Ryk) receptor TK interacting protein, protein inter-
acting with C kinase (Pick) 1, Syntenin, a syndecan-interacting protein and two glutamate
receptor interacting proteins 1 (GRIP1) and GRIP2 (Hock et al., 1998a,b; Torres et al., 1998;
Brückner et al., 1999; Kullander and Klein, 2002).
Two conserved tyrosine residues of the EphB receptors are not present in EphA receptors. This
may be important for the EphA and EphB receptors to trigger distinct responses. For example,
during the establishment of visual system topography, EphA receptors mediate axon repul-
sion, whereas EphB receptors appear to provide a stop signal to the growth cone (Hindges
et al., 2002; Mann et al., 2002).
In many cell types a unique feature of Ephs among the family of RTKs is their inability to me-
diate signals leading to proliferation and differentiation (Klein, 2001; Miao et al., 2001). One
recent study could show that EphA receptors direct the differentiation through a mitogen-
activated protein kinase (MAPK)-dependent pathway in mammalian neuronal precursor cells
(Aoki et al., 2004). Many of the signalling proteins identified in the Eph signalling pathways,
are known to be involved in the regulation of the cell attachment, shape and mobility.
Cytoskeletal regulation
Cell migration and adhesion require a dynamic reorganization of the actin cytoskeleton. An
important regulator of the actin cytoskeleton is the Rho family of small GTPases, which in-
cludes Rho, Rac and Cdc42 (Hall and Nobes, 2000). Activated Rho promotes stress fiber for-
mation and growth cone collapse, whereas activated Rac and Cdc42 mediate the extension
of filopodia and lamellopodia formation, respectively. The activity of Rho family GTPases
is controlled by guanine nucleotide exchange factors (GEFs) that promote the exchange from
guanosine diphosphate (GDP) to GTP. The identification of the novel Rho GEF Eph-interacting
exchange factor (Ephexin) provided a direct link between EphA receptors and Rho family GT-
Pases (Figure 4.7)(Shamah et al., 2001). Ephexin is preferentially expressed in the nervous
system and interacts directly with the kinase domain of EphA4. EphrinA-mediated activa-
tion of Eph receptors activates Rho on the one hand and inhibits Rac and Cdc42 on the other
hand, shifting the actin dynamics to increased contraction and reduced extension. Expression
of dominant-negative form of Ephexin and the use of specific inhibitors of Rho GTPases in-
hibit or reduce ephrinA-induced growth-cone collapse, respectively (Wahl et al., 2000; Shamah
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Figure 4.7. Molecular mechanisms of cytoskeletal regulation downstream of EphA forward signalling. Activa-
tion of EphA receptors by ephrinA binding leads to the recruitment and activation of SFKs (Src and Fyn) to the
juxtamembrane tyrosines. SFKs regulate cytoskeleton dynamics, which may be required for growth cone collapse.
Activation of the cytoplasmic tyrosine kinases Abl promotes neurite outgrowth, which is inhibited by Eph receptor
activation. The recruitment of RasGAP inhibits the extracellular-signal regulated kinase (ERK)/MAPK pathway,
which reduces its impact on actin cytoskeleton motility and might be the reason for the missing proliferative re-
sponse following Eph receptor activation. The Rho guanine nucleotide exchange factor Ephexin shifts the balance
of Rho family GTPase activity towards Rho thereby inducing growth cone collapse.
et al., 2001).
Other known downstream targets of Eph receptors, such as Abl and Src kinases, are regula-
tors of the actin cytoskeleton and might also contribute to Eph-mediated actin reorganization
(Zisch et al., 1998; Yu et al., 2001; Takasu et al., 2002; Battaglia et al., 2003). The non-receptor
TKs, Abl and Arg, were identified as new binding partners of EphB2 and EphA4 in a yeast-
two hybrid screen and interact with EphB2 independently of phosphorylation through their
C-terminal tail and to tyrosine phosphorylated motifs of EphB2 through their SH2 domain
(Yu et al., 2001). A third interaction between Abl and Eph requires tyrosine phosphorylated
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EphB2 and is probably mediated by a SKF, as these are known to regulate Abl kinase activity
(Plattner et al., 1999) and are well-characterized interactors with Eph receptors (Zisch et al.,
1998). Abl and Ephs are localized in the neuronal growth cone. Activation of endogenous
EphB2 receptors through stimulation with ephrinB1 decreases Abl kinase activity in a neu-
ronal cell line (Yu et al., 2001). In contrast, activation of Abl in cultured neurons promotes
neurite outgrowth (Zukerberg et al., 2000). These findings are consistent with the known op-
posite effects of these kinases on neurite outgrowth and providing a conceivable explanation
of why Abl promotes neurite outgrowth and activated Eph receptor growth cone collapse.
4.4.4.3. Signal transduction through ephrin reverse signalling
Eph receptor binding leads to clustering and activation of the membrane attached ephrinA
or ephrinB, which enable ephrins to transduce signals into the cell, resulting in a cellular
response (Henkemeyer et al., 1996; Holland et al., 1996; Brückner et al., 1997; Davy et al., 1999;
Wang et al., 1999; Davy and Robbins, 2000). But so far, little is known about the signal pathway
that act downstream of ephrin ligands.
EphrinB
In case of the ephrinB proteins, activation leads to phosphorylation of the conserved tyrosine
residues in the cytoplasmic domains by the cytoplasmic SFK Src (Holland et al., 1996; Brück-
ner et al., 1997; Palmer et al., 2002), thereby generating docking sites for SH2-containing adap-
tor proteins such as Grb4 (Cowan and Henkemeyer, 2001). Grb4 (Nck2) is a SH2-SH3 adaptor
protein, which was the first identified interactor in a modified yeast two-hybrid screen of
tyrosine-phosphorylated ephrinBs (Cowan and Henkemeyer, 2001). The Grb4 SH3 domains
can bind to several polyproline-containing proteins, including Abl interacting protein-1 (Abi-
1), axin, a scaffold protein in the Wnt signalling pathway and c-Cbl associated protein (CAP).
These and other Grb4 binding adaptors could function as potential links to modify cell mor-
phology through reorganization of the actin cytoskeleton, but a role in synapses has not been
discovered. Activation of cells overexpressing ephrinB1 increases focal adhesion kinase (FAK)
activity, thereby recruiting the FAK-binding protein Paxillin from the plasma membrane, caus-
ing reduction of actin stress fibers and disassembly of integrin-mediated focal adhesion, even-
tually resulting in a detachment of the cells from the substratum (Figure 4.8) (Cowan and
Henkemeyer, 2001).
The C-terminal PDZ-binding motif (YKV) mediates association with several distinct PDZ-
domain proteins. Some of them, such as GRIP1, GRIP2 and syntenin are adaptor proteins
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Figure 4.8. Summary of ephrinB signal transduction pathway described in the text. Activation of ephrinB leads
to the recruitment and activation of SFKs that phosphorylate the tyrosine residues of ephrinB and concomitant
recruitment of Grb4 and its SH3-binding partners, such as Abl-1, Axin and CAP. These proteins initiate a cascade of
signalling events that regulate cytoskeleton dynamics. Additionally, the phosphorylation of FAK recruits Paxillin
from the cell membrane, thereby inhibiting integrin-mediated focal adhesion. The delayed recruitment of the
phosphatase PTP-BL might cause a switch from the phosphotyrosine- to the PDZ-domain-dependent signalling.
PDZ-RGS3 inhibits cell migration mediated by SDF-1/CXCR4.
that contain only PDZ-domains. Others are linked to a functional subunit, including PDZ-
regulator of heterotrimeric G-protein signalling (PDZ-RGS3), PICK1, pleckstrin-homology-
domain interacting protein/ephrin interacting protein (PHIP) and protein tyrosine
phosphatase-basophil-like (PTP-BL) (Torres et al., 1998; Brückner et al., 1999; Lin et al., 1999;
Lu et al., 2001; Palmer et al., 2002). PTP-BL is recruited to ephrinB membrane clusters with
delayed kinetics, thereby acting as a negative regulator of ephrinB phosphorylation and Src
activity, suggesting a switch from the phosphotyrosine-dependent signalling to the PDZ-
domain-dependent signalling (Palmer et al., 2002).
Like the EphB receptors, ephrinBs can regulate signals downstream of heterotrimeric G-
proteins coupled receptors. PDZ-RGS3, a GTPase-activating protein (GAP) for heterotrimeric
G-proteins (Lu et al., 2001), binds constitutively to the PDZ-binding motif of ephrinB1. Follow-
ing activation of ephrinB1 by EphB2 in cellular granule neurons, PDZ-RGS3 inhibits chemoat-
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traction by the chemokine stromal-cell-derived factor-1 (SDF-1). The chemoattractant SDF-1
activates the serpentine receptor CXCR4. This G-protein coupled receptor acts then as a GTP
exchange protein by inducing the Gα subunit to catalysing the replacement of bound GDP
by GTP, causing a dissociation of the heterotrimeric Gαβγ-protein complex into a Gβγ and a
GTP-Gα subunit. These subunits can then activate downstream effectors. EphrinB reverse sig-
nalling via PDZ-RGS3 interferes with the SDF-1/CXCR4 activation because its RGS domain
promotes the hydrolysis of GTP to GDP by its “GAP” activity, thereby acting as a negative
regulator of the G-protein signalling (Figure 4.8). During cerebellar development, ephrinB1-
activation may mediate inhibition of the chemotactic response of cerebellar granule cells to
SDF-1, contributing to the correct layering of these cells in the cerebellum (Lu et al., 2001).
EphrinA
Although ephrinA ligands lack a cytoplasmic tail, they are still able to mediate signal trans-
duction. Signalling through ephrinA ligands may be mediated by the recruitment of adaptor
proteins. It has been shown that ephrinA are localized to lipid rafts, which contain other
signalling proteins, indicating that ephrinA ligands may activate a number of signalling path-
ways (Huai and Drescher, 2001).
Lipid rafts are small plasma membrane microdomains (∅ 50-100 nm), rich in cholesterol and
sphingolipids. These subcompartments within the plasma membrane are enriched in GPI-
anchored proteins (such as ephrinA), transmembrane proteins (such as ephrinB), as well as
doubly acylated proteins (such as SFKs). Therefore, rafts acts as platforms for the signal trans-
duction and lateral clustering can lead to fusion of dispersed rafts to larger patches, thereby
forming higher order signalling units (Simons and Ikonen, 1997; Brown and London, 1998,
2000; Simons and Toomre, 2000). EphrinAs and ephrinBs are localized to lipid rafts, but in
contrast to the ephrinAs, which are permanently localized to this membrane microdomains,
the localization of ephrinBs critically depends on the cytoplasmic tail and its associated pro-
teins (Brückner et al., 1999; Huai and Drescher, 2001). Clustering of ephrinA5 by the soluble
EphA5 receptor ectodomain recruits and activate the SFK Fyn to lipid rafts (Davy and Rob-
bins, 2000). This is accompanied by tyrosine phosphorylation of a 120 kDa lipid raft protein
and prolonged activation of the MAPK Erk1 and Erk2. At the cellular level, the redistribution
of vinculin, a cytoskeletal protein (binds to actin filaments), to focal adhesion complexes and
increased cell substrate adhesion through β1 integrin is induced by ephrinA activation (Davy
et al., 1999; Davy and Robbins, 2000; Huai and Drescher, 2001). Therefore, ephrinA ligands
are capable of transducing signals that influence actin dynamics, attachment and migration.
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4.4.5. Repulsion and adhesion in cell-to-cell contact
The ephrin/Eph interaction-induced signal transduction generally results in a repulsive re-
sponse after cell-to-cell contact. A growth cone encountering an ephrin-expressing cell via its
Eph receptors, responds with a collapse. At the cellular level, this involves retraction of lamel-
lipodia and filopodia mediated by depolymerization of the actin cytoskeleton. The questions
that remain to be solved are about how the initially high-affinity adhesive interaction between
ephrins/Ephs turned into a repulsive effect. Recent data by our group and others are now pro-
viding two possible answers: first, the proteolytical cleavage of ephrinA by a metalloprotease
and second, the regulated receptor-ligand internalization from juxtaposed cell surfaces (Hat-
tori et al., 2000; Mann et al., 2003; Marston et al., 2003; Zimmer et al., 2003). Thus, signalling
and adhesive forces generated by binding of ephrins to Eph receptors can be modulated by
ephrin cleavage or Eph receptor-ephrin internalization.
4.4.5.1. Cleavage of ephrin ligands
EphrinA reverse signalling may be modulated through its constitutive association with the
metalloprotease A-Disintegrin-And-Metalloprotease (ADAM)-10/Kuzbanian (Kuz). Binding
of EphA-ephrinA activates cleavage of ephrinA by the Kuz protease, thus releasing ephrinA
from the cell surface and allowing the receptor-bearing cell to withdraw (Figure 4.9A) (Hat-
tori et al., 2000). In contrast, EphA receptor expressing axons encounter cells expressing an
ectopically uncleavable form of ephrinA2, causing a great delay in growth cone collapse and
repulsion of the axon in an in vitro assay (Hattori et al., 2000).
The cleavage of endogenous ephrinB ligands by metalloprotease is induced by phorbol ester
treatment, a stimulus that promotes the ectodomain shedding of a variety of transmembrane
proteins. However, ephrinB cleavage upon EphB receptor stimulation is very inefficient in
primary cells and sometimes not detectable (G.A. Wilkinson, R.K., unpublished).
A mechanism to maintain adhesive contacts between ephrinAs and EphAs could be the inhi-
bition of ephrinA cleavage. Interestingly, a splice variant of ephrinA1 – ephrinA1b – has been
found to strongly inhibit the proteolysis of the cleavable form of ephrinA1 after the interaction
with their receptors by coexpression of ephrinA1 and ephrinA1b in human embryonic kidney
(HEK) 293 cells (Finne et al., 2004). It is not clear yet if the cleavage mechanism terminates cell
surface signalling of ephrinA.
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Figure 4.9. Repulsion and adhesion in cell-to-cell contact. (A) An ephrinA-expressing cell comes in close prox-
imity with an EphA receptor-expressing cell (upper panel) and attaches by forming an adhesive complex (middle
panel), thereby initiating signal transduction in the cells. Activation of the ephrinA-associated metalloprotease
Kuzbanian by some of these signals leads to cleavage of the ligand ectodomain, thereby allowing the cells to de-
tach (lower panel). (B) Contact between EphB- and ephrinB-expressing cells leads to bi-directional endocytosis,
preferentially in the EphB-expressing cell (top panel). C-terminal truncation or inactivation of the kinase domain
of the EphB receptor completely inhibits forward endocytosis, but strengthens reverse endocytosis into the ligand-
expressing cell (second panel and third panel). C-terminal truncation of the ligand abolishes reverse endocytosis
but does not affect forward endocytosis (bottom panel).
4.4.5.2. Regulated endocytosis of Eph-ephrin complexes
When Henrietta Lacks (HeLa) cells expressing fluorescently tagged ephrinB1 (enhanced cyan
fluorescent protein, ECFP) were seeded and juxtapositioned next to fluorescently tagged EphB2
(enhanced yellow fluorescent protein, EYFP) expressing cells, clusters of EphBs and ephrinBs
are initially formed locally at site of cell-to-cell contact and EphB2-ephrinB complexes are
rapidly trans-endocytosed bi-directionally into adjacent cells (Figure 4.9B).
This event requires signalling through their respective cytoplasmic domains because ephrinB1
or EphB2 endocytosis can be blocked by C-terminal truncation of ligand and receptor in the
ectopically expressing cell, respectively. For example, when ephrinB1 encounters truncated
EphB2, endocytosis of both proteins occurs only uni-directional into the ephrinB1-expressing
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cell. In addition, the kinase-dead (KD) version of EphB2 could only be transcytosed into the
ephrinB1-expressing cell and also causes abnormal adhesion. Remarkably, the uni-directional
endocytosis of EphB2-expressing cells after interaction with truncated ephrinB1 have a
stronger repulsion response than cells that show bi-directional endocytosis. Interaction be-
tween truncated forms of ephrinB1s and truncated forms of EphB2s are not endocytosed from
juxtaposed cell surfaces into the expressing cells, causing enlarged ephrin-Eph clusters on the
cell surface and resulting in an abnormally prolonged adhesion between the cells (Zimmer
et al., 2003). Therefore, removing Eph-ephrin complexes from the cell surface requires uni-
directional or bi-directional endocytosis, thereby enabling cells to detach and separate from
each other.
Endocytosis has been considered merely as a mechanism for signal termination by downreg-
ulation of the activated receptors such as epidermal growth factor receptors (EGFR) and other
RTKs, at the plasma membrane and their degradation in the lysosomes. However, internal-
ized EGF and nerve growth factor (NGF) receptors are still able to signal (Burke et al., 2001;
Barker et al., 2002). Endocytosed EGFR are phosphorylated and can be sorted to the surface of
the endoplasmatic reticulum, where they become dephosphorylated by the protein tyrosine
phosphatase-1B (PTP1B)(Haj et al., 2002). EphB2s in intracellular vesicles are phosphorylated
(Marston et al., 2003), suggesting that EphB2s may also contribute to signalling after endocy-
tosis.
Both the internalization of the receptor-ligand complex and the subsequent cell retraction
event are dependent on actin-polymerization, which in turn is dependent on Rac signalling
within the receptor-expressing cell. EphrinB-EphB clusters do not colocalize with known
markers of endocytic pathways, such as clathrin and caveolin (Marston et al., 2003; Zimmer
et al., 2003), therefore the underlying mechanism of EphB2 endocytosis may resemble phago-
cytosis (Chimini and Chavrier, 2000) or macropinocytosis (Nichols and Lippincott-Schwartz,
2001).
Full-length ephrinB together with portions of the plasma membrane are transferred into the
EphB4-expressing cell after binding to Eph receptor (Marston et al., 2003). Other proteins,
such as the ion channels could also be removed by the endocytosis of the Eph receptor from
the cell surface, when the Eph-complexes are incorporated into endocytic vesicles containing
plasma membrane fragments, thereby influencing synaptic transmission.
Recent data by Marston et al. (2003) indicate that prolonged cell-to-cell contact may favour for-
ward endocytosis by receptor-expressing cells using Swiss 3T3 and primary endothelial cells
(human umbilical cord venous endothelial cells, HUVECs). Very immature primary neurons
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from mouse forebrain show little forward, but rather pronounced ephrinB reverse endocyto-
sis (Zimmer et al., 2003). Similar results were obtained with primary neurons from embryonic
Xenopus retina when stimulated with soluble ectodomain fusion proteins (Mann et al., 2003).
On the cell biological level, bi-directional transcytosis of two full-length transmembrane pro-
teins is a new phenomenon.
These mechanisms provide conceivable explanations for the differences observed after
Eph-ephrin interactions resulting in either (i) an adhesive effect by inhibiting the endocy-
tosis or by expressing the splice variant of ephrinA1 or (ii) in a repulsive response through
bi-directional endocytosis or the proteolytic cleavage of ephrinAs.
4.5. Eph receptors in the adult brain
In the past few years it has been shown that Eph receptors and their ligands are important
in the adult nervous system, for example during the development of excitatory synapses,
dendritic spine formation, and activity-dependent synaptic plasticity (Dalva et al., 2000; Ethell
et al., 2001; Grunwald et al., 2001; Henderson et al., 2001; Contractor et al., 2002; Irie and
Yamaguchi, 2002; Takasu et al., 2002; Henkemeyer et al., 2003; Penzes et al., 2003; Grunwald
et al., 2004).
4.5.1. Expression patterns of ephrins/Ephs in the adult hippocampus
This work mainly concentrates on EphB2 and its binding partners in the hippocampus and
only their expression patterns will be described. Ephs/ephrins are expressed at high levels
in the embryonic nervous system (Flanagan and Vanderhaeghen, 1998). Many Eph receptors
and their ligands continue to be expressed in the adult brain and Eph receptors can be local-
ized to postsynaptic sites in the hippocampus (Torres et al., 1998; Buchert et al., 1999; Dalva
et al., 2000; Murai and Pasquale, 2003). Interestingly, some Eph receptors change their local-
ization from axonal to dendritic compartments with dendritic maturation (Henderson et al.,
2001). Using immunogold electron microscopy, EphB2, EphB3 and EphA7 receptors are lo-
calize at the postsynaptic densities of the CA1 region in the adult rat hippocampus (Buchert
et al., 1999).
In situ hybridization experiments demonstrated that EphB2 and EphA4 mRNAs are detectable
at high levels in all regions of the hippocampus (Grunwald et al., 2001). While, EphB1 mRNA
is expressed at middle levels in the DG, highly enriched in the CA3 and absent in the CA1
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region; EphB3 mRNA shows a complementary expression pattern: absent in the DG, barely
detectable in CA3 and high levels in CA1 region. EphrinB ligand mRNA is absent or barely
detectable in the CA3 region. EphrinB3 mRNA has prominent levels in the DG and CA1,
whereas ephrinB1 mRNA was found at low levels in the DG. EphrinB2 mRNA expression
was mostly confined to CA1 and weak in the DG (Grunwald et al., 2001). At the CA1-CA3
synapse, mRNAs of EphB2 and EphA4 are most-likely both expressed pre- and postsynapti-
cally, whereas EphB3 is mainly postsynaptic and EphB1 exclusively presynaptic. In addition,
the mRNA of the ligands ephrinB2 and ephrinB3 are expressed mainly if not exclusively at
the postsynapic CA1 site (Grunwald et al., 2001). EphrinA5 is expressed in mature neurons in
the DG (Gao et al., 1998b). Recent evidence suggests that ephrinBs are presynaptic in mossy
fiber-CA3 synapses but postsynaptic in CA3-CA1 synapses of the hippocampus (Grunwald
et al., 2001; Henderson et al., 2001; Contractor et al., 2002; Klein, 2004). In addition, ephrinA3
and EphA4 are also expressed in astrocytes that surround synapses (Murai et al., 2003; Gold-
shmit et al., 2004).
The Eph/ephrinB are expressed in overlapping and specific patterns, suggesting multiple
sites of interaction and redundancy throughout the hippocampal formation.
4.5.2. Dendritic spine morphogenesis during development and plasticity
Dendritic spine formation
In the rat hippocampus, first synapses are formed as early as postnatal day 1 (P1) (Fiala et al.,
1998) and the density of synapses gradually increases during the following weeks – doubling
from P7 to P15 and from P15 to adulthood (Harris and Stevens, 1989; Harris et al., 1992). In
dissociated hippocampal neuronal cultures, synapse development follows roughly in a sim-
ilar time course: during the second week the synapse number doubles or triples and keeps
increasing until the third week, after which it tends to fall (Papa et al., 1995; Boyer et al., 1998).
Synapses are frequently found on filopodia (long thin protrusions), on stubby spines and on
dendritic shafts in the brain (Miller and Peters, 1981; Fiala et al., 1998); they are later gradu-
ally replaced by or converted to, synapses on mushroom-like spines that have a well-defined
head (Harris, 1999). Filopodia are remarkably more motile than mushroom-shaped spines
and with a mean lifetime of only v10 minutes versus hours and days. These thin protrusions
are more transient than mature dendritic spines in culture (Dailey and Smith, 1996; Ziv and
Smith, 1996). Filopodial motility might help to contact the “right” axon and can therefore
be related to synaptogenesis (Ziv and Smith, 1996; Bonhoeffer and Yuste, 2002). Filopodia
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have been proposed to be the precursors of mature mushroom-shaped spines (Ziv and Smith,
1996; Harris, 1999; Bonhoeffer and Yuste, 2002) and once formed, synapses are not rigid. Dur-
ing development, synaptic connections undergo an activity-dependent remodelling (Katz and
Shatz, 1996; Shatz, 1996) and also in the adult brain synapses undergo long-term modifica-
tions (synaptic plasticity) that are believed to be the basis of information storage (learning and
memory) (Bonhoeffer and Yuste, 2002; Li and Sheng, 2003).
The polymerization of actin, the main cytoskeletal element of the spine, is necessary for the
shape and motility of the spine (Matus et al., 2000; Bonhoeffer and Yuste, 2002). As described
in more detail before, many signalling proteins downstream of Eph receptors are known reg-
ulators of actin dynamics and therefore the activation of these receptors is required for spine
development and maintenance.
Kalirin & Intersectin
EphB2 also promotes dendritic spine development through the activation of the GEFs Kalirin
and Intersectin, which activate the two Rho family GTPases, Rac1 and Cdc42, respectively (Irie
and Yamaguchi, 2002; Penzes et al., 2003). In the first pathway, long-term activation of EphB2
by ephrinB1-Fc induces clustering, phosphorylation and synaptic translocation of the endoge-
nous Rho-GEF Kalirin to the postsynaptic site in immature hippocampal neurons and pro-
motes spine morphogenesis. Unlike Intersectin and Ephexin, Kalirin binds only to activated
EphB2 receptors. EphB2 activation also upregulates the activation of the serine/threonine
kinase p21 activated kinase (Pak), a Rac1 downstream effector that promotes actin cytoskele-
ton rearrangement. Transfection of dominant negative forms of Kalirin, Rac1 and the Pak
inhibitory domain all prevent spine morphogenesis in response to ephrinB1 stimulation, sug-
gesting that Kalirin regulates Rac1 activation downstream of activated EphB2 receptors (Pen-
zes et al., 2003). The second downstream pathway that link EphB2 to spine morphogenesis in-
volves Intersectin and Cdc42. Intersectin, an exchange factor for Cdc42, is predominantly ex-
pressed in neurons and associated in an activity-independent manner with the kinase-domain
of EphB2, but not EphA4. EphB2 cooperates synergistically with neural Wiskott-Aldrich syn-
drome protein (N-WASP) to activate Intersectin, which in turn activates Cdc42. N-WASP
bind to the actin-related protein 2/3 (Arp2/3) complex in the presence of activated Cdc42 and
activate Arp2/3-mediated polymerization of branched actin filaments (Irie and Yamaguchi,
2002). Transfection of dominant-negative forms of Cdc42, Intersectin and N-WASP inhibit
spine morphogenesis (Figure 4.10). Thus, this pathway provides a direct link between EphB
receptor activation and actin dynamics and has been proposed to promote branching of actin
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Figure 4.10. EphB receptors drive dendritic spine morphogenesis. Phosphorylation of the proteoglycan
syndecan-2 downstream of activated EphB2 receptors is critical for promoting dendritic spine formation. Ac-
tivated EphB2 receptors also activate the Rho-GEF proteins, Intersectin and Kalirin, which in turn activate the
Rho family GTPases, Cdc42 and Rac1, respectively. The activated GTPases interact with downstream effector
proteins which induce actin rearrangements, thereby promoting the EphB2-induced spine morphogenesis. The
phosphorylation of syndecan-2 downstream of EphB2 is critical to induce association with EphB2 and its cluster-
ing. Clustered syndecan-2 recruits its cytoplasmic ligands toward subsynaptic localization, thereby promoting the
morphological maturation of spines.
filaments, leading to the enlargement of the spine head.
Syndecan-2
Ethell et al. found that clustering of the cell surface proteoglycan syndecan-2 promotes den-
dritic spine maturation (Ethell and Yamaguchi, 1999). In a follow-up study they could demon-
strate that tyrosine phosphorylation of syndecan-2 downstream of EphB2 receptor activation,
but not EphAs, induces syndecan clustering and transforms immature filopodia-like dendritic
protrusions into mature, mushroom-shaped dendritic spines in cultured hippocampal neu-
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rons. EphB2 phosphorylates syndecan-2 on two cytoplasmic tyrosines and this phosphoryla-
tion is necessary for the association of both proteins (Ethell et al., 2001). Clustered syndecan-2
recruits cytoplasmic proteins, such as CASK, syntenin and Synbindin through the interaction
of the C-terminal EFYA sequence, leading to the morphological maturation of spines (Figure
4.10)(Ethell and Yamaguchi, 1999).
NMDA receptor
Four recent studies demonstrate the involvement of Eph receptors forward signalling in the
assembly of postsynaptic complexes at the excitatory synapses (Dalva et al., 2000; Ethell et al.,
2001; Takasu et al., 2002; Penzes et al., 2003). The activation of the EphB receptor by solu-
ble preclustered ephrinB1-Fc induces the direct association of EphB2 receptors with the NR1
subunit of the NMDA glutamate receptor in large raft-like patches within one hour in young
immature cultured neurons. This interaction is mediated by the extracellular regions of the
two receptors. Although this interaction is independent from the kinase activity of EphB re-
ceptors, the authors showed that forward signalling via EphB2 is required for further steps in
synapse formation. This is all very important because the NMDA receptor plays a central role
in synaptic plasticity and is known to be the first recruited glutamate-gated ion channel to
the immature synapse. Ca2+/Calmodulin-dependent kinase II (CamKII) and Grb10 were also
found to colocalize with NR1 and EphB2 following ephrinB stimulation (Dalva et al., 2000).
More recent data showed that EphB2 recruits and activates the cytoplasmic tyrosine kinase
Src, which in turn phosphorylates subunits of the NMDA receptor (Grunwald et al., 2001;
Takasu et al., 2002). Phosphorylation of the NR2B subunit enhances Ca2+ influx through the
NMDA receptor in response to glutamate and increases phosphorylation of the transcription
factor Ca2+/cAMP-responsive element binding protein (CREB) and CREB-dependent tran-
scriptional events that may affect synapse formation, maturation and plasticity (Grunwald
et al., 2001; Takasu et al., 2002).
EphB-knockout mice
Consistent with these in vitro findings, EphB2 null mice show reduced levels of NR1-containing
NMDA receptors in hippocampal synapses (Henderson et al., 2001) and show deficits in
activity-dependent synaptic plasticity (LTP and LTD). Targeted expression of a truncated
kinase-deficient form of EphB2 rescued the EphB2-knockout phenotype, suggesting that
ephrinB reverse signalling might play a role at the synapse. However, EphB2-knockout mice
have normal hippocampal synapse morphology and density, which indicates that EphB2 is
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Figure 4.11. NMDA and EphB2 receptor and their possible roles during synapse formation, maturation and
synaptic plasticity. EphB2 receptor activation leads to the recruitment of SFKs, direct interaction with the NR1
subunit and clustering of the NMDA receptor (in young cultures). The activated SFKs phosphorylate the NMDA
receptor subunits NR2B (grey spheres), which enhances Ca2+ influx through the ion channel after glutamate (pink
spheres) stimulation and potentiates phosphorylation (grey spheres) of the transcription factor CREB. CREB-
dependent transcriptional events and other EphB2 downstream signalling cascades may influence synapse for-
mation, maturation and synaptic plasticity. The site of ephrin localization has not yet been addressed (question
marks).
not critically required for most aspects of synapse development (Grunwald et al., 2001; Hen-
derson et al., 2001). In contrast, overexpression of kinase-deficient EphB2 in dissociated hip-
pocampal neurons (one week old) that presumably block phosphorylation of multiple EphB
family members (EphB1-B3), results in a decrease of synapse density (Dalva et al., 2000) and
dendritic protrusions remain filopodial in old cultures (three weeks old)(Ethell et al., 2001).
Hippocampal neurons from triple EphB1/EphB2/EphB3-knockout mice fail to form spines in
vitro and develop abnormal spines in vivo, indicating that multiple EphB receptors cooperate
to promote spine morphogenesis and synapse formation in the hippocampus (Henkemeyer
et al., 2003). Thus, EphB receptor signalling pathways are required for spine morphogenesis.
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Glia-dendritic spine formation
EphA4 activation by application of ephrinA3-Fc induces a marked spine shortening in slices
of adult hippocampus. EphA4-knockout mice or mice ectopically expressing kinase-deficient
EphA4 show irregularly shaped dendritic spines that are longer than normal. EphrinA3 was
found to be highly expressed on astrocyte processes near synaptic terminals. This evidence
suggests that astrocyte ephrinA3 and neuronal EphA4 interaction, leads to forward signalling
in the synapse that stabilizes spine morphology and possibly synapses in the hippocampus
(Murai et al., 2003).
4.6. The thesis project
Recent evidence strongly suggests that Eph receptor tyrosine kinases and their ligands con-
tribute to synapse formation and synaptic plasticity (Dalva et al., 2000; Ethell et al., 2001;
Grunwald et al., 2001; Henderson et al., 2001; Contractor et al., 2002; Irie and Yamaguchi,
2002; Takasu et al., 2002; Henkemeyer et al., 2003; Penzes et al., 2003; Grunwald et al., 2004).
EphB2 receptors were found to be highly enriched in synapses and to specifically interact with
the NR1 subunit of the NMDA receptor (Dalva et al., 2000). Furthermore, clustering of the re-
ceptors and interaction with NMDA receptor can be rapidly induced upon stimulation with
ephrinB ligands, possibly mimicking initial steps of excitatory synapse formation. Addition-
ally, EphB2 receptor activation leads to phosphorylation of syndecan-2 (Ethell et al., 2001), a
protein that is involved in spine formation and spine morphogenesis. Moreover, our groups
and others could demonstrate that lack of EphB2 leads to the impairment of two forms of
synaptic plasticity in the hippocampus, namely LTD and LTP (Grunwald et al., 2001; Hen-
derson et al., 2001). These initial findings strongly indicate a role for this receptor family in
plasticity and synapse formation. However, the details of the mechanisms remain unclear.
The aim of this study was therefore to visualize EphB2 receptors in the living cell to under-
stand their role during synapse formation. We therefore decided to generate fluorescently
tagged EphB2 receptors (EphB2-ExFP) as a tool to study their dynamics of trafficking, inser-
tion and clustering in neurons in vitro and in vivo.
For the in vitro approach, hippocampal cultures were transfected to exogenously express the
fluorescently tagged EphB2 receptors and to analyze their motility and clustering behaviour
in neurons.
For the in vivo approach, EphB2-EYFP transgenic mice were generated to monitor the in vivo
behaviour of these fluorescently tagged proteins. Slices of these transgenic mice should allow
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a closer look into the dynamics and cluster behaviour of EphB2 receptors during synaptogen-
esis and also in spines and synapses of more mature neurons.
Recent findings by our lab and others could demonstrate that an adhesive contact between
interacting cells can be turned into a retraction response by bi-directional EphB/ephrinB-
triggered trans-endocytosis in cell lines and in immature growth cones upon contact with
EphB2-expressing HeLa cells (Zimmer et al., 2003; Marston et al., 2003). A second major aim of
this study was therefore to demonstrate the existence and relevance of Eph/ephrin-mediated
transcytosis in mature hippocampal cultures.
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5.1. Materials
5.1.1. Chemicals, enzymes and commercial kits
Chemicals were purchased in the highest purity from the companies Merck, Serva, Sigma,
Fluka and Roth. The water used to prepare all solutions was filtered with the “Milli-Q-Water-
System” from Millipore. Restriction enzymes were purchased from the companies: Roche and
New England Biolabs (NEB). Other suppliers and kits used are mentioned in the methods
section. Company contact details are given under 5.3 (see ordering information).
Table 5.1. Chemicals & commercial kits
Chemicals & commercial kits ordering infor-
mation
supplier
30% (w/v) Acrylamide:0.8% (w/v) Bisacry-
lamide stock solution (37.5:1), ProtoGel®
#EC-890 National Diagnos-
tics
Aprotinin #A-4529 Sigma
β-Mercaptoethanol #M-7522 Sigma
BES #B-6420 Sigma
Bovine albumin powder #A-7906 (WB),
#A-3294 (IHC)
Sigma
DMSO #41641 Fluka
DNA ladder (Ready-load 1 kb plus) #12308-011 Invitrogen
Complete EDTA-free, Protease inhibitor cocktail
tablets
#1873580 Roche
ECL Western blot detection reagent #RPN2132 Amersham
EphB2-Fc chimera, mouse #467-B2-200 R&D
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EphrinB1/B2-Fc chimera, mouse #473-EB-200,
#496-EB-200
R&D
Gel/Mount #M∅1 Biomeda
Human IgG Fc-fragment #009-000-008 Dianova
Films, Kodak BioMax MS Film #Z363049-50EA Sigma
Mouse-laminin, natural #23017-015 Invitrogen
Nonidet P-40 (IGEPAL CA-630) #I-3021 Sigma
Normal donkey serum #017-000-121 Jackson ImmunoRe-
search
Normal goat serum #005-000-121 Jackson ImmunoRe-
search
Normal sheep serum #013-000-121 Jackson ImmunoRe-
search
Orange G #O-1625 Sigma
Paraffin, non caking, solidification point 57-60°C #107158 Merck
PMSF #P-7626 Sigma
Poly-D-lysine #P-7886 Sigma
Poly-L-lysine #P-2636 Sigma
Poly-DL-ornithine #P-8638 Sigma
PonceauS solution #33427 Serva
Precision Plus ProteinTM Standards #161-0373 Bio-Rad
Protein A-sepharose 4B #17-0780-01 Amersham
Protein G-sepharose 4B #17-0618-01 Amersham
QuikChangeTM Site-directed mutagenesis kit #200518 or -19 Stratagene
QuikChangeTM XL Site-directed mutagenesis kit #200516 or -17 Stratagene
TOPO TA Cloning®kit #K4660-40 Invitrogen
TEMED #161-0801 Bio-Rad
Triton X (TX)-100 solution #93443 Serva
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Tween®20 (Polyoxyethylene sorbitan monolau-
rate)
#170-6531 Bio-Rad
5.1.2. Equipment
Table 5.2. Equipment
Equipment Model Supplier
Centrifuge SORVALL RC 5Bplus Kendro
Centrifuge Varifuge 3.0R Kendro
Centrifuge Centrifuge 5810 Eppendorf
Rotor GSA rotor & type 3 Sorvall
Table centrifuge Centrifuge 5415 D Eppendorf
Mini centrifuge Quickspin Minifuges, C-1200 International Labnet
Hybridisation oven Model U Memmert
Incubator shaker Unitron-Pro Infors
Water bath Type 3043 Köttermann
Water bath Type 1083 GFL
Thermo mixer Thermomixer comfort Eppendorf
Balance XT2220M-DR Precisa
Fine balance XT2220A-FR Precisa
Magnetic stirring bar 50 × 8 mm Brand
pH Meter Inolab, pH Level 1 WTW
Electrophoresis power sup-
ply
EPS 301 Amersham
Water purification system Milli-Q Biocel A10 Millipore
PCR machine Peltier Thermal Cycler, PTC-225 MJ Research
Shaker IKA Schüttler MTS 4 IKA® Werke
Shaker POLYMAX 2040 Heidolph
Magnetic stirrer with heating IKAMAG®Ret IKA® Werke
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Hood HERAsafe Kendro
Laminar air flow hood HERAguard Kendro
CO2 incubator HERAcell® 240 Kendro
Spectrophotometer Ultrospec 3000 Amersham
Pipettes P2, P20, P100, P1000 Gilson
Multi pipette Multipette® plus Eppendorf
Multi channel pipette 20-200 µl, Transferpette-8 Brand
Multi channel pipette 0.5-10 µl, research Eppendorf
Pipette help Pipetboy acu Integra Biosciences
Vacuum sucking system VacuSafe Integra Biosciences
Burner Fireboy ecu Integra Biosciences
Sequencer ABI Prism 377 DNA sequencer Applied Biosystems
Vortexer VF2 IKA® Werke
Hemacytometer Neubauer improved (depth
0.100 mm, 0.0025 mm2)
Brand
Epifluorescence microscope Zeiss Axioplan Zeiss
Digital camera SpotRT Diagnostics Instru-
ments
for Western Blot analysis:
Semidry blotting apparatus Pharmacia
Electrophoresis power sup-
ply
Power Pac 200, Power Pac 300 Bio-Rad
Bio-Rad gel system Bio-Rad
Dissection instruments:
Straight forceps, Biology tip Dumont #5 (#11252-20) Fine Science Tools
Vannas-Tübingen spring scis-
sors
#15003-08 Fine Science Tools
Fine iris scissor 11 cm (#14090-11 ) Fine Science Tools
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Extra fine iris scissor, model
“Bonn”
8.5 cm (#14084-08) Fine Science Tools
Bent forceps, Biologie tip Dumont #7 (#11297-10) Fine Science Tools
Dissection stereomicroscope Stemi SV 11 Zeiss
Dissection lamp KL 1500 LCD Leica
Equipment for time lapse imaging:
Inverted epifluorescence mi-
croscope
Zeiss Axiovert 200M Zeiss
CO2-incubation chamber EMBL
Digital camera CoolSNAP-fx PhotoMetrics
All other instruments used are mentioned with the methods.
5.1.3. Consumable material
Table 5.3. Consumable materials
Material Type Supplier
Live-cell dishes with a glass bottom ∅ 3.5 cm (#P35G-0-14-C) MatTek
Coverslips, glass ∅ 10 mm, 13 mm Marienfeld
Syringe 5 ml, 10 ml, 50 ml Becton Dickinson
Combitips plus 5 ml, 10 ml, 0.5 ml Eppendorf
Injection needles, disposable 20G, 22G, 23G, 26G, 27G Terumo
Tissue culture plastic dishes,
NunclonTM∆
∅ 6 cm Nunc
Tissue culture plastic dishes, Fal-
con®
∅ 3.5 cm, 6 cm, 10 cm Becton Dickinson
Conical bottom, screw-top tube, Fal-
con®
15 ml, 50 ml Becton Dickinson
Conical bottom, screw-top tube 15 ml, 50 ml Greiner
Pasteur pipettes, glass, Volac length 150 mm Poulten & Graf
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Multiwell cell culture plates, Fal-
con®
6 well, 12 well Becton Dickinson
Multiwell cell culture plates, Costar 24 well Corning
Plastic pipettes, Falcon 1 ml, 2 ml Becton Dickinson
Plastic pipettes, Cellstar® 5 ml, 10 ml, 50 ml Greiner
Exam gloves, powder-free, nitrile SAFESKIN, Purple Ni-
trile, Size S
Kimberly-Clark
Parafilm® Parafilm® “M” American National
Can
Tissue culture flasks, NunclonTM∆ 75 cm2 Nunc
Tissue culture flasks, Falcon® 50 ml, 250 ml Becton Dickinson
Cryo tubes 1.5 ml Nunc
Reaction tubes, safelock 1.5 ml, 2 ml Eppendorf
Pipette tips 20 µl, 200 µl, 1000 µl PESKE
Reaction tubes, safelock 1.5 ml, 2 ml Eppendorf
PCR lids 8-lid-strips (#7-9717) NeoLab
PCR reaction tubes Thermo-Fast 48 (#AB-
0648)
ABgene
Precision wipes KIMTECH Science Kimberly-Clark
PVDF membrane Immobilon Millipore
Nitrocellulose membrane 0.45-µm pore size, Protran Schleicher & Schüll
Blotting paper 3 mm Chr Whatman
Filter systems:
Syringe driven filter unit, Millex®-
GV
0.22 µm Millipore
Steritop, bottle top filter 250 ml, 500 ml (0.22 µm) Millipore
Stericup, filtration system 250 ml, 500 ml (0.22 µm) Millipore
All other consumable materials are mentioned with the methods.
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5.1.4. Oligonucleotides
All oligonucleotides were synthesized by Metabion (www.metabion.de). Desalted or HPLC-
purified oligonucleotides were used for sequencing reaction or mutagenesis, respectively. All
sequences are shown from their 5’ to their 3’ end.
Table 5.4. Oligonucleotides
S: Sequencing reaction, IS: in situ, M: Mutagenesis, GT: Genotyping
Name Oligonucleotide sequence Use
T7 universal primer TAATACGACTCACTATAGGG S, IS
T3 promoter primer ATTAACCCTCACTAAAGGGA S
SP6 ATTTAGGTGACACTATAG S, IS
BGH _reverse TAGAAGGCACAGTCGAGG S
pAdlox_afterMCS_rev (pExFP) GGTTCAGGGGGAGGTGTGGG S
CMV_sense_II (pExFP, pcDNA3) CCATCCGCACATGCCACCCTCC S
EGFP-N (Clontech) CGTCGCCGTCCAGCTCGACCAG S
EGFP-C (Clontech) CATGGTCCTGCTGGAGTTCGTG S
5’vor_ATG_EphB2 GGACCTGGGAGTGGACACCTGTGG S
5’mEphB2(356) AACCTCTACTACTATGAGGC S
5’mEphB2(841) CATCAGGAACCTTCAAGGC S
3’mEphB2(1507) ACAGTGACTGTGTTGGTGG S
3’mEphB2(1973) TACAAAGATCTCTCTCTTGCC S
EphB2(2122) CTCCTGTGTCAAGATTGAGC S
3’mEphB2(2535) CGTTGATTACGTCTTGATTGG S
5’EphB2(3132-3153) GCGTTGGGGTCACTCTAGCTGG S
EphB2_afterCDR_rev CGACGTAGGGGCTCAGGGG S
5’ephrinB2_1713-1731 CCAAGATGTGAAATTCACC S
3’ephrinB2_2098-2116 GGATGGATCATCTTCATCG S
5’FgB2c3_HindIII_to_EcoRV CGACTCACTATAGGGAGACCCgAtaTcGAGGTGTGGCAGGC M
3’FgB2c3_HindIII_to_EcoRV GCCTGCCACACCTCgAtaTcGGGTCTCCCTATAGTGAGTCG M
5’ExFP_ClaI_Stop CGAGCTGTACAAGggcggcggcagcatcgatTAAAGCGGCCGCG M
3’ExFP_ClaI_Stop CGCGGCCGCTTTAatcgatgctgccgccgccCTTGTACAGCTCG M
5’EphB2_Y604F_Y610F GGCATGAAGATCTtTATAGATCCTTTCACCTtTGAAGATCC M
3’EphB2_Y604F_Y610F GGATCTTCAaAGGTGAAAGGATCTATAaAGATCTTCATGCC M
5’FgB2c3_NheI_344_ClaI GGGCCCCTGATGctagcgggcggcatcgatGACTCTACGACAGC M
3’FgB2c3_NheI_344_ClaI GCTGTCGTAGAGTCatcgatgccgcccgctagCATCAGGGGCCC M
5’FgB2c3_NheI_1999_ClaI GCCGACTCAGAGctagcgggcggcatcgatTACACGGACAAGC M
3’FgB2c3_NheI_1999_ClaI GCTTGTCCGTGTAatcgatgccgcccgctagCTCTGAGTCGGC M
5’FgB2c3_NheI_2958_ClaI CCATGGCACCCCTGctagcgggcatcgatTCCTCTGGCATCAACC M
3’FgB2c3_NheI_2958_ClaI GGTTGATGCCAGAGGAatcgatgcccgctagCAGGGGTGCCATGG M
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5’deletion_PDZ_motif_EphB2 CCAGATCCAGTCTTGACATTCGCCTGCC M
3’deletion_PDZ_motif_EphB2 GGCAGGCGAATGTCAAGACTGGATCTGG M
5’K660R(FgB2c3_K630R) GAGATCTTTGTAGCCATCAgGACCCTCAAGTCAGG M
3’K660R(FgB2c3_K630R) CCTGACTTGAGGGTCcTGATGGCTACAAAGATCTC M
5’KOZAK_EphB2 CATTTCTGATCGACGgcCAcCATGgACTTTATCCCAGTCG M
3’KOZAK_EphB2 CGACTGGGATAAAGTcCATGgTGgcCGTCGATCAGAAATG M
Nt_HindIII_HA-ephrinB2 AAGCTTGCCTACCCATACGATGTTCCAGATTACGCTatctccagatcgatagt ttta-
gagcc
PCR
Ct_HindIII_HA-ephrinB2 GCGGCCGCCAGTGTGATGGATATCTGCAGAATtcagaccttgtagtaaatgtt ggc PCR
5’ephrinB2_DC_EcoRV ccacagcacacgaccacgTGAGATATCctgtctctcagcacactgg M
3’ephrinB2_DC_EcoRV ccagtgtgctgagagacagGATATCTCAcgtggtcgtgtgctgtgg M
Thy1F1 (Feng et al., 2000) TCTGAGTGGCAAAGGACCTTAGG GT
3’EphB2_358-340 CGTTGCTGTCGTAGAGTCC GT
5.1.5. Bacteria
Table 5.5. Bacterial strains
Strain relevant genotype
XL1-Blue supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac-
XL2-Blue MRF’ ∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1
gyrA96 relA1 lac[F’ proAB laclqZ∆M15 Tn10 (Tetr) Amy Camr]
XL10-Gold Tetr∆ (mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1
gyrA96 relA1 lac Hte
TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80 lacZ ∆M15 ∆lacX74 recA1
ara∆139 ∆(ara-leu7697) galU galK rpsL (Strr) endA1 nupG
DH5α supE44 ∆lacU169 (Φ80 lacZ ∆M15) hsdR17 recA1 endA1 gyrA96 thi-1
relA1
K12 (dam minus) supE44 ∆lacU169 (Φ80 lacZ ∆M15) hsdR17 recA1 endA1 gyrA96 thi-1
relA1
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Table 5.6. Vectors
Plasmid Size (kb) Resistance Supplier
pBluescriptII SK/KS 3.0 Amp Stratagene
pcDNA3.1 plus 5.5 Amp Invitrogen
pExFP-N1 4.7 Kan Becton Dickinson
pExFP-C1/C2/C3 4.7 Kan Becton Dickinson
pCRII-TOPO 3.9 Amp & Kan Invitrogen
pCR2.1-TOPO 3.9 Amp & Kan Invitrogen
5.1.6. Plasmids
5.1.6.1. EphB2 expression constructs
Expression constructs encoding full-length (FgB2c3) and truncated mouse flagEphB2
(FgB2Trc2) are described in Dalva et al. (2000). For more information see GenBank acces-
sion number NM_010142 (www.ncbi.nlm.nih.gov).
EphB2-EcoRV (pJK1):
In the FgB2c3 plasmid the HindIII cloning site upstream of the coding sequence of the signal
petide was changed by site-directed mutagenesis using the primer pairs
5’FgB2c3_HindIII_to_EcoRV & 3’FgB2c3_HindIII_to_EcoRV to an EcoRV restriction site. After
the mutagenesis it was possible to clone the coding sequence of EphB2 in other constructs by
using, e.g. EcoRV and NotI as restriction enzymes.
EphB2-KD (pJK2):
An expression construct encoding kinase-deficient EphB2 was generated by site-directed mu-
tagenesis leading to exchange of lysine (aa660) to arginine using the primer pairs
5’K660R(FgB2c3_K630R) & 3’K660R(FgB2c3_K630R) with the Stratagene QuikChangeTM kit.
EphB2-2F (pJK3) & EphB2-KD-2F (pJK4):
The two tyrosine residues, aa603 and aa609, of the juxtamembrane region were mutated to
phenylalanine by site-directed mutagenesis using the primer pairs 5’EphB2_Y604F_Y610F &
3’EphB2_Y604F_Y619F of the kinase-active (pJK1) and the kinase-deficient (pJK2) construct,
respectively, encoding the full-length flagEphB2.
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EphB2-∆PDZ (pJK5):
The C-terminal PDZ-motif VEV in the full-length kinase-active EphB2 (pJK1) was removed
by site-directed mutagenesis using the primer pairs 5’deletion_PDZ_motif_EphB2 & 3’dele-
tion_PDZ_motif_EphB2.
5.1.6.2. EphB2-ExFP expression constructs
Strategy:
In fluorescent fusion proteins the ExFP-protein is usually fused to the N- or the C-terminus
of the protein. Because of EphB2 structural features we wanted to generate fusion proteins
with the insertion of ExFP was between domains. As a control we decided to construct a N-
terminal fusion protein, being aware that the ligand binding ability of the domain could be
impaired.
The crystal structure of EphB2 was studied. The aim was to find ideal insertion sides, where
the protein structure could still be intact after the ExFP-insertion between the protein domains.
For the N-terminal fusion (EphB2-N-ExFP) we chose an insertion site downstream of the sig-
nal peptide. The two C-terminal insertions were designed close to the juxtamembrane region
or between the kinase and the SAM domains.
pExFP-N1-ClaI-STOP (pJKm1-pJKm3):
To insert a glycine-serine linker followed by a ClaI cloning site into the expression constructs
pECFP-N1, pEGFP-N1 and pEYFP-N1 (pExFP-N1) by site-directed mutagenesis, the follow-
ing primer pairs were used: 5’ExFP_ClaI_Stop & 3’ExFP_ClaI_Stop.
EphB2-Nhe1-344/1995/2958-ClaI (pJKm4-pJKm6):
NheI and ClaI restriction site were inserted by mutagenesis using the primer pairs: 5’FgB2c3_
NheI_344_ClaI & 3’FgB2c3_NheI_344_ClaI for EphB2-Nhe1-344-ClaI (pJKm4), 5’FgB2c3_
NheI_1999_ClaI & 3’FgB2c3_NheI_1999_ClaI for EphB2-Nhe1-1995-ClaI (pJKm5)
and 5’FgB2c3_NheI_2958_ClaI & 3’FgB2c3_NheI_2958_ClaI for EphB2-Nhe1-2958-ClaI
(pJKm6).
EphB2-N-ExFP (pJK7-pJK9):
To generate an expression construct encoding EphB2-N-ExFP, EphB2-Nhe1-344-ClaI (pJKm4)
and pExFP-N1-Cla1-STOP (pJKm1-pJKm3) were cleaved with NheI and HindIII. The most N-
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terminal NheI restriction site of the multiple cloning site (MCS) from the ExFP-N1 plasmids
was used. The MCS can act as a linker increasing the likelihood that the fusion proteins will
be functional (personal communication with Becton Dickinson). ExFP fragments were cloned
in frame in the N-terminal region of EphB2, resulting in the following amino acid sequence:
(ExFP)-DSTTATAE... .
EphB2-C1-ExFP (pJK10-pJK12 ):
An expression construct encoding EphB2-C1-ExFP was generated, as described above, by
cloning the ExFP-N1 fragment (from pJKm1-pJKm3) in frame into the juxtamembrane region
of EphB2 (pJK5). The flanking aa sequence of the EphB2 juxtamembrane region is
...GFERADSE-(ExFP)-YTDKLQHY... .
EphB2-C2-ExFP (pJK13-pJK15 ):
The EphB2-C1-ExFP construct was generated, as described above, by cloning the ExFP-N1
fragment (from pJKm1-pJKm3) in frame between the kinase and the SAM domain of EphB2
(pJK5). The aa sequence of the EphB2-ExFP fusion protein at the site of the insertion is
...PNSLKAMAPL-(ExFP)-SSGINLPLLD... .
EphB2-∆C-ExFP (pJK16-pJK18 ):
To generate an expression construct encoding EphB2-∆C-ExFP, almost all the cytoplasmic se-
quence from EphB2-C1-ExFP was replaced by ExFP. For this, both pJK10-12 and pExFP-N1
were cleaved with NheI and NotI and the ExFP-fragment was cloned in frame into the cut
EphB2 construct. The remaining aa sequence of the EphB2 cytoplasmatic domain is
GFERADSE followed by the ExFP sequence.
EphB2-C1-KD-ExFP (pJK25-27):
The sequence for the ATP-binding site in the kinase domain of the pJk10-12 plasmids was mu-
tated by site-directed mutagenesis using the primer pairs 5’K660R(FgB2c3_K630R) &
3’K660R(FgB2c3_K630R) in order to generate expression constructs encoding kinase-deficient
EphB2-C1-ExFP (see EphB2-KD (pJK2)).
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5.1.6.3. Thy1-EphB2-EYFP expression constructs for injection
The Thy-1.2 construct (pUC18-Thy-1.2) containing the mouse Thy-1.2 expression cassette was
kindly provided by Dr. Pico Caroni (Friedrich Miescher Institute, Switzerland). It contains 6.5
kb of the murine thy-1.2 gene, extending from the promoter to the intron following exon 4, but
lacking exon 3 and its flanking regions and is described in Caroni (1997).
KOZAK-EphB2-C1-EYFP (pJK19-21):
A kozak in the plasmids pJK12 (EphB2-C1-EYFP), pJK27 (EphB2-C1-KD-EYFP), pJK18 (EphB2-
∆C-EYFP) was generated by site-directed mutagenesis using the primer pairs:
5’KOZAK_EphB2 & 3’KOZAK_EphB2.
Thy1-EphB2-C1-EYFP (pJK22), Thy1-EphB2-C1-KD-EYFP (pJK23), Thy1-EphB2-∆C-EYFP
(pJK24):
To put full-length, kinase-deficient and C-terminal truncated EphB2-C1-EYFP under the con-
trol of the Thy-1.2 expression cassette, the corresponding EphB2 construct were first cleaved
with NotI. The 3’ overhang was filled in with dNTPs and the fragments were then incubated
with the restriction enzyme XmnI. These blunt-ended fragments were cloned into the blunt-
ended XhoI site of the opened pUC18-Thy-1.2 plasmid.
5.1.6.4. ExFP-HA-ephrinB1 and -ephrinB2 expression constructs
E(C/Y)FP-HA-ephrinB1 (pJK30, pJK31) & ExFP-HA-ephrinB1∆C (pJK32, pJK33):
To generate expression constructs encoding a blue or yellow fluorescent HA-ephrinB1 (pJK30,
pJK31) or HA-ephrinB1∆C (pJK32, pJK33), the E(C/Y)FP coding region was cloned into
pJP136 or pJP139 (Brückner et al., 1999) using SalI and BsRGI restriction sites.
ExFP-HA-ephrinB2 (pJK36-pJK38):
The coding region for ephrinB2 was amplified from a pcDNA3.1-ephrinB2 plasmid (from
George Wilkinson) using the primer pairs: Nt_HindIII_HA-ephrinB2 & Ct_HindIII_HA-
ephrinB2 and cloned into the pCR2.1-TOPO plasmid. To generate expression constructs cod-
ing for ExFP-HA-ephrinB2, ephrinB2 was cloned in place of the ephrinB1 sequence in the
ExFP-HA-ephrinB1 constructs (pJK30, pJP136 & pJK31) by cleaving these plasmids and the
pCR2.1-TOPO-ephrinB2 (pJK35) with HindIII and NotI.
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ExFP-HA-ephrinB2∆C (pJK42-pJK44):
To generate expression constructs coding for ExFP-HA-ephrinB2∆C an EcoRV restriction site
was inserted by site directed mutagenesis into ExFP-HA-ephrinB2 plasmids (pJK36-pJK38)
using the primer pairs 5’ephrinB2_DC_EcoRV & 3’ephrinB2_DC_EcoRV. The sequence encod-
ing most of the cytoplasmatic domain was cleaved with EcoRV. The remaining aa sequence of
the ephrinB2∆C is ...RKHSPQHTTT.
5.1.7. Cell lines
Human embryonic kidney (HEK) 293 cells
organism: Homo sapiens (human)
ATCC number: CRL-1573
For more information: www.atcc.org
5.1.8. Antibodies
(IHC: Immunohistochemistry, IP: Immunoprecipitation, WB: Western Blotting, d: donkey, g:
goat, m: mouse, r: rabbit, h: human, minX: minimal crossreactivity)
5.1.8.1. Primary antibodies
Table 5.7. Primary antibodies
Antibodies Dilutions
Preclustering of Fc-fusion proteins
g anti-human Fcγ, minX (#109-005-098, Jackson
ImmunoResearch)
Fc-clustering: 1/10 (w/w)
m anti-human Fcγ, minX (#209-005-098, Jackson
ImmunoResearch)
Fc-clustering: 1/10 (w/w)
c-Myc tag
m ascites anti-c-Myc (#1 667 149 (9E10), Roche) WB: 1:1000
r anti-c-Myc agarose beads (#A7470, Sigma) IP: 40 µl/IP (= 10 µl beads)
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HA tag
m anti-HA [0.4 µg/µl] (#1 583 816 (12CA5), Roche) IHC: 8 µg/ml, WB: 1:1000, IP: 4
µg/IP
FLAG tag
m anti-FLAG M2 [4 µg/µl] (#F3165, Sigma) IHC: 1:2000, WB: 1:2000, IP: 1 µl/IP
GFP
m anti-JL-8 (ExFP) [1 µg/µl] (#8371-2, Clontech) IHC: 2-5 µg/ml, WB: 1:1000, IP: 2
µg/IP
r anti-GFP [1 µg/µl] (#RDI-GRNFP4abr, RDI) IHC: 1:1000, WB: 1:2000, IP: 1 µg/IP
NMDA1 receptor
m anti-NR1 [2 µg/µl] (#60021A, PharMingen) WB: 1:1000, IP: 5µl/IP
m anti-NR1 [1 µg/µl] (#114011 (M 68), SySy) IHC: 1:1000
AMPA receptor
r anti-GluR2/3 [0.1 µg/µl] (#AB1506, PharMin-
gen)
IHC: 1:30 - 1:100, WB: 1:1000, IP: 2
µg/IP
r anti-GluR1 [0.1 µg/µl] (#AB1504, PharMingen) IHC: 1:30 - 1:100, WB: 1:1000, IP: 2
µg/IP
MAP2
m ascites anti-MAP2 (#M4403 (HM-2), Sigma) IHC: 1:12000
PSD95
m anti-PSD95 (#P-246 (7E3-IB8), Sigma) IHC: 1:200, WB: 1:2000, IP: 3-4
µl/IP
Synaptophysin
r anti-Synaptophysin (#101002, SySy) IHC: 1:50 - 1:100
m anti-Synaptophysin (#S-5768 (SVP-38), Sigma) IHC: 1:100
m anti-Synaptophysin [1 µg/µl] (#MAB5258 (Sy
38), Chemicon)
IHC: 1:500 - 1:1000, WB: 1:1000
Synapsin
r anti-Synapsin (#AB1543, Chemicon) IHC: 1:500
56
5.1. Materials
Phosphotyrosine
m anti-Phosphotyrosine [1 µg/µl] (#05-321 (4G10),
UBI)
WB: 1:5000
ephrinB
r serum anti-ephrinB, #200 (Brückner et al., 1999) IHC: 1:100
ephrinB1/2
g anti-m ephrinB1 [0.1 µg/µl](#AF473, R&D) IHC: 1:50
r anti-m/h ephrinB1-B3 [0.2 µg/µl](#C-18, Santa
Cruz)
IHC: 1:50
rat anti-m ephrinB1 [0.5 µg/µl](#MAB473, R&D) IHC: 1:250
ephrinB2
g anti-m ephrinB2 [0.1 µg/µl] (#AF496, R&D) IHC: 0.4 µg/ml (1:250)
EphB2/3
g anti-m EphB2 [0.1 µg/µl](#AF467, R&D) IHC: 4 µg/ml (1:25)
g anti-m EphB3 [1 µg/µl](#AF, R&D) IHC: 1:250
EphA4
g anti-m EphA4 [0.1 µg/µl](#AF641, R&D) IHC: 1:50
r anti-m/h EphA4 [0.2 µg/µl](#S-20, Santa Cruz) IHC: 1:50
5.1.8.2. Secondary antibodies
Table 5.8. Secondary antibodies
Antibodies Dilutions
Anti-Mouse
d anti-m-Cy3, -Cy5, minX [0.75 µg/µl] (#715-165-151, #715-175-
151, Jackson ImmunoResearch)
IHC: 1:200 - 1:400
g anti-m-Alexa488 [2 µg/µl] (#A11001, Molecular Probes) IHC: 1:400
d anti-m-Texas Red, minX [0.70 µg/µl] (#715-075-150, Jackson Im-
munoResearch)
IHC: 1:50 - 1:100
sheep anti-m-HRPO conjugate (#NA931V, Amersham) WB: 1:3000
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Anti-Rabbit
d anti-r-Cy3, -Cy5, minX [0.75 µg/µl] (#711-165-152, #711-175-152.
Jackson ImmunoResearch)
IHC: 1:200 - 1:400
d anti-r-Alexa488, minX [2.0 µg/µl] (#A21206, Molecular Probes) IHC: 3.75 µg/ml
Anti-Goat
d anti-g-Cy3, minX [0.75 µg/µl] (#705-165-147, Jackson Im-
munoResearch)
IHC: 1:200 - 1:400
d anti-g-HRPO conjugate [0.75 µg/µl] (#705-035-147, Jackson Im-
munoResearch)
WB: 1:3000
Anti-Rat
d anti-rat-Cy3, minX [0.75 µg/µl] (#712-165-153, Jackson Im-
munoResearch)
IHC: 1:200 - 1:400
Protein A
HRPO-labelled Protein A (#NA9120, Amersham) WB: 1:3000
5.1.9. Media and standard solutions
Dulbeccos Phosphate-buffered saline (D-PBS)
137 mM NaCl → NaCl 8 g
2.7 mM KCl → KCl 0.2 g
8 mM Na2HPO4 → Na2HPO4 1.15 g
1.5 mM KH2PO4 → KH2PO4 0.24 g
Dissolve all ingredients in 800 ml of distilled water. Adjust to pH 7.4 with HCl and adjust volume to 1 l. Sterilize
by autoclaving and store at room temperature (RT).
10× D-PBS
1.37 M NaCl → NaCl 80 g
27 mM KCl → KCl 2 g
81 mM Na2HPO4 → Na2HPO4 11.5 g
15 mM KH2PO4 → KH2PO4 2.4 g
Dissolve all ingredients in 800 ml of distilled water. Adjust to pH 7.4 with HCl and adjust volume to 1 l. Sterilize
by autoclaving and store at RT.
58
5.1. Materials
0.5 M EDTA, pH 8.0
disodium EDTA·2H2O 186.1 g
Dissolve all ingredients in 800 ml of distilled water. Adjust to pH 7.4 with HCl and adjust volume to 1 l. Sterilize
by autoclaving and store at RT.
1 M Tris-HCl, pH 7.4 or 8.0
Tris base 121.1 g
pH 7.4→ HCl 70 ml
pH 8.0→ HCl 42 ml
Dissolve Tris base in 800 ml of distilled water. Adjust pH to the desired value by adding concentrated HCl. Adjust
volume to 1 l. Sterilize by autoclaving and store at RT.
Tris-EDTA (TE) buffer, pH 8.0
10 mM Tris-HCl
1 mM EDTA
Adjust to pH 8.0 by adding concentrated HCl. Adjust volume to 1 l. Sterilize by autoclaving and store at RT.
50× Tris-acetate-EDTA (TAE) electrophoresis buffer
Tris base 242 g
Glacial acetic acid 57.1 ml
0.5 M EDTA (pH 8.0) 100 ml
Add distilled water to 1 l. The pH should be v8.3. Store at RT. Dilute the concentrated stock buffer prior to use
and prepare both the gel solution and the electrophoresis buffer from this concentrated stock solution.
6× Agarose gel-loading buffer
50% Glycerol (v/v) → 87% Glycerol 57 ml
1× TAE buffer → 50× TAE buffer 2 ml
0.2% Orange G (w/v) → Orange G 0.2 g
Add distilled water to 100 ml and store at RT.
4% Paraformaldehyde (PFA)
PFA (w/v) 20 g
D-PBS 500 ml
5N NaOH 200 µl
HCl, min. 37% 75 µl
Heat D-PBS to approximately 70°C, add PFA powder and stir at high speed. Add NaOH to dissolve the PFA
completely and HCl, min. 37% to pH 7.3. Store in 50-ml aliquots at -20°C.
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5.1.9.1. Media and antibiotics for bacterial culture
Luria-Bertani (LB) medium
Bacto-Tryptone 10 g
Bacto-Yeast extract 5 g
NaCl 5 g
Add distilled water to 1 l. The pH should be 7.5. Sterilize by autoclaving and store at RT.
LB plates
LB media 1 l
Bacto-Agar 15 g
Autoclave and store at 4°C.
Psi broth
Bacto-Tryptone 20 g
Bacto-Yeast extract 5 g
MgSO4 5 g
Add distilled water to 1 l. Adjust to pH 7.6 with 1N KOH. Sterilize by autoclaving and store at RT.
Antibiotics
1000× stock solutions:
Ampicillin 100 mg/ml
Kanamycin monosulfate 50 mg/ml
400× stock solutions:
Tetracycline 5 mg/ml in 100% EtOH
Dissolve in distilled water and sterilize by filtration. Store in aliquots at -20°C.
5.1.9.2. Media and supplements for tissue culture
DMEM-FBS medium
DMEM (Sigma, #D-5523) 500 ml
FBS, heat-inactivated (#10270-106, Invitrogen) 50 ml
Penicillin/Streptomycin (5000 U/ml, 100 µg/ml)(#15070-063, Invitrogen) 5 ml
200 mM L-Glutamine (100×)(#25030-024, Invitrogen) 5 ml
100 mM Sodium pyruvate (100×)(#11360-039, Invitrogen) 5 ml
Store at 4°C.
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5.1.9.3. Media and supplements for primary cell culture
Borate buffer
Boric acid 1.24 g
Borax (#B-3545, Sigma) 1.90 g
Dissolve in 400 ml of distilled water. The pH should be 8.5, filter-sterilize and store at 4°C.
Neurobasal-B27 medium
Neurobasal medium (#21103-049, Invitrogen) 500 ml
B27 supplement (#17504-044, Invitrogen) 10 ml
Store at 4°C.
DMEM-FBS
DMEM (#61965-026, Invitrogen) 100 ml
FBS, heat-inactivated (#F-7524, Sigma) 10 ml
Sterilize by filtration through a 0.22-µm membrane and store at 4°C.
1M MgCl2
MgCl2·6H2O 20.33g
Dissolve in 100 ml of distilled water, filter-sterilize and store in small aliquots because of its hygroscopic property.
Store at RT.
1M HEPES
HEPES, free acid (#9105.2, Roth) 23.83 g
Dissolve in 100 ml of distilled water. The pH should be 7.3, filter-sterilize and store at 4°C.
Dissection medium (cooled on ice before use)
HBSS (Invitrogen, #24020-091) 500 ml
Penicillin/Streptomycin (5000 U/ml, 100 µg/m)(Invitrogen, #15070-063) 5 ml
1M MgCl2, pH 7.3 5 ml
1M HEPES 3.5 ml
200 mM L-Glutamine (100×)(Invitrogen, #25030-024) 5 ml
Store at 4°C.
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5.1.9.4. Reagents for primary culture of astrocytes
5.5% NaHCO3 (w/v)
NaHCO3 5.5 g
Dissolve in 100 ml of distilled water. Sterilize by filtration through a 0.22-µm membrane and store at 4°C.
20% Glucose (w/v)
D(+)-Glucose 20 g
Dissolve in 100 ml of distilled water. Sterilize by filtration through a 0.22-µm membrane and store at 4°C.
NMEM-B27 medium (Goetze et al., 2003)
10× MEM (#21430-020, Invitrogen) 50 ml
5.5% NaHCO3 20 ml
20% glucose 15 ml
100 mM sodium pyruvate (100×)(#11360-039, Invitrogen) 5 ml
200 mM L-Glutamine (100×)(#25030-024, Invitrogen) 5 ml
B27 supplement (#17504-044, Invitrogen) 10 ml
Add distilled water to 500 ml. Sterilize by filtration through a 0.22-µm membrane. Store at 4°C and use within 10
days.
MEM-HS medium (de Hoop et al., 1998)
10× MEM (#21430-020, Invitrogen) 50 ml
50× MEM amino acids (#11130-036, Invitrogen) 10 ml
100× MEM non-essential amino acids (#1140-035, Invitrogen) 5 ml
5.5% NaHCO3 20 ml
20% glucose 15 ml
100 mM sodium pyruvate (100×)(#11360-039, Invitrogen) 5 ml
200 mM L-Glutamine (100×)(#25030-024, Invitrogen) 5 ml
Horse serum, heat-inactivated (#16050-122, Invitrogen) 50 ml
Mix all ingredients with approximately 350 ml distilled water. Adjust to pH 7.4 with 1N NaOH and adjust volume
to 500 ml. Sterilize by filtration through a 0.22-µm membrane. Store at 4°C and use within 2 weeks.
5.1.9.5. Media and solutions for cell transfection
1M CaCl2
CaCl2·2H2O 2.94g
Add distilled water to 20 ml. Sterilize by filtration through a 0.22-µm membrane and store 1-ml aliquots at -20°C.
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2× BES-buffered saline (2×BBS)
50 mM BES → BES 1.07 g
280 mM NaCl → NaCl 1.6 g
1.5 mM Na2HPO4·2H2O → Na2HPO4·2H2O 0.027 g
Dissolve in 90 ml of distilled water. Adjust the pH with NaOH to 6.96-7.22. The optimal pH changes according to
different sizes and preparations of plasmid DNA, then adjust the volume to 100 ml. Sterilize by filtration through
a 0.22-µm membrane and store in 1-ml aliquots at -20°C.
5.1.9.6. Reagents for live-cell imaging
External solution (Bi and Poo, 1998)
145 mM NaCl → NaCl 8.474 g
3 mM KCl → KCl 0.224 g
10 mM HEPES → HEPES 2.383 g
3 mM CaCl2 → CaCl2·2H2O 0.441 g
2 mM MgCl2 →MgCl2·6H2O 0.407 g
8 mM D(+)-Glucose → D(+)-Glucose ·1H2O 1.585 g
Dissolve one ingredient after another in approximately 900 ml distilled sterile water. Adjust to pH 7.3 with 1N
NaOH and adjust volume to 1 l. Use within 1 day.
50 mM KCl-stimulation solution (Bi and Poo, 1998)
98 mM NaCl → NaCl 2.864 g
50 mM KCl → KCl 1.864 g
10 mM HEPES → HEPES 1.191 g
3 mM CaCl2 → CaCl2·2H2O 0.221 g
2 mM MgCl2 →MgCl2·6H2O 0.203 g
8 mM D(+)-Glucose → D(+)-Glucose ·1H2O 0.793 g
Dissolve one ingredient after another in approximately 400 ml distilled sterile water. Adjust to pH 7.3 with 1N
NaOH and adjust volume to 500 ml. Use within 1 day.
5.1.9.7. Solutions and buffers for western blot analysis
6× Sample buffer for reducing conditions
12% SDS → SDS 3.6 g
300 mM Tris-HCl, pH 6.8 → 1.5 M Tris 6 ml
600 mM DTT → DTT 2.77 g
0.6% Bromophenol blue → bromophenol blue 0.18 g
60% Glycerol → 18 ml
Add distilled water to 30 ml. Store in aliquots at -20°C.
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Lysis buffer
50 mM Tris-HCl, pH 7.5 → 1M Tris, pH 7.5 5 ml
150 mM NaCl → 5M NaCl 3 ml
0.5-1% Triton X(TX)-100 → TX-100 0.5-1 ml
Add distilled water to 100 ml. Store at 4°C.
Add fresh to 100 ml:
1 mM Sodium ortho vanadate (Na3VO4) → 100 mM Na3VO4 1 ml
10 mM NaPPi → NaPPi 0.45 g
20 mM NaF → NaF 0.084 g
Protease inhibitor cocktail tablets (complete) → 2 tablets
4% Laemmli stacking gel, 10 ml
30% w/v Acrylamid/bisacrylamide 1.3 ml
0.5 M Tris-HCl (pH 6.8), 0.4% SDS 2.6 ml
H2O 6.1 ml
10% APS 100 µl
TEMED 10 µl
Always prepare fresh.
7.5% Laemmli separating gel, 10 ml
30% (w/v) Acrylamide/bisacrylamide 2.5 ml
1.5 M Tris-HCl (pH 8.8), 0.4% SDS 2.6 ml
H2O 4.85 ml
10% APS 50 µl
TEMED 5 µl
Always prepare fresh.
10% Laemmli separating gel, 10 ml
30% (w/v) Acrylamide/bisacrylamide 3.3 ml
1.5 M Tris-HCl (pH 8.8), 0.4% SDS 2.6 ml
H2O 4.05 ml
10% APS 50 µl
TEMED 5 µl
Always prepare fresh.
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5× Laemmli electrophoresis buffer
Tris base 154.5 g
Glycine 721 g
SDS 50 g
Add distilled water to 10 l. Store at RT.
10× Transfer buffer
Tris base 60.5 g
Glycine 281.5 g
SDS 25 g
Add distilled water to 2.5 l. Store at RT.
⇒ Add 20% methanol to the 1× Transfer buffer before use.
Sodium phosphate buffer, pH 7.2
1 M Na2HPO4 68.4 ml
1 M NaH2PO4 31.6 ml
2% SDS
Add distilled water to 1 l. Store at RT.
PBS-Tween (PBST)
1× D-PBS
0.1% Tween®20
Store at RT.
Blocking solution (w/v)
PBST
7.5% Milk powder, non-fat (Roth, #T145.2)
Always prepare fresh for use.
Stripping buffer
5 mM Sodium phosphate buffer, pH 7-7.4
2 mM β-Mercaptoethanol
2% SDS
Always prepare fresh for use.
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5.1.9.8. Solutions for embedding of vibratome sections
0.1 M Acetate buffer, pH 6.5
1 M Sodium acetate 99 ml
1 M Acetic acid 960 µl
Adjust to pH 6.5 and adjust volume to 1 l. Store at RT.
Embedding solution
1) Ovalbumin (Sigma, #A-S253) 90 g
0.1 M Acetate buffer, pH 6.5 200 ml
Dissolve albumin in acetate buffer by stirring for several hours at RT. Filter the solution
with gauze to remove air bubbles and big clumps of undissolved albumin.
2) Gelatin 1.5 g
0.1 M Acetate buffer, pH 6.5 100 ml
Dissolve gelatin in acetate buffer by short heating. Let the solution cool down to RT!
Mix the two solutions (1+2) without making air bubbles. Store 11-ml aliquots at -20°C.
5.1.9.9. Solutions for in situ hybridization
5% CHAPS (w/v)
Chaps (#C-3023, Sigma) 0.25 g
Distilled water (#W-3500, Sigma) 5 ml
Always prepare fresh for use.
Formamide deionized (deio)
Formamide (#K31880384 318, Merck) 500 ml
Resin (AG 501-X8 (D)) (#142-6425, Bio-Rad) 25 g
Stir for 45 min, filtrate and store in 50-ml aliquots at -20°C.
Heparin solution, 50 mg/ml (w/v)
Heparin 500 mg
Distilled water (#W-3500, Sigma) 10 ml
Store in 500-µl aliquots at -20°C.
Proteinase K solution, 20 mg/ml (w/v)
Proteinase K 100 mg
Distilled water (#W-3500, Sigma) 5 ml
Store in 50-µl aliquots at -20°C.
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Prehybridization buffer
50% Formamide deio
0.2% Tween®20
0.5% Chaps
5 mM EDTA, pH 8.0
50 µg/ml Heparin
50 µg/ml tRNA (#R-5636, Sigma)
5× SSC, pH 4.5
0.2% Blocking reagent
Add distilled water (#W-3500, Sigma) to 50 ml, dissolve at 70°C and store at 20°C.
Solution I
50% Formamide deio
5× SSC, pH 4.5
0.2% Tween®20
0.5% Chaps
Add distilled water (#W-3500, Sigma) to 50 ml. Always prepare fresh for use.
Solution II
50% Formamide deio
2× SSC, pH 4.5
0.2% Tween®20
0.1% Chaps
Add distilled water (#W-3500, Sigma) to 50 ml. Always prepare fresh for use.
Solution III
2× SSC, pH 4.5
0.2% Tween®20
0.1% Chaps
Add distilled water (#W-3500, Sigma) to 50 ml. Always prepare fresh for use.
5× Maleic acid buffer (MAB)
Maleic acid 58 g
NaCl 44 g
Adjust to pH 7.5 first with 25 to 30 g NaOH pellets, then with 5N NaOH. Add distilled water (#W-3500, Sigma) to
1 l. Store at -4°C.
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MAB-Tween (MABT)
1× MAB
0.1% Tween®20
Store at RT.
Blocking solution (w/v)
1× MABT
0.2% Blocking reagent (#1 096 176, Roche)
Incubate at 70°C until blocking reagent is dissolved (4 to 5 hours), then put on ice. Always prepare fresh for use.
NTMT
5 M NaCl 4 ml
1M Tris-HCl (pH 9.5) 20 ml
1M MgCl2 10 ml
Tween®20 200 µl
Add distilled water (#W-3500, Sigma) to 200 ml. Always prepare fresh for use.
20× SSC, pH 4.5
Sodium citrate 69.2 g
Citrit Acid 13.7 g
NaCl 175 g
Adjust to pH 4.5 and adjust volume to 1 l. Store at RT.
5.1.9.10. Reagents for electrophysiology
Artificial Cerebrospinal Fluid (ACSF)
124 mM NaCl → NaCl 7.25 g
3 mM KCl → KCl 0.224 g
1.25 mM KH2PO4 → KH2PO4 0.17 g
26 mM NaHCO3 → NaHCO3 2.184 g
2.5 mM CaCl2 → CaCl2·2H2O 0.368 g
2 mM MgSO4 →MgSO4·7H2O 0.493 g
10 mM D(+)-Glucose → D(+)-Glucose ·1H2O 1.98 g
Dissolve one ingredient after another in approximately 900 ml distilled sterile water. Adjust volume to 1 l. Satu-
rate ACSF with 95% O2 and 5% CO2. Use within 1 day.
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5.2. Methods
5.2.1. Molecular Biology
5.2.1.1. Preparation of plasmid DNA
Plasmid DNA was purified from small-scale (5 ml, minipreparation) or from large-scale (300
ml, maxipreparation) bacterial cultures. Hereby, single colonies of transformed bacteria or
from a bacterial glycerol stock were picked each into LB medium containing 100 µg/ml ampi-
cillin or kanamycin and grown overnight (O/N) at 37°C with vigorous shaking. The bacterial
suspension was pelleted by centrifugation at 4,000 rpm for 5 min at RT. The pellet was resus-
pended in buffer P1 (QIAGEN). Mini- and Maxipreparation of plasmid DNA were carried out
according to the QIAGEN protocol using lysis of the cells and binding of the plasmid DNA to
a special resin. After washing, elution and precipitation the plasmid DNA was redissolved in
a suitable volume of buffer EB (QIAGEN) for minipreparation or pure water (#W-3500, Sigma)
for maxipreparation. DNA concentration was measured in a UV spectrometer at 260 nm. The
following formula was used:
dsDNA: OD × 50 × dilution factor = X µg/ml
5.2.1.2. Enzymatic treatment of DNA
Cleavage of plasmid DNA: Approximate 2-6 µg of DNA was cut in 30 µl of the appropriate
buffer and 2 to 5 units (U) restriction enzyme for 1 to 2 hours (hrs) at an appropriate tempera-
ture.
Dephosphorylation of DNA fragments: For the dephosphorylation of DNA fragments 10×
buffer, pure water (#W-3500, Sigma) and 1 U (1 µl) of calf intestine alkaline phosphatase (#713
023, Roche) was added to the restriction enzyme reaction to get a total reaction volume of 40
µl, incubated for 20 min at 37°C and heat-inactivated at 75°C for 15 min. Subsequently the
dephosphorylated DNA fragments were purified from the reaction mix (see purification of
DNA).
Generation of blunt-end DNA fragments: To generate blunt-ends of DNA fragments by fill-
ing in the 5’ overhang , 5 U (1 µl) of Klenow (fragment of the DNA polymerase I)(#M0210S,
NEB) was incubated with the DNA fragments (see cleavage of DNA) at 37°C for 20 min in
the presence of 2 µl of dNTPs (25 mM each, Amersham). The enzyme was then inactivated at
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75°C for 10 min. Subsequently the filled in DNA fragments were purified from the enzymatic
reaction (see purification of DNA).
To generate blunt-ends of DNA fragments by removing the 3’ overhang , the DNA-fragments
(whole reaction from “cleavage of DNA”) were incubated with 5 U (1 µl) of Klenow poly-
merase (#M0210S, NEB) at RT for 20 min. The enzyme was then inactivated at 75°C for 10
min. Subsequently the blunt-ended DNA fragments were purified from the reaction mix (see
purification of DNA).
Ligating vector and target DNA fragments: A 10 µl reaction containing purified linearized
vector (approximate 0.1 µg) and DNA fragments (“insert”) in an 1:5 ratio, 0.5 µl of T4 DNA
ligase (#M0202L, NEB), ligation buffer (10× T4 DNA ligase buffer, NEB) was incubated O/N
at 16°C or at RT for 2 hrs, followed by 30 min at 37°C for sticky end ligations. Then the whole
reaction was used to transform competent bacteria.
5.2.1.3. Separation of DNA on agarose gels
The DNA mix and circa one sixth of the volume of 6× loading buffer were loaded onto an
0.8-2% agarose gel in TAE buffer containing ethidium bromide (#2218.2, Roth; use 6 µl per 100
ml) and run for approximate 30 to 35 min at 100-180 V. After electrophoresis a photograph of
the gel was taken in the transilluminator on a UV light box and printed.
In a preparative gel, the DNA band was excised from the agarose gel with a clean, sharp
scalpel and purified (see purification of DNA).
5.2.1.4. Purification of DNA
From agarose gel: Following extraction, purification of DNA fragments from agarose gels
was carried out using the QIAquick Gel Extraction Kit (#28704, QIAGEN) as recommended
by the manufacturer. The DNA was eluted in 30 µl of buffer EB (QIAGEN).
From enzymatic reactions: To clean-up DNA fragments or oligonucleotides
(> 17 nucleotides) from salts, enzymes, unincorporated nucleotides, the QIAquick Nucleotide
Removal Kit (#28104, QIAGEN) was used according to the protocol of QIAGEN. The DNA
was eluted in 30 µl of buffer EB (QIAGEN).
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5.2.1.5. Preparation of competent E.coli
The E.coli XL2-Blue supercompetent cells (Table 5.5) were streaked on a LB-tetracycline (tet)
agar plate and incubated O/N at 37°C. One single colony of E.coli was picked into 10 ml of
LB-tet medium, and cultured O/N at 37°C with vigorous shaking. The bacterial suspension
was added to 1 l Psi broth without tet and grown for 2.5 to 3 hrs at 37°C until the OD reached
> 0.48 at 600 nm. To harvest, the flask was chilled on ice for 20 to 30 min and centrifuged in
a cold rotor at 3,000 rpm for 15 min at 4°C. The pellet was gently resuspended in a total of
400 ml of ice-cold TFBI (30 mM potassium acetate, 100 mM KCl, 10 mM CaCl2, 50 mM MnCl2,
15% glycerol, adjusted to pH 5.8 with acetic acid and filter-sterilized) and kept on ice for 15
min. After re-centrifugation, the bacterial pellet was gently resuspended in 20 ml of ice-cold
TFBII (10 mM MOPS, 10 mM KCl, 75 mM CaCl2, 15% glycerol, adjust to pH 6.5 with KOH
and filter-sterilized) and incubated on ice for 15 min. Then the E.coli suspension was frozen in
200 µl-aliquots in liquid nitrogen, and stored at -80°C.
5.2.1.6. Transformation of competent E. coli using calcium chloride
50 µl of chemical competent bacteria were gently thawed on ice and mixed with the ligation
product. The tube was incubated on ice for 30 min. A heat shock was given by incubation at
42°C for 1 min. The tube was immediately placed back on ice for 2 min. Then 0.5 ml of LB
medium was added, incubated at 37°C for 15 to 60 min with shaking at 225-250 rpm, plated
on LB agar plates containing the appropriate antibiotic for the plasmid vector and incubated
at 37°C O/N.
5.2.1.7. Transformation of competent E. coli by electroporation
50 µl of electro competent bacteria were gently thawed on ice, mixed with 3-5 µl of the ligation
product and placed on ice for 1 min. Sterile 0.2 cm (green) cuvettes were placed on ice. Gene
pulser apparatus (Bio-Rad) was set at 25 µF and to 2.5 kV; the pulse controller to 200 Ω. The
mixture of bacteria and DNA was transferred to a cold electroporation cuvette and shaken
to the bottom of the cuvette. The cuvette was placed in the chamber slide, pushed into the
chamber and pulsed once at the above settings. 1 ml LB medium was immediately added to
the cuvette. The cells were resuspended, transferred to a reaction tube and incubated at 37°C
for 15 to 60 min with shaking at 225-250 rpm. The bacteria were then plated on LB agar plates
containing the appropriate antibiotic for the plasmid vector and incubated at 37°C O/N.
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5.2.1.8. Screening bacterial colonies using X-gal and IPTG
For blue-white colour screening the LB agar plate containing the appropriate antibiotic was
prepared 30 min prior to plating of the transformations. Hereby, 20 µl of 10% (w/v in Dimethyl-
formamide) X-gal and 20 µl of 100 mM IPTG were pipetted into a 100 µl pool of LB medium,
and then the mixture was spread across the plate. If mixed before adding to LB medium IPTG
and X-gal may precipitate. The transformation was spread and incubated O/N at 37°C. If the
gene of interest was successfully cloned into the lacZ gene of the pBluescriptII SK/KS, plas-
mid the β-galactosidase reading frame is shifted or interrupted and E. coli cells appear then
white instead of blue on the LB plates.
5.2.1.9. Polymerase chain reaction (PCR) & TOPO cloning
ExFP-HA-ephrinB2:
100 ng of plasmid DNA (ephrinB2-pcDNA3, kindly provided by George Wilkinson) were
mixed with each 500 ng of 5’ primer Nt-HindIII-HA-ephrinB2 and 3’ primer Ct-HA-ephrinB2,
0.4 µl of dNTPs (25 mM each), 5 µl of 10× Expand High Fidelity System buffer and 2.5 U
(=1 µl) of PfuTurbo DNA polymerase (#600250, Stratagene) and pure distilled water (#W-3500,
Sigma) was added to a volume of 50 µl.
PCR cycling parameters:
Segment Cycles Temperature Time
1 1 95°C 2 min
2 5 95°C 1 min
60°C 30 sec
72°C 1 min (1 min/kb)
3 25 95°C 1 min
60°C + 0.5°C /cycle 30 sec
72°C 70 sec
4 1 72°C 10 min
5 1 10°C forever
→ 5 µl of the PCR product were loaded on an 1% agarose gel and revealed a predicted band
of approximatly 1 kb in size.
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TOPO cloning:
The TOPO mix contained 4 µl of PCR product, 1 µl diluted (1:4) salt solution and 1 µl of
TOPO Vector (pCR2.1-TOPO). It was incubated for 30 min at RT. Chemical competent bacte-
ria were transformed with 2 µl of the TOPO reaction and spread on a X-gal and IPTG treated
LB-kanamycin plate for blue-white colour screening. White colonies were picked and DNA
preparations were checked by restriction analysis and sequenced.
5.2.1.10. Mutagenesis
All mutagenesis (see plasmids) were performed with the QuikChange Site-Directed Muta-
genesis Kit according to the protocol of Stratagene. All desired mutations were verified by
sequencing procedure (Mrs. Thyrlas, Max-Planck-Institute of Neurobiology).
5.2.1.11. Cloning and generation of in situ probes
Cloning of the EYFP in situ RNA probe
To generate a pCRII-TOPO-EYFP construct the insert encoding exon 12 of c-Ret (kindly pro-
vided by Laura Knott) was replaced by EYFP. For this, both pCRII-TOPO-cRet-ex12 and
pEYFP-N1 were cleaved with HindIII and XbaI and the EYFP-fragment was cloned into the
cut pCRII-TOPO plasmid.
Generation of the EYFP in situ RNA probe
Plasmid digestion: The primers (Sp6 or T7) for the RNA amplification must be chosen, de-
pending on the direction of the insert in the TOPO vector. Here, the insert’s 5’ end was located
next to the SP6 RNA polymerase sequence and the 3’ end next to the T7 RNA polymerase.
The vector had to be cleaved to linearize the plasmid upstream of the insert for the antisense
probes produced by the T7 RNA polymerase and downstream for the sense probes transcribed
by the SP6 RNA polymerase.
5 µg of pCRII-TOPO-EYFP plasmid were first digested with HindIII, which cleaves upstream
of the insert (for the antisense probe) and then cut downstream of the insert with XbaI (for the
sense probe). 20 U (2 µl) of each enzyme in the appropriate 10× buffer were used. The reaction
was carried out with a final volume of 30 µl and incubated at 37°C for 1 hr. 2 µl of the reaction
were loaded on an agarose gel to check if digestion was complete. In the case of complete lin-
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earization, the DNA was purified with the PCR Purification Kit (#28104, QIAGEN) and eluted
in 30 µl buffer EB (QIAGEN). DNA concentration was measured with a spectrophotometer at
260 nm.
Labelling reaction (for 20 µl):
300 ng linearized DNA
2 µl 10× Transcription Buffer (#1 465 384, Roche)
2 µl 0.1 M DTT
2 µl 10× DIG RNA labeling mix (#1 277 073, Roche)
1 µl RNase inhibitor (RNasin) (#3 335 399, Roche)
1 µl specific RNA polymerase (SP6 (#810 274, Roche) or T7 (#881 767, Roche))
to 20 µl distilled water, RNAse free (#W-3500, Sigma)
The reaction was incubated for 3 hrs at 37°C with gentle rocking. After the incubation, 2
µl were loaded on an agarose gel to check the transcription efficiency.
In order to precipitate the RNA probe 100 µl of TE buffer, 10 µl 4M LiCl and 300 µl EtOH
were added. Samples were spun for 20 min at 4°C with 13,000 rpm. After two washing steps
with 70% EtOH, the pellets were dried on ice. Subsequently, the dried pellet was resuspended
in 100 µl TE buffer and stored in 50-µl aliquots at -80°C.
5.2.1.12. Extraction of genomic DNA and genotyping using PCR
DNA preparation:
DNA was prepared from mouse tail by treatment with NaOH. 100 µl of 50 mM NaOH was
added to each approximate 2 mm mouse tail, which was placed at 95°C for 20 min and re-
turned to 10°C in the PCR machine for 2-3 times and vortexed thoroughly in between the
boiling steps. Before neutralization with 100 µl 10 mM Tris-HCl (pH 6.8), the tubes were
shortly centrifuged (4-15C, Sigma) at 5,000 rpm to avoid mixing of fluids. The samples were
vortexed and shortly centrifuged.
PCR:
1 µl per 51 µl reaction of DNA was used for PCR amplification to check the DNA for the
presence of the transgene.
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PCR master mix:
5.1 µl 10× PCR buffer (NEB)
0.4 µl dNTPs (25 mM each)
1 µl 33 µM 5’ primer (Thy1F1)
1 µl 33 µM 3’ primer (3’EphB2_358-340)
2-5 µl homemade Taq polymerase or 0.5µl T4-Taq polymerase (#M0267L, NEB)
1 µl genomic DNA
to 51 µl add distilled water
The master mix was filled into the wells of a 48-well or 96-well PCR plate. Then 1 µl of
DNA was added and mixed throughly. The samples were placed into the PCR machine and
the program with following PCR cycling parameters was started:
Segment Cycles Temperature Time
1 1 95°C 2 min
2 35 95°C 1 min
68°C 1 min
72°C 1 min (1 min/kb)
3 1 10°C forever
The PCR product was mixed with 6× loading buffer, loaded on a 1% agarose gel and then
electrophoresed for approximate 30 min at 200 V. After electrophoresis, a photograph was
taken under UV light.
5.2.1.13. Generation of transgenic mice
Vector sequences, particularly prokaryotic promoter and origin (ori) sequences impair the ex-
pression of the transgene. Therefore, single cutting restrictions sites should flank the final
DNA fragment and this should be taken into consideration during design of the construct.
Purification of DNA fragments for pronuclear injection:
Plasmid digestion:
Plasmids Thy1-EphB2-C1-EYFP (pJK22), Thy1-EphB2-C1-KD-EYFP (pJK23) and Thy1-EphB2-
∆C-EYFP (pJK24) (see plasmids) were purified from large-scale bacterial cultures using the
Endofree Plasmid Kit (#12362, QIAGEN). About 25 µg of each plasmid were digested with 30
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U of the restriction enzymes PvuI and NotI. 1 µl of the reaction mix was loaded and run on an
agarose gel to check if digestion was complete.
Gel electrophoresis:
In the case of complete linearization, the cut DNA was loaded onto a 0.8% preparative agarose
gel with a comb width of at least 5 cm in TAE buffer (in a clean gel running chamber) contain-
ing 10 mg (0.8 µl) ethidium bromide per 100 ml agarose solution and run for approximately
4 to 5 hrs at 140 to 180 V. DNA size marker should not be used in order to prevent cross con-
tamination with the DNA fragment!
Electroelution:
After separation of the specific DNA fragment from the vector backbone, the fragment of in-
terest was cut out of the agarose gel with a fresh scalpel under low intensity UV light with a
wavelength of 320 nm to avoid DNA damage. The DNA-agarose piece was transferred in a
dialysis tube (#132 111, Spectra/Por-7 dialysis membrane, Spectrum Laboratories) sealed on
one end by a plastic clamp. The dialysis bag was then filled with running buffer, closed by
a second plastic clamp and fixed in the running chamber across the electric field (e.g. with
a glass plate). The electrophoresis was continued for approximately 1 hr at 80 V to elute the
DNA fragment out off the agarose gel piece. Subsequently, the polarity was changed for 30
sec to force the eluted DNA back from the dialysis membrane into the solution. The electroe-
lution was controlled under low density UV light. At least 90% of the DNA should be eluted
in the dialysis bag. The DNA solution was transferred, free of any agarose particles, into a 15
ml tube with the help of a 5 ml-syringe with a needle connected to the bag.
Purification of the DNA fragment:
The DNA fragment was purified with the Elutip-D minicolumns (#10462615, Elutip-D-
Column-Set, NA010/0, Schleicher & Schuell). The Elutip-D column were equilibrated with
5 ml low salt buffer (0.2 M NaCl, 20 mM Tris-HCl, 1 mM EDTA, pH 7.4). After cutting off the
column’s tip, removing the protection cap and connecting the column to a syringe, the buffer
was gently pressed through the column with a flow rate of 0.5 to 1.0 ml per min.
The DNA solution was diluted with two volumes of low salt buffer and gently pressed through
the column with a flow rate of 1 ml per min (= 1 drop per second) to absorb the DNA to the
column matrix. The column was washed twice with 5 ml of low salt buffer and then the DNA
was eluted with 400 µl of high salt buffer (1 M NaCl, 20 mM Tris-HCl, 1 mM EDTA, pH 7.4)
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in an eppendorf reaction tube.
In order to precipitate the DNA 1 ml of 100% EtOH was added and mixed. The samples were
then spun for 15 min at 13,000 rpm. The pellet was washed three times with ice-cold 70%
EtOH and then dried at 50°C. Subsequently, the DNA pellets were resuspended in a small
volume (25 µl) of injection buffer (10 mM Tris-HCl, 0.2 mM EDTA, pH 7.5; in water of highest
purity (#W-3500, Sigma)). DNA concentration was determined by UV spectrophotometry and
adjusted to 100 ng/µl. Additionally the DNA concentration was checked by gel electrophore-
sis. 50 ng, 100 ng and 200 ng DNA per lane were loaded and compared with reference DNA
of known concentration.
Pronuclear injection:
The pronuclear injection was carried out by the transgenic mice service (Michael Bösel, Max-
Planck-Institute of Neurobiology). The DNA solution was injected into fertilized oocytes from
FVB mice (FVB/NCrlMpi, animal house, Max-Planck-Institute of Neurobiology) which were
implanted in pseudo pregnant females.
5.2.2. Cell culture
5.2.2.1. Propagation and freezing of mammalian cells
HEK293 cells were grown at 37°C with 5% CO2 in DMEM-FBS medium. To harvest adherent
cells, plates were washed once with D-PBS and treated with Trypsine/EDTA (#25300-054, In-
vitrogen) until cells deattached. Cells were usually seeded at a 1:8 ratio.
Cells were frozen in 8% DMSO/92% FBS, stored shortly on ice and then transfered to -80°C
or liquid nitrogen. Cells were thawed quickly in 10 ml DMEM-FBS medium, pelleted, resus-
pended in DMEM-FBS medium and seeded.
5.2.2.2. Primary culture of hippocampal neurons
Before preparation coverslips and live-cell dishes were precoated with 1mg/ml Poly-D-lysine
in borate buffer for at least 4 hrs at 37°C. Dishes were washed twice with sterile water and
dried in a sterile hood. After coating O/N at 37°C with 5 µg/ml mouse laminin in D-PBS,
dishes were washed twice with D-PBS. For high-density cultures, D-PBS was replaced with
Neurobasal-B27 medium and for low-density cultures with DMEM-B27. Media were left to
equilibrate for at least 1 hr in the incubator with a 5% CO2 atmosphere.
Hippocampal neurons were taken from pregnant CD1 mice (MpiCrlIcr:CD1, animal house,
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Max-Planck-Institute of Neurobiology) at embryonic day 16.5 (E16.5) or from pregnant Wistar
rats (MpiChbb:Thom, animal house, Max-Planck-Institute of Neurobiology) at E18.5. Preg-
nant rat was deeply anesthetized using diethyl ether. After decapitation (rat) or cervical dis-
location (mouse), embryos were obtained and kept in ice-cold dissection medium. The prepa-
ration was then continued under an open sterile hood. Embryo heads were cut off and the
scull opened to take out the brain. Embryonic brains were placed in fresh dissection medium
and dissected under a stereomicroscope. Brain cortices were removed from the midbrain and
brainstem and the meniges were pulled off. The striatum was cut out. The hippocampus was
separated from the cortex and placed in fresh 15 ml dissection medium on ice. After removing
the medium, hippocampi were incubated in 1.5 ml 0.25% Trypsin/1mM EDTA-HBSS-solution
(#25200-056, Invitrogen) for 20 min at 37°C. The digestion reaction was stopped first by care-
fully removing Trypsin/EDTA-HBSS-solution and then by washing hippocampi three times
with 3 ml DMEM-FBS. Then the tissue was triturated approximatly 20 times with the help of a
fire-polished glass pasteur pipette until the suspension was homogeneous. Subsequently, the
cell suspension was centrifuged for 5 min at 80g to remove debris. Pellet was resuspended in
2 ml Neurobasal-B27 medium. Cells were counted in a hemacytometer and plated on coated
glass coverslips in a 24-well plate at a density of 45,000 cells per well (high-density) or on
coated glass bottom live-cell dishes. Depending on the length of culture, different numbers of
cells were plated and incubated for 3-28 days in vitro (DIV) at 37°C in a humidified incubator
with an atmosphere of 5% CO2.
For time lapse experiments, glass bottom live-cell dishes were coated as described above. For
high-density cultures 160,000 cells and for low-density cultures 40,000 cells were seeded in 2
ml of growing medium, respectively. After 14 DIV the hippocampal cultures were transfected
using the Calcium-phosphate-DNA precipitation procedure.
5.2.2.3. Primary culture of glia
Preparation of astrocytes
Cerebral hemispheres (without meninges) were collected when preparing the hippocampi
from pregnant Wistar rats (MpiChbb:Thom, animal house, Max-Planck-Institute of Neurobi-
ology) at E17.5 to E18.5. The hemispheres were kept in dissection medium at 37°C during
trypsinization of the hippocampi. After replacing the dissection medium with 5 ml of 0.25%
Trypsin/1mM EDTA-HBSS-solution (#25200-056, Invitrogen), the tissue was incubated for 15
min at 37°C. The digestion reaction was first stopped by removing carefully Trypsin/EDTA-
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HBSS-solution and then by washing three times with dissection medium or MEM-HS medium.
Subsequently, the hemispheres were triturated approximately 20 times in 5 ml MEM-HS with
the help of a fire-polished glass pasteur pipette until the suspension was homogeneous. To
grow astrocytes, cell were plated at a density of approximately 60,000 cell per cm2 onto un-
treated Nunc tissue culture flasks (approximately 5 million cells per 75 cm2, approximately
4-5 hemispheres) containing MEM-HS. The next day, after cell attachment, the medium was
changed completely to remove cell debris. When the cells reached about 80% confluency (7-10
days), they were trypsinized and split at 1:3 ratio. The astrocyte cultures can be passed up to
four times.
Preparation of feeder layer for neuronal low density cultures
For low-density cultures hippocampal neurons were seeded as described above. After three
days in culture the astrocytes feeding-layer and conditioned medium were put into the live-
cell dishes.
One week before plating the neurons, twelve coverslips (∅ 10-mm) with paraffin dots are
placed onto one ∅ 6-cm tissue culture dish to maximize the glass surface. 80% confluent glia
cells from one flask were trypsinized, resuspended in 30 ml MEM-HS and plated onto six ∅
6-cm tissue culture dishes with the coverslips. One day later the medium was replaced with
fresh MEM-HS. On the day of preparation of the neuronal cultures MEM-HS was replaced
with NMEM-B27 medium in order to let glia cells secrete survival factors in the medium.
Three days after plating of the hippocampal low-density cultures, the coverslips with approx-
imately 80% confluent astrocytes were grabbed using sterile forceps and flipped over into
the dishes containing the neurons (1 to 2 coverslips/∅ 3-cm dish). Half of the NMEM-B27
medium (approximately 1 ml) in the neuronal dish was then replaced with the conditioned
NMEM-B27 medium from the astrocytes. Every 10 days half of the old medium was replaced
with fresh NMEM-B27.
5.2.2.4. Transfection of cell lines, primary neurons
HEK293 cells were transiently transfected using Effectene (QIAGEN) according to the proto-
col.
For the calcium phosphate transfection method all solutions were warmed to room tempera-
ture. The plasmid DNAs were briefly spun down in a mini centrifuge. For transfection of neu-
rons growing (i) in live-cell dishes, part of the medium was removed, leaving 0.9 ml medium
in the dish and (ii) on coverslips (∅ 13-mm) in a 24-well plate, leaving 0.25 ml. The remaining
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medium was collected, filter-sterilized and kept at 37°C in a humidified incubator with an at-
mosphere of 5% CO2. For 1 ml transfection solution 3-7.5 µg DNA (depending on the plasmid
size) were slowly added to freshly diluted 250 mM CaCl2 solution by stirring with the pipette
tip, the final volume being 50 µl. 50 µl of 2× BBS was added drop wise to the DNA-CaCl2
solution. The reaction tube was gently shaken each time after addition of three drops of 2×
BBS. The solution was then thoroughly mixed. The CaCl2-DNA-BBS mixture was added drop
wise to the hippocampal neurons and the dishes gently swirled in order to mix medium and
transfection mixture and to ensure a homogeneous formation of the DNA-calcium phosphate
precipitation.
For the transfection of neurons on coverslips the CaCl2-DNA-BBS mixture was added drop
wise to 0.9 ml medium in a polystyrene-tube (Falcon) while vortexing. After collecting the re-
maining medium from 2 to 4 wells, 250 µl of the transfection solution was immediately added
to each well. The collected medium was filter-sterilized and again kept in the incubator.
Cells were incubated at 37°C in a humidified incubator with an atmosphere of 5% CO2 for the
desired transfection time (2-4 hrs). If the formation of precipitate was too strong, the trans-
fection medium was removed and cultures were washed with prewarmed HBSS (#14025-050,
Invitrogen) until the DNA-calcium phosphate precipitation was completely washed off from
the cells, subsequently they were incubated in the “old” kept culture medium. The expres-
sion time for time lapse experiments was typically 2 to 3 days and up to 10 days for some
immunohistochemistry experiments.
5.2.2.5. Stimulation of cells with Eph receptors or ephrin ligands
Activation of the Ephs and ephrins was induced with clustered multimeric ligands or recep-
tors, respectively. Hereby, ephrin-Fc, Eph-Fc or as a control Fc were multimerized for at least
30 min at room temperature using 1/10 (w/w) anti-human Fcγ. In Immunohistochemistry
experiments, a concentration of 4 µg/ml of preclustered ligands was used to stimulate Eph
receptors and 1-2 µg/ml to activate the ephrin ligands.
5.2.2.6. Time lapse imaging
Live-cell imaging was performed with a Zeiss Axiovert 200M microscope equipped with a
temperature-controlled CO2-incubation chamber set to 37°C, 60-70% humidity, 5% CO2 and a
FluoArc system (Zeiss, Germany) set to 30-50%. Images were aquired using a 63× oil immer-
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sion objective with a CoolSNAP-fx camera. Sequential couples of EYFP and phase contrast
images were taken at a rate of 1-2 frames per minute and processed using MetaMorph (Vis-
itron, Germany) and ImageJ software (rsb.info.nih.gov/ij/download.html).
5.2.2.7. Chemical stimulation of neurons
For KCl-stimulation experiments of transfected neurons the live-cell dishes were transferred
to the above described “time lapse setup”. Before starting the live-cell imaging, cultures were
constantly perfused (speed=5.2, Minipuls 3, Gilson) for at least 30 min with external solution
Bi and Poo (1998). YFP images were taken at a rate of 1 frame per min. After 15 to 20 min
the neuronal cultures were stimulated with 50 mM KCl or 50 µM glutamate for 4 to 5 min by
washing in and out (speed=8) the KCl-stimulation solution. Time-lapse imaging was contin-
ued for about 1 hr.
5.2.3. Biochemistry
5.2.3.1. Cell lysis and immunprecipitation of proteins
Cell lysis Transiently transfected HEK293 cells were washed once with ice-cold D-PBS and
lysed in lysis buffer on ice for approximately 5 min. After scraping off and collecting the cells
from the dish, the cell lysate was centrifuged at 10,000g for 15 min at 4°C to remove insoluble
material (nuclei, cytoskeletal components and insoluble membranes). The supernatant was
placed in a fresh eppendorf tube and directly loaded onto a SDS-Polyacrylamide (PA) gel or
purified further (see below). Before loading on a gel, samples were boiled in 2× sample buffer
for 5 min to denature the proteins.
Immunoprecipitation of proteins Depending on the specific immunopreciptation X µg of
the antibody against the protein of interest (see table secondary antibodies) was prebound to
20 µl of protein A-sepharose (for rabbit polyclonal antibodies) or 20 µl of protein G-sepharose
(for mouse monoclonal and goat polyclonal antibodies) for 30 min on ice. The total lysate
from the different samples was added and incubated for 2 to 3 hrs on a rotating wheel at 4°C.
Subsequently, the mixture was spun down at 3,000 rpm for 5 min at 4°C. The supernatant
was discarded and the beads were washed three times with lysis buffer to remove traces of
unbound proteins. 20 µl of 2× sample buffer was added to the beads and the mix was then
heated to 95°C for 5 min to elute the proteins and antibodies from the beads. The full sample
81
5. Materials and Methods
was loaded on a SDS-PA gel under reducing conditions and further processed, typically using
SDS-PAGE and western blot analysis.
5.2.3.2. Immunoblotting
Protein samples derived from the procedures described above were separated by 7.5% or 10%
SDS-PAGE and transferred to nitrocellulose or PVDF membranes by semi-dry blotting (1 mA
per cm2 for 1 to 1.5 hrs). Membranes were blocked at least for 1 hr at RT or O/N at 4°C in
blocking solution. Following the blotting, membranes were incubated either 1-3 hrs at RT or
O/N at 4°C with a primary antibody diluted in blocking solution. Subsequently, membranes
were washed three times for 10 min in PBST at RT. Secondary antibodies linked to horseradish
peroxidase (HRPO) were used to specifically recognize the primary antibody diluted in block-
ing solution. After incubation for 1 hr at RT, membranes were washed three times for 10 min
in PBST. To visualize signals, the membrane was incubated with ECl solution for 1 min at RT
and exposed to films (BioMax MS/MS, Kodak). The films were developed in an Optimax (Typ
TR, MS Laborgeräte). For reprobing, membranes were stripped with stripping buffer.
5.2.4. Mouse work
Transgenic mice were crossed in a C57/Black6 (C57BL/6NCrlMpi, animal house, Max-Planck-
Institute of Neurobiology) genetic background. For experiments with adult mice, mice were
separated from their parents at the age of about three weeks, males and females were housed
separately. Tail biopsies were taken and mice were ear tagged using six-digit number eartags
from the Nationalband & Tag company. For all experiments a heterozygous transgenic male
was crossed with wild type females and the mice of one litter were compared. For experi-
ments with embryos, breedings were set up with one male and two females. Vagina plugs
were checked starting on the next morning from the start of breeding. A plug was counted
as pregnancy for 0.5 days. Embryos were taken according to experimental procedures, but
typically at E16.5.
5.2.5. Histology
5.2.5.1. Cryosections
Cryosections were used to analyze the different founder lines from the transgenic mice or
for immunostainings on floating sections. Therefore, transgenic mice (age: P50 to P120)
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were shortly anesthetized with diethyl ether and decapitated with a guillotine (Max-Planck-
Institute of Neurobiology). The head was opened and the whole brain quickly dissected out
of the skull and placed into 15 ml ice-cold D-PBS for 2 min to elinimate blood. Brains were
then fixed in 4% paraformaldehyde (PFA)/4% sucrose for 2.5 to 4 hrs. Subsequently brains
were transferred in 30% sucrose in D-PBS and incubated O/N at 4°C.
For cryosections the brain was cut at the midline with a razor blade (between left and right
hemisphere) and one half was frozen in embedding medium (Tissue-Tek O.C.T. compound,
#4583, Sakura Finetek) on a cooling platform (cortex side down, cut side up). Sagittal sections
were cut at a thickness of 20 µm to 100 µm on a sliding microtome (HM400, MICROM). Single
sections were picked up with a fine brush and immersed in PBS.
5.2.5.2. Vibratome sections
In situ analysis of expression in adult brain was carried out using vibratome sections. There-
fore, brains which were left O/N in 4% PFA at 4°C were washed three times with D-PBS and
then immersed in a mixture of gelatin and ovalbumin in acetate buffer (see embedding solu-
tion). For embedding, a 11-ml aliquot was thawed at 37°C and cooled down at RT. A base
was prepared by adding 100 µl of glutaraldehyde (25%, Sigma) to 2 ml embedding medium,
mixed quickly and poured into the molds. After polymerization of the embedding medium
the half brain was placed on top of it. Liquid was carefully removed with tissue paper and 350
µl of glutaraldehyde (25%, Sigma) were added to the remaining 7 ml of embedding medium,
then mixed quickly and poured on the sample. For complete solidification the polymerized
sample was stored 1 hr at 4°C in PBS.
For vibratome sections a small block including the brain tissue was cut out of the mould with
a razor blade and glued to the holder (Leica). 80 µm and 100 µm sagittal sections were cut on
a microtome (VT1000S, Leica), immersed in D-PBS and immediately processed further for in
situ hybridization.
5.2.5.3. Antibody staining
20 µm to 40 µm cryosections were incubated for 1 hr at RT in 10% serum (typically from the
same animal species used for the production of secondary antibody) in D-PBS, 0.2% TX-100
(blocking solution). The primary antibody was diluted in blocking solution and incubated
O/N at 4°C. After washing three times with D-PBS for about 30 min, slices were incubated
with fluorescent labeled secondary antibody diluted in D-PBS for 2 hrs at RT. After 3 washes
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with D-PBS slices were mounted in Gel/Mount media and dried at RT.
5.2.5.4. Immunocytochemistry
Immunostaining of cells
For normal immunocytochemistry of total protein distribution, neurons grown on coverslips
were fixed with 4% PFA/4% sucrose in D-PBS for 13 min at RT, washed once with D-PBS,
then incubated with 50 mM ammonium chloride in D-PBS for 10 min at RT and washed again
before permeabilization for 5 min with ice-cold 0.1% TX-100 in D-PBS at 4°C. After wash-
ing, coverslips were blocked for about 30 min at RT or O/N at 4°C with 2% bovine albumin
(#A-3294, Sigma) and 4% serum (depending on the secondary antibody used: donkey, goat,
sheep and/or rat serum, Jackson ImmunoResearch) in PBS. After blocking, coverslips were
transferred into a dark moist chamber, face up. Primary antibodies for total stainings were
incubated for at least 60 min at RT in 50 µl blocking solution. After 3 washing steps with
D-PBS for 5 min, secondary antibodies, previously diluted in 50 µl of blocking solution, were
added to the coverslips for 30 min at RT in the dark. After washing, samples were mounted
in Gel/Mount media and dried at RT. Images were acquired using an epifluorescence mi-
croscope (Zeiss) equipped with a digital camera (SpotRT, Diagnostic Instruments) and the
MetaMorph software (Visitron Systems).
Immunofluorescence internalization assay
Cells were fixed with 4% PFA/ 4% sucrose in D-PBS for 13 min at RT, washed once with D-
PBS, then incubated with 50 mM ammonium chloride in D-PBS for 10 min at RT and rinsed
again before blocking for about 30 min at RT with 2% bovine albumin (#A-3294, Sigma) and
4% serum (depending on the secondary antibody used: donkey, goat, sheep and/or rat serum,
Jackson ImmunoResearch) in PBS. Primary antibodies for surface labeling were applied for 60
min at RT in blocking solution. Cells were washed three times for 5 min with D-PBS and then
permeabilized for 5 min with ice-cold 0.1% TX-100 in D-PBS at 4°C. After washing, the cover-
slips were blocked for 30 min at RT or O/N at 4°C. Primary antibodies for total stainings were
applied for at least 60 min at RT in blocking solution. After three washing steps with D-PBS for
5 min, secondary antibodies, diluted in blocking solution, were applied to the coverslips for
30 min at RT in the dark. After washing, samples were mounted in Gel/Mount media and let
dry at RT. Images were acquired using an epifluorescence microscope (Zeiss) equipped with a
digital camera (SpotRT, Diagnostic Instruments) and the MetaMorph software (Visitron Sys-
tems).
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5.2.5.5. in situ hybridization
Brain sections were prepared with the vibratome and processed directly in situ hybridization
using a whole mount protocol. All solutions used were RNase free. 80 µm sections were col-
lected in D-PBS and subsequently dehydrated in methanol diluted in D-PBS (25% for 5 min,
50% for 5 min, 75% for 5 min, 100% for twice 5 min). Sections were stored for up to several
months at -20°C in 100% methanol or further processed after at least 2 hrs at -20°C. Sections
were then placed into a solution made out of 80% methanol and 20% of a 30% H2O2 solution
(final concentration of 6% H2O2) for 1 hr at RT. Rehydration was carried out in 50% methanol
in D-PBS for 5 min followed by 25% methanol in D-PBS for 5 min. Finally, the samples were
washed three times in PBST for 5 min at RT. To remove proteins from RNA, sections were
treated with Proteinase K (20 µg/ml in D-PBST) for 13 min at RT. In order to stop the reaction,
sections were washed twice with PBST on ice. Subsequently, sections were refixed in fresh
4% PFA containing 0.2% glutaraldehyde for 40 min at RT. Following two washes in PBST, sec-
tions were gently rocked in prehybridization buffer for at least 1 hr at 70°C. DIG-labeled RNA
probes (= 12.5 µl/ml) were diluted in prehybridization buffer, preheated for 7 min to 70°C,
and incubated with the sections O/N at 70°C.
The next day, sections were first rinsed for 5 min and then washed three times for 30 min in
Solution 1 at 70°C. From this point on, RNase-free solutions were no longer required. Follow-
ing 5-min rinsing and three 30-min washes in Solution 2 at 66°C, sections were initially rinsed
for 5 min and then washed three times for 30 min in Solution 3 once at 66°C and twice at 68°C.
Subsequently, sections were washed twice with MABT for 5 min at RT and then twice for 30
min at 70°C. Unspecific antibody binding was prevented using blocking solution for 1.5 hrs
at RT. To detect DIG-labeled RNA, sections were incubated O/N at 4°C with an anti-DIG Fab
fragment conjugated with alkaline phosphatase (AP) (1:2000 in blocking solution, #1 093 274,
Roche).
The next day, sections were washed 8 to 10 times with MABT for 30 min to get rid of unbound
or unspecifically bound Fab fragments and to prevent endogenous AP activity. After washing,
sections were rinsed once in freshly made NTMT and then equilibrated in NTMT for 10 to 20
min. Developing solution was added (1.4 µl nitroblue tetrazolium (NBT) and 1.1 µl 5-bromo-
4-chloro-3-indolyphosphate (BCIP) per ml NTMT) to give a dark purple color. Reaction and
sample were kept in the dark. Sections were left in substrate solution at 37°C until enough
staining was obtained. Upon development, sections were washed in PBST and postfixed in
4% PFA O/N. The sections were then mounted and stored in a solution made of 1 part 4%
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PFA and 1 part glycerol.
5.2.6. Electrophysiology
Electrophysiological experiments were conducted by Dr. Martin Korte and Volker Staiger in
the laboratory of Prof. Dr. Tobias Bonhoeffer at the Max-Planck-Institute of Neurobiology,
Martinsried, Germany.
5.2.6.1. Organotypic acute hippocampal slices
Mice were shortly anesthetized using diethyl ether. After decapitation, embryonic brains were
quickly dissected out and placed into ice-cold artificial cerebrospinal fluid (ACSF) for 2 min.
To ensure constant pH and oxygen levels the ACSF was constantly aerated with Carbogen
(95% O2 and 5% CO2). After cooling for a few minutes, the hemispheres were separated
and the hippocampus was isolated. Intact hippocampi were cut with a so-called “egg-slicer”
(Katz, 1987). The egg-slicer separates 400-µm thick transverse hippocampal sections via a fine
wire-net that acts in a guillotine-like fashion. The sections were then separated with the help
of a pair of fine forceps and maintained in ACSF for several hrs before and during the experi-
ments.
5.2.6.2. Electrophysiological recordings
The Thy1-EphB2-EYFP+/-(A line) and Thy1-EphB2-∆C−EYFP+/-(Df line) transgenic mice were
between P41 and P60 for LTP (E-LTP, L-LTP) experiments. The ACSF was saturated with
95% O2 and 5% CO2. The hippocampi were cut as described above. Slices were main-
tained in ACSF at RT for at least 1.5 hrs before recording. Recordings were started after a
20-min equilibration phase in the recording chamber. Synaptic responses were evoked in the
CA3 region of the mouse hippocampus by stimulating Schaffer collaterals with 0.1 ms pulse
through a monopolar tungsten electrode. Field excitatory postsynaptic potentials (fEPSPs)
were recorded extracellularly in the striatum radiatum of the CA1 pyramidal cell region (ap-
proximately 100 µm below slice surface) using glass microelectrodes (borosilicate: 1.0 mm
OD × 0.58 mm ID + inner filament, Clark) filled with 3 M NaCl (8-10 MΩ). For baseline
recordings slices were stimulated at 0.1 Hz for 20 min at stimulation intensities that resulted
in half-maximal fEPSP-amplitudes (30-180 mA). Paired-pulse facilitation (PPF) was tested by
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applying two pulses separated by intervals ranging from 10-160 ms.
LTP was induced by applying thetaburst stimulation (TBS): TBS consists of three bursts (10-s
interval), each of them composed of 10 trains (5 Hz) with four pulses each (100 Hz).
5.2.6.3. Data analysis
Electrophysiological data were sampled at 5 kHz on a personal computer using a customized
LabView program (National Instruments), which was also used for offline analysis. All mea-
surements were carried out and analyzed in a strictly blind fashion. Therefore, the genotype
of the slices was revealed after the measurement and its analysis had been completed. As an
indicator of synaptic strength the initial slope of the evoked fEPSPs was measured, averaged
across 6 or 7 consecutive measurements and expressed as percentages relative to the baseline
mean. The normalized data of each experiment were then time-matched, averaged across ex-
periments and expressed as means (±SEM). PPF was expressed as the increase in initial slope
of the second fEPSP relative to the first. Post tetanic potentiation (PTP) was measured as the
mean fEPSP-slope during the first 3 min after the application of TBS relative to baseline.
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5.3. Ordering information
Table 5.9. Order Information
COMPANY (WEB) ADDRESS
ABgene Germany www.abgene.com
Amersham Biosciences Europe GmbH www4.amershambiosciences.com
Applied Biosystems www.appliedbiosystems.com
Becton Dickinson and Company www.bdbiosciences.com
Biomeda Corporation. www.biomeda.com
Bio-Rad Laboratories www.bio-rad.com
Brand GmbH & Co.KG www.brand.de
Carl Zeiss AG Deutschland www.zeiss.de
Chemicon Europe www.chemicon.com
Clark, Electromedical Instruments PO Box 8 Pangbourne, Reading RG8 7HU, UK
Corning Incorporated www.corning.com
Diagnostics Instruments, Inc. www.diaginc.com
Dianova GmbH www.dianova.de
EMBL www.embl-heidelberg.de
Eppendorf AG www.eppendorf.de
Fine Science Tools GmbH www.finescience.com
Fluka www.sigma-aldrich.com
GFL - Gesellschaft für Labortechnik mbH www.gfl.de
Gilson, Inc. www.gilson.com
Greiner Bio-One GmbH www.gbo.com/bioscience
Heidolph Instruments GmbH & Co. KG www.heidolph.com
IKA® Werke GmbH & Co. KG www.ika.net
International Labnet Co. www.labnetlink.com
Integra Biosciences AG www.integra-biosciences.com
Invitrogen GmbH www.invitrogen.com
Infors GmbH www.infors-ht.com
Jackson ImmunoResearch www.jacksonimmuno.com
Kendro Laboratory Products GmbH www.kendro.com
Kimberly-Clark Europe www.kimberly-clark.com
Köttermann GmbH & Co.KG www.koettermann.de
Labnet International www.labnetlink.com
Leica Mikrosysteme Vertrieb GmbH www.leica.com, www.leica-microsystems.com
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MatTek Corporation www.mattek.com
Memmert GmbH & Co.KG www.memmert.com
Merck KGaA www.merckeurolab.de
Metabion www.metabion.de
MICROM International GmbH www.microm.de
Millipore Corporate Headquarters www.millipore.com
MJ Research www.aibltd.com
Molecular Probes www.probes.com
MS Laborgeräte www.ms-l.de
Nationalband & Tag company www.nationalband.com
National Diagnostics www.nationaldiagnostics.com
National Instruments (LabView) www.ni.com
NeoLab www.neolab.de
New England Biolabs GmbH, NEB www.neb-online.de
Nunc GmbH & Co.KG www.nunc.de
Paul Marienfeld GmbH & Co. KG www.superior.de
PESKE, Medizintechnik/Laborbedarf Beratung und Vertrieb, Von Schaezler Str. 18
D-86447 Aindling, Germany
PharMingen www.pharmingen.com
PhotoMetrics, Inc www.photomet.com
Poulten & Graf GmbH, Volac Am Bildacker 3-7, D-97877 Wertheim, Germany
Precisa Instruments AG www.precisa.com
QIAGEN GmbH www.qiagen.com
R&D www.RnDSystems.com
RDI, Research Diagnostics, Inc. www.researchd.com
Roche www.roche.com
Roth www.carl-roth.de
Sakura Finetek Europe www.sakura-americas.com
Santa Cruz www.scbt.com
Schleicher & Schuell BioScience GmbH www.schleicher-schuell.com
Serva www.serva.de
Sigma-Aldrich Chemie GmbH www.sigma-aldrich.com
Spectrum Laboratories www.spectrapor.com
Stratagene www.stratagene.com
Synaptic Systems, SySy www.sysy.com
TERUMO Deutschland GmbH www.terumo-europe.com
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Upstate Biotechnology, UBI www.upstate.com, www.upstatebiotech.com
Visitron Systems GmbH www.visitron.de
Whatman www.whatman.com
WTW www.wtw.com
90
6. Results
6.1. Generation of fluorescently tagged EphB2 receptors
In order to better understand the role of EphB2 receptors and to study their trafficking dy-
namics, insertion and clustering in neurons during synapse formation and synaptic plasticity,
the EphB2 receptor was fluorescently tagged with blue (ECFP), green (EGFP) or yellow flu-
orescent protein (EYFP) (generally indicated as: ExFP). Eph receptors interact N-terminally
with their different ephrin ligands via their globular domain and C-terminally with a large
number of signalling proteins via their PDZ-motif. Thus N- or C-terminal tagging could neg-
atively influence important protein-protein interaction. Surprisingly, it has been shown by
our group that the N-terminal fusion of ExFP to ephrinB1 does not affect the clustering of
ephrinB1 (Brückner et al., 1999; Zimmer et al., 2003).
Figure 6.1. Schematic view of the ExFP insertions sites in the EphB2 receptor. To visualize the EphB2 receptors
one variant of the enhanced blue, green or yellow fluorescent protein (ExFP) was fused to the receptor. ExFP
was inserted in one of the three different positions (blue arrows) of the EphB2 receptor: the N-terminus (EphB2-
N), a site close to the juxtamembrane domain (EphB2-C1) and between two functional relevant domains of the
cytoplasmic part of EphB2 (EphB2-C2).
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The crystal structure of EphB2 was analyzed to find ideal insertion sites, where the protein
structure could still be intact after the ExFP-insertion, for example between the functional
protein domains. Three different tagging sites were chosen: (i) the N-terminus, (ii) a site
adjacent to the juxtamembrane region or (iii) between the kinase domain and the SAM do-
main (Figure 6.1). According to the EGFP-ephrinB1 and other N-terminal fusion proteins
the N-terminally tagged ExFP-EphB2 (named EphB2-N) was expected to be the most likely
functionally intact fusion protein and was therefore generated as a “control” fusion protein,
however with the potential caveat that the ligand binding ability of the domain could be im-
paired. The two intracellularly tagged EphB2 receptor versions, EphB2-C1 and EphB2-C2,
have unconventional ExFP insertions into the receptor sequence and were therefore more un-
predictable concerning receptor function and fluorescence properties (for details see Material
and Methods/Plasmids/EphB2-ExFP expression constructs).
6.1.1. Analysis of tagged EphB2 receptors
6.1.1.1. Expression
HEK293 cells can be readily and very efficiently transfected with plasmid DNA. The three dif-
ferent EphB2-ExFP receptors, EphB2-N, EphB2-C1 and EphB2-C2, were expressed in HEK293
cells and showed intense fluorescence at the membrane level (Figure 6.2A-C). Compared to
only ExFP-expressing cells, the fluorescently tagged EphB2 receptors are less bright (data not
shown), but bright enough for live-cell imaging or in combination with immunostaining ex-
periments. The fluorescence intensity was comparable to EGFP-ephrinB1 or EGFP-ephrinB1-
∆C overexpressing HEK293 cells (Figure 6.2).
Figure 6.2. Expression of fluorescently tagged EphB2 receptors and ephrinB1. HEK293 cells were transfected
with plasmid DNA encoding EphB2-N (A), EphB2-C1 (B), EphB2-C2 (C), EGFP-ephrinB1 (D) or EGFP-ephrinB1-
∆C (E). Images were taken two days after transfection.
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6.1.1.2. Tyrosine phosphorylation
Activation of Eph receptors induces autophosphorylation on multiple residues, including the
two tyrosines within a highly conserved juxtamembrane motif and a tyrosine in the kinase
activation segment (Dodelet and Pasquale, 2000). In the absence of exogenous ephrin ligands
overexpressed Eph receptors are constitutively autophosphorylated in HEK293 cells (Kullan-
der et al., 2001).
To analyze the autophosphorylation potential of fluorescently tagged EphB2 receptors, kinase-
active and kinase-deficient versions of non-fluorescently tagged and fluorescently tagged
EphB2 receptors were expressed in HEK293 cells. All of the different EphB2 receptors carried
an N-terminal FLAG-epitope tag. EphB2 proteins were immunoprecipitated with monoclonal
anti-FLAG antibodies from cell lysates. Immunoprecipitations (IPs) were analyzed by SDS-
PAGE and immunoblotted (WB) with anti-phosphotyrosine (pY) antibodies (Figure 6.3, upper
panel). The blot was stripped and reprobed with anti-FLAG antibodies to determine protein
levels (Figure 6.3, lower panel). Like the wild type (wt) receptor, the fluorescently tagged
Figure 6.3. Tyrosine phosphorylation of EphB2 receptors. Untransfected HEK293 cells (MOCK, lane 1) or HEK293
cells transfected with expression vectors encoding epitope-tagged (FLAG) wild type EphB2 (EphB2, lane 2),
kinase-deficient FLAG-EphB2 (EphB2-KD, lane 3), FLAG-EphB2 with mutated juxtamembrane tyrosine residues
to phenylalanine (EphB2-Y→F, lane 4), fluorescently-tagged FLAG-EphB2-N (EphB2-N, lane 5), fluorescently-
tagged FLAG-EphB2-C1 (EphB2-C1, lane 6), fluorescently-tagged kinase-deficient FLAG-EphB2-C1 (EphB2-C1-
KD, lane 7), fluorescently-tagged FLAG-EphB2-C2 (EphB2-C2, lane 8) or fluorescently-tagged kinase-deficient
FLAG-EphB2-C2 (EphB2-C2-KD, lane 9). Cell lysates were immunoprecipitated (IP) with monoclonal anti-FLAG
antibody and then immunoblotted (WB) with monoclonal antibodies against phosphotyrosine (anti-pY) (upper
panel). The stripped blot was reprobed with antibodies against FLAG to visualize expression levels (lower panel).
The migration positions of molecular size marker (in kilodaltons) are indicated on the left.
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EphB2 receptors were autophosphorylated and migrated with an apparent molecular mass of
v140 kDa (Figure 6.3, lane 5-6 and 8). Wt EphB2, EphB2-N and EphB2-C1 proteins gave high
levels of tyrosine phosphorylation. The EphB2-C2 fusion protein showed somewhat reduced
tyrosine phosphorylation (Figure 6.3, compare lane 2, 5-6 with 8). In contrast, drastically re-
duced levels of tyrosine phosphorylation or even no tyrosine phosphorylation were detected
as expected in kinase-deficient EphB2 mutants, generated by a replacement of lysine (aa660)
to arginine in the kinase domain (= mutated ATP binding site) (Figure 6.3, lane 3, 7 and 9). As
in the EphA4 receptor, substitution of the two conserved juxtamembrane tyrosines in EphB2
with phenylalanine inhibited autophosphorylation of non-fluorescent EphB2 (Figure 6.3, lane
4)(Kullander et al., 2001).
Interaction partners
Unlike EphA4 receptors, EphB2 receptors interact via the extracellular part with the NMDA
receptor subunit NR1 upon ephrinB stimulation in cultured cortical neurons. NR1 and EphB2,
could be co-immunoprecipitated when expressed in HEK293T cells or from cortical lysates
(Dalva et al., 2000). In addition, the C-terminal PDZ motif of EphB2 interacts with the synap-
tic protein GRIP (Figure 6.4A) (Torres et al., 1998).
To test whether the fluorescently tagged EphB2 receptor is capable of interacting with known
proteins, such as NR1 and GRIP2, HEK293 cells were transiently transfected with expression
constructs encoding one of the variants of the EphB2 receptors or in combination with vec-
tors coding for NR1 or MYC-epitope tagged GRIP2. Before lysis cells were stimulated with
preclustered fusion bodies of Fc fragments (Fc) with ephrinB2 ectodomains (ephrinB2-Fc) or
Fc for 10 min. EphB2 and NR1 proteins were immunoprecipitated with anti-FLAG and anti-
NR1 antibodies, respectively. After stripping, blots were reprobed with anti-FLAG or anti-
NR1 antibodies (Figure 6.4B-D, lower panels). IPs were resolved by SDS-PAGE and probed
with anti-FLAG or anti-NR1 antibodies to visualize protein levels (Figure 6.4B-C, upper pan-
els). As shown in figure 6.4B, NR1 was co-precipitated with anti-FLAG antibodies only from
cell lysates overexpressing both proteins (Figure 6.4B, compare lanes 2-5 with lanes 6-9). In
the reverse experiment, co-immunoprecipitation of EphB2 proteins with NR1 could also be
observed (Figure 6.4C, lanes 3-6).
In case of the interaction partner GRIP2, wt and fluorescently tagged EphB2 receptors could be
co-immunoprecipitated with MYC-GRIP2 protein only from cells that had been co-transfected
with an expression plasmid encoding GRIP2, albeit with low efficiency. In the converse exper-
iment, presumably due to technical reasons, co-IP of EphB2 with MYC-GRIP2 protein could
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Figure 6.4. Interaction of EphB2-ExFP receptors with NR1 and GRIP2. (A) Schematic representation of the re-
gions of EphB2 interacting with NR1 and GRIP2. (B) Co-precipitation of EphB2 with NR1. HEK293 cells overex-
pressing wt EphB2 (wt, lane 5 and 9) or EphB2-ExFP (EphB2-N, lane 2 and 6; EphB2-C2, lane 3 and 7; EphB2-C1,
lane 4 and 8), either alone or in combination with NR1 (lane 6-9) were stimulated with ephrinB2-Fc (+) for 10
min before lysis. IPs using anti-FLAG antibodies were analyzed with SDS-PAGE and immunoblotted (WB) with
anti-NR1 antibodies (upper panel). Blot was stripped and reprobed with anti-FLAG antibodies to visualize EphB2
protein levels (lower panel). (C) Reverse experiment of (B) with IPs using anti-NR1 antibodies and immunoblot-
ted with anti-FLAG antibodies. The stripped blot was reprobed with anti-NR1 antibodies. (D) GRIP2 interacts
with EphB2. HEK293 cells were transfected and stimulated as indicated above and under each panel. IPs were
performed using anti-FLAG antibodies and then immunoblotted with anti-MYC to visualize MYC-GRIP2 protein
levels.
not be detected, suggesting that the MYC-tag of GRIP2 is less accessible (data not shown).
Taken together, fluorescently tagged EphB2 fusion proteins interact with the NR1 subunit of
the NMDA receptor and with the PDZ-domain containing protein GRIP2.
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6.1.2. Cluster behaviour of the different EphB2-ExFP receptors
Binding of Eph receptors to their ephrin ligands results in high-order clustering by the aggre-
gation of multiple Eph-ephrin complexes, thereby initiating downstream signalling into both
the Eph receptor and ephrin ligand expressing cell. In the biochemical experiments used to
test the binding of interaction partners of EphB2-ExFP receptors, cells had been stimulated
Figure 6.5. Comparison of the different EphB2-ExFP proteins before and after ephrinB stimulation. Hippocam-
pal neurons were transfected at day 5 in vitro (DIV5) with expression constructs encoding EphB1-N, EphB2-C1 or
EphB2-C2. Two days later (DIV5+2), neurons were stimulated with preclustered ephrinB2-Fc (lower panel) or as
a control with preclustered Fc (upper panel) before fixation. 63-times magnification.
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with preclustered ephrinB2-Fc. The aim of the ephrinB2-Fc application was to induce the
cluster formation of the different variants of fluorescently-tagged EphB2 receptors, thereby
associating activated receptors with their interaction partners. In contrast to young cultured
neurons, Eph receptors and NR1 are capable of interacting in the absence of exogenously
applied ephrinB-Fc in cell lines (HEK293T). This may be due to overexpression of EphB2 or
by the presence of ephrins within the serum-containing media (Dalva et al., 2000). There-
fore, the addition of ephrinB-Fc to stimulate EphB2-expressing HEK293 cells was perhaps not
required to induce the association of different EphB2-ExFP receptors with their interaction
partners in the biochemical experiments. The next step was therefore to analyze in the cell
type we were interested in – the neurons – if cluster formation of fluorescently-tagged Eph
receptors could be induced upon stimulation with preclustered ephrinB-Fc. For this, young
rat hippocampal neurons were transfected at day 5 in vitro (DIV5) with one of the three differ-
ent expression constructs encoding fluorescently tagged EphB2 proteins (EphB2-N, EphB2-C1
or EphB2-C2). Two days later neurons were treated with preclustered ephrinB2-Fc or with
preclustered Fc in the control experiment before fixation. Treatment of EphB2-C1 expressing
neurons with clustered ephrinB2 resulted in a dramatic increase of cluster formation. In con-
trast, only few clusters were visible in the neurons treated with Fc alone as a control (Figure
6.5, middle row). Surprisingly, EphB2-N or EphB2-C2 expressing neurons showed no visible
clusters upon ephrinB2 stimulation, indicating that the insertion of the fluorescent protein at
the N-terminus or between the kinase domain and the SAM domain impaired the clustering
behaviour of the tagged molecules.
6.1.3. Clustering of fluorescently tagged EphB2-C1 receptors
The next step was to further investigate cluster formation of the fluorescent EphB2-C1 protein
in neuronal cultures. To do this, hippocampal neurons were transfected on DIV3 with plas-
mids encoding EphB2-C1-YFP and ECFP. ECFP was co-transfected to highlight the structure
of neurons expressing EphB2-C1-EYFP, which is recruited into clusters after ephrinB stim-
ulation (Figure 6.5, middle column, control versus ephrinB2). At DIV6 preclustered Fc or
ephrinB1-Fc was added to the cultures for 1 hour before fixation. In Fc-stimulated neurons
only few clusters of EphB2-C1 were visible and fluorescent receptors were more evenly dis-
tributed in the neuron (Figure 6.6A-D). In contrast, ephrinB1-Fc treatment of neurons express-
ing EphB2-C1-EYFP induced dramatic clustering of the tagged EphB2 receptors mainly along
all neuronal processes (Figure 6.6E-J). EphB2-clusters were present on the shaft of dendrites
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and axons and on the tips of filopodia. These results indicate that despite the presence of
the ExFP “domain” fluorescently tagged EphB2-C1 receptors interact and cluster normally in
response to ephrinB1-Fc stimulation.
Figure 6.6. Clustering of EphB2-C1 before and after ephrinB1 stimulation in 6-day-old neuronal cultures. Af-
ter 3 days in culture hippocampal neurons were co-transfected with expression constructs containing an EphB2-
C1-EYFP cDNA and to visualize the cell morphology with ECFP cDNA. All panels show the merge of the two
fluorescent signals with EphB2-C1 in green and ECFP in blue. Neurons were stimulated with either preclustered
Fc (A-D) or ephrinB1-Fc (E-J) for 1 hour before fixation. Dashed boxes in panels A-B and E-G indicate the areas
that are magnified (C-D) and (H-J), respectively. White arrowheads indicate filopodial EphB2 clusters; red arrows
indicate shaft EphB2 clusters. Scale bars represent 10 µm and 5 µm for the enlargement.
98
6.1. Generation of fluorescently tagged EphB2 receptors
6.1.4. Cluster formation of EphB2-C1 in young and old cultures
In young hippocampal cultures EphB2-ExFP expressing neurons displayed little cluster for-
mation before ephrinB stimulation. These cultures were immature and had less arborization,
few contacts with other neurons and showed many filopodia-like protrusions. To answer
the question whether clustering of EphB2-C1 receptors before and after stimulation with the
ligand differs in some ways in young and mature cultures, hippocampal neurons were trans-
fected with the EphB2-C1 construct at DIV3 and DIV10. Three days later either preclustered
Fc or ephrinB1-Fc was added for 2 hours to the cultures before fixation.
In comparison to young cultures, old neurons showed smaller clusters without ephrinB stim-
ulation (Figure 6.7A-B, upper panels). Application of preclustered ephrinB induced a dra-
matic increase in cluster size and number in both 6-day-old and 13-day-old cultures (Figure
6.7A-B, lower panels). Without any exogenous stimulation, older neurons (approximately 3-4
weeks old cultures) showed a higher number of clusters compared to young neurons (Figure
6.8). In mature neurons that had already developed spines, clusters were often localized at
the head of a spine (Figure 6.8). This suggests that ligands provided by the interaction with
other cells may also induce the formation of EphB2 clusters possibly associated with synaptic
sites. In addition, many EphB2 clusters were always visible in the proximity of the cell body
and along the dendritic shaft. As will be demonstrated in this thesis, most of these clusters
represent endogenous vesicle-trafficking (i) from the production site (in general the cell body)
to the target site in the dendrite or axon and perhaps (ii) vice versa from the plasmalemma
to either degradative compartments or recycled to the cell membrane for reuse (Figure 6.14;
supplementary information on CD Rom, movies 4-7).
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Figure 6.7. Comparison of control-stimulated versus ephrinB1-stimulated EphB2-C1 expressing neurons in
young and older cultures. 3-day-old (A) and 10-day-old (B) hippocampal neurons were transfected with expres-
sion constructs encoding EphB2-C1. Three days later, cultures were stimulated with either preclustered Fc (A-B,
upper panel) or ephrinB1-Fc (A-B, lower panel) for 2 hours before fixation. 63-times magnification.
Figure 6.8. Clusters of the EphB2 receptor are visible in dendritic spines of a mature neuron (DIV23) without
ephrinB stimulation. The 23-day-old hippocampal neuron expressing EphB2-C1 shows clusters located to several
dendritic spine heads without stimulation indicated by arrowheads. 100-times magnification.
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6.1.5. Specificity of EphB2-C1 clustering
In order to test the specificity of EphB2-ExFP clustering, EphB2-C1 expressing hippocampal
neurons were stimulated on DIV14 with preclustered ephrinB1, ephrinB2, EphB2 or Fc for
two hours before fixation (Figure 6.9). As expected, the known EphB2 ligands, ephrinB1 and
ephrinB2, revealed strong cluster formation of EphB2-C1 (Figure 6.9A-B), whereas stimula-
tion with EphB2 and Fc caused no effect (Figure 6.9C-D). In addition, another non-interacting
ligand of EphB2, ephrinA1, showed no clustering effect of EphB2 (data not shown). As a sum-
mary, only known ligands of EphB2 induced clustering of the fluorescently tagged EphB2-C1
receptor.
Figure 6.9. Stimulation of EphB2-C1 expressing hippocampal neurons with different Fc fusion proteins. Hip-
pocampal neurons transfected at DIV10 with expression constructs containing an EphB2-C1 gene were stimulated
at DIV14 with either preclustered ephrinB1-Fc (A), ephrinB2-Fc (B), EphB2-Fc (C) or Fc (D) for 2 hours before
fixation. Scale bar = 10 µm.
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6.1.6. Localization of EphB2-C1 in the neuron
To determine the subcellular localization of EphB2-C1 in neurons, dissociated hippocampal
neurons were transfected with EphB2-C1 expression plasmid at DIV10. At DIV14, the neu-
ronal cultures were stimulated with preclustered ephrinB1-Fc or ephrinB2-Fc or as a control
with preclustered EphB2-Fc or Fc for two hours, respectively (Figure 6.10 and 6.11). Fixed cul-
tures were stained with antibodies against the cytoskeletal microtubule-associated protein 2
(MAP2), which is widely used as dendritic marker and is present in the somata and dendrites
of most neurons, but virtually absent from most axons (Banker and Goslin, 1998). Comparing
the EphB2-C1 fluorescent signal with the MAP2 staining revealed that EphB2-C1 is present in
axons, dendrites and neuronal cell bodies in both ephrinB- and control-stimulated neurons.
Clusters of EphB2-C1-EYFP could be induced in all three compartments upon ephrinB1/2-
stimulation, but surprisingly also in EphB2-stimulated neurons. In contrast, application of Fc
as a control showed a more homogeneous distribution of EphB2-C1 in the entire neuron.
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Figure 6.10. EphB2-C1 is located in axons and dendrites of control-stimulated hippocampal neurons. Hip-
pocampal neurons transfected at DIV10 with EphB2-C1 expression constructs were stimulated on DIV14 with
preclustered EphB2-Fc (A) or Fc (B) for 2 hours prior fixation. Fluorescence images of EphB2-C1-EYFP expressing
neurons are shown in the left panel. Antibodies against MAP2 revealed neuronal cell bodies and their dendrites
(middle panel). The merge of the two signals with EphB2-C1 fluorescence in green and anti-MAP2 stainings in
red is shown in the right panel. Arrowheads indicate the axonal expression of EphB2-C1. Scale bar = 10 µm
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Figure 6.11. EphB2-C1 is expressed in axons and dendrites of ephrinB-stimulated hippocampal neurons. Hip-
pocampal neurons transfected at DIV10 with expression constructs encoding EphB2-C1 were stimulated on DIV14
with preclustered ephrinB1-Fc (A) or ephrinB2-Fc (B) for 2 hours prior fixation. Fluorescence images of EphB2-C1-
EYFP expressing neurons are shown in the left panel. Antibodies against MAP2 revealed neuronal cell bodies and
their dendrites (middle panel). The merge of the two signals with EphB2-C1 fluorescence in green and anti-MAP2
stainings in red is shown in the right panel. Arrowheads indicate the axonal expression of EphB2-C1. Scale bar =
10 µm
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6.1.7. Localization of fluorescently tagged EphB2 receptors in filopodia and
other dendritic protrusions
So far, stimulation with preclustered ephrinBs indicated that EphB2-C1 receptors were ex-
pressed on the plasma membrane of neurons similar as seen before in cell lines (HEK293).
To investigate in more detail if EphB2-C1 receptors are inserted into the neuronal cell mem-
brane, dissociated hippocampal neurons were transfected at DIV13 with expression plasmids
Figure 6.12. Fluorescently tagged EphB2 receptors are located in filopodia and other dendritic protrusions. 13-
day-old dissociated hippocampal neurons were transfected with expression constructs encoding EphB2-C1-EYFP
(A) or EphB2-∆C-EYFP (B). At DIV15 cultures were fixed and immunostained with antibodies against the FLAG-
tag to reveal surface expression of EphB2-C1-EYFP or EphB2-∆C-EYFP (A-B, middle panel, surfaceFLAG). After
permeabilization the total distribution of the overexpressed EphB2 versions were visualized with an antibody
directed against the C-terminal EYFP protein of EphB2-C1-EYFP or EphB2-∆C-EYFP (A2-A3 and B, lower panel,
totalEYFP). The merge of the anti-surfaceFLAG stainings and the EphB2-C1 fluorescence (A1-A2, lower panel,
EYFP) or total anti-totalEYFP stainings (A3-A4 and B, lower panel, totalEYFP) is shown in the upper panel.
The label colour from images of the middle and lower panel indicate the colour of this image in the merge.
Arrowheads indicate the surface expression of fluorescent EphB2 receptors in dendritic protrusions (A1-2, A4, B)
and a growth cone (A3). 63-times magnification.
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coding for EphB2-C1-EYFP or EphB2-∆C-EYFP. Two days later, cultures were fixed in ab-
sence of detergents (pre-permeabilization) and immunostained for the N-terminal FLAG-tag
of EphB2 proteins to reveal surface expression of EphB2-C1-EYFP or EphB2-∆C-EYFP (Figure
6.12, middle panel, surfaceFLAG). After permeabilization (post-permeablilization), cultures
were stained with antibodies against the intracellular EYFP protein of the EphB2 fusion pro-
teins to determine the total pool of the overexpressed EphB2 versions (Figure 6.12A3-A4 & B,
lower panel, totalEYFP). The fluorescent signals of EphB2-EYFP proteins (Figure 6.12A1-A2,
lower panel, EYFP) were compared with the signals of the totalEYFP stainings to analyze fluo-
rescence intensity of fusion proteins without immunostaining and specificity of the totalEYFP
stainings.
The surfaceFLAG immunostaining revealed that EphB2-C1 is located on the surface of den-
drites and filopodia (Figure 6.12A-B), even on the tip of thin filopodia (Figure 6.12A3). Com-
paring the surface expression of EphB2-C1 with its total distribution showed that the majority
of the EphB2-C1 proteins were inserted into the membrane (yellow colour in figure 6.12, upper
panel, merge). The growth cone in figure 6.12A3 showed an internal pool of EphB2-EYFP in
the central core of the growth cone (green staining in merge). As expected, the fluorescent sig-
nal of EphB2-C1 is almost identical to the totalEYFP staining of EphB2 proteins (Figure 6.12,
compare A1 (EYFP) with A4 (totalEYFP)). Interestingly, the C-terminal truncation of EphB2
does not seem to alter the described localization and surface expression of EphB2-∆C-EYFP in
transfected neurons (Figure 6.12B).
In addition, immunostaining of total surface EphB2 (endogenous and exogenous) was car-
ried out with an antibody against its N-terminus in neurons expressing EphB2-C1 before
permeabilization (Figure 6.13A-B, middle panel, surfaceEphB2). After permeabilization the
expressed EphB2-C1 proteins were immunostained with an antibody against EYFP (Figure
6.13A-B, lower panel, totalEYFP).
In comparison to the total EphB2-C1 stainings (totalEYFP) from figure 6.12 the surface EphB2-
immunostaining gave a stronger signal in EphB2-C1 overexpressing neurons. This was ex-
pected because the preEphB2 immunostaining also stained endogenous EphB2 receptors. In
addition to the cytoplasmic EphB2-EYFP receptors (Figure 6.13A, merge, green colour), a
strong staining of surface EphB2 receptors (endogenous and exogenous) along the plasma
membrane was visible (Figure 6.13A, yellow colour in merge).
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Figure 6.13. EphB2 receptors are located at the surface of filopodia and other dendritic protrusions. 13-day-old
cultured hippocampal neurons were transfected with EphB2-C1-EYFP expression constructs. Two days later, cul-
tures were fixed and immunostained with antibodies against EphB2 to reveal surface expression of endogenous
and fluorescently tagged EphB2 receptors (middle panel, surfaceEphB2). After permeabilization, the total distri-
bution of the transiently expressed EphB2-C1 was visualized with an antibody directed against the intracellular
EYFP of EphB2-C1-EYFP receptor (lower panel, totalEYFP). The merge of the two signals with anti-EphB2 sur-
face stainings in red (A) or green (B) and total anti-EYFP stainings in green (A) or red (B) is shown in the upper
panel (merge). Arrowheads indicate the surface expression of EphB2 receptor in filopodia and other dendritic
protrusions. 63-times magnification.
6.1.8. Cytoplasmic clusters of fluorescently tagged EphB2 receptors
Besides the surface localization, EphB2 receptors were also localized in the cytoplasm of the
neuron. To visualize the cytoplasmic distribution of fluorescently tagged EphB2 receptors in
neurons, hippocampal cultures were transfected and immunostained as described previously
(for more details, see caption of figure 6.14). A comparison of the totalEYFP staining with the
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Figure 6.14. Cytoplasmic clusters of fluorescently tagged EphB2 receptors in neurites. 15-day-old hippocam-
pal neurons expressing EphB2-C1 for 2DIV were immunostained after fixation with antibodies against the en-
dogenous and transiently expressed EphB2 receptors (A, middle panel, surfaceEphB2) or the N-terminal FLAG-
epitope of EphB2-C1 proteins (B-C, middle panel, surfaceFLAG). After permeabilization the fluorescently tagged
EphB2 receptors were stained with antibodies against EYFP (A-C, lower panel, totalEYFP). The merge of the two
signals with total EphB2 surface stainings in red (A) or Flag staining in green (B-C) and total anti-EYFP stainings
in green (A) or red (B-C) is shown in the merge of the upper panel. Blue arrowheads indicate surface expression of
EphB2 receptors. White arrowheads indicate cytoplasmic clusters of EphB2 receptors along the dendrite. 63-times
magnification.
surface immunolabelling revealed that numerous EphB2-EYFP clusters appeared exclusively
after permeabilization (white arrowheads in Figure 6.14). Thick dendritic branches proximal
to the cell body showed numerous little cytoplasmic clusters along the dendrite (Figure 6.14B,
totalEYFP). However, thinner arborization distal to the cell body displayed less clusters (Fig-
ure 6.14A, totalEYFP).
Combining these immunostaining results with later observations from the live-cell imaging
experiments (see Live cell imaging of tagged EphB2 receptors), indicates that the punctuate
pattern throughout the cytoplasm represents vesicle trafficking. These vesicles containing
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either internalized receptors from the cell surface or secretory vesicles carrying newly synthe-
sized EphB2-C1 proteins on route to the plasma membrane.
6.2. Live cell imaging of tagged EphB2 receptors
The aim of the following studies was to investigate (i) if there are trafficking vesicles of fluo-
rescent EphB2 receptors in transfected neurons and (ii) if the impaired kinase activity or the C-
terminal truncation of the EphB2-C1 protein has any effects (in comparison to the full-length
EphB2-C1 receptor) observed during live-cell imaging. Two additional EphB2-C1 receptors
were therefore generated: a kinase-deficient and a C-terminal truncated version of the fluo-
rescently tagged EphB2-C1 protein (Figure 6.15). Both of these proteins are kinase-deficient
and act as a dominant-negative receptor.
Figure 6.15. Schematic diagram of the EphB2-C1 variants. Two additional variants of the EphB2-C1 fusion pro-
tein (A, EphB2-C1) were created: a kinase-inactive EphB2-ExFP receptor (B, EphB2-C1-KD) and a C-terminal
truncated version (C, EphB2-∆C).
Young and old primary hippocampal cultures were transfected with expression constructs
coding for EphB2-C1-EYFP (Figure 6.16-17, left column; supplementary information on CD-
Rom, movie 1 and 4), EphB2-C1-KD-EYFP (Figure 6.16-17, middle column; supplementary
information on CD-Rom, movie 2 and 5) or EphB2-∆C-EYFP (Figure 6.16-17, right column;
supplementary information on CD-Rom, movie 3 and 6). Neuronal cultures were imaged by
acquiring fluorescence images at a frequency of 1 frame per minute. In addition, prior to start-
ing time lapse microscopy, a phase contrast image was taken (Figure 6.16-17, upper panel).
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Figure 6.16. Comparison of unstimulated versus ephrinB2-stimulated young neurons (DIV2+1) expressing
one variant of EphB2-C1-EYFP during live-cell imaging. 2-day-old primary hippocampal cultures were trans-
fected with expression constructs encoding either EphB2-C1-EYFP (left column; supplementary information on
CD-Rom, movie 1), EphB2-C1-KD-EYFP (middle column; supplementary information on CD-Rom, movie 2) or
EphB2-∆C-EYFP (right column; supplementary information on CD-Rom, movie 3). After 1DIV, transfected neu-
rons were imaged by time lapse microscopy at 1 frame per min. The upper and middle panels show phase contrast
and fluorescence images 10 minutes before stimulation (-10’), respectively. After 10 min, preclustered ephrinB2-Fc
was added. The lower panel shows fluorescent images 30 min after ephrinB2-Fc stimulation (30’). Note the accu-
mulation of bright fluorescent clusters upon stimulation with ephrinB2-Fc. Time points of imaging are indicated
in upper right corners. Scale bar = 10 µm.
Before stimulation with ephrinB ligands, young transfected neurons revealed fast moving
vesicles along the neuron. In addition to these moving vesicles, neurons displayed a more
homogeneous distribution of fluorescently tagged EphB2-C1 receptors along dendrites and
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axons. After adding the preclustered ephrinB2-Fc, cluster formation was visible within a few
minutes. In addition, the fluorescent intensity of the plasma membrane was enhanced due to
the recruitment of fluorescently tagged EphB2 receptors to the cell surface, thereby altering
the homogeneous fluorescence of the young unstimulated neuron. On addition of the ligand,
vesicular trafficking was no longer detectable, presumably due to the insertion of the EphB2
receptors into the cell membrane. The initially formed clusters increased with time and some-
times neighbouring clusters merged to form larger clusters. In most cases these clusters were
static, only occasionally they did displayed movement. This was observed in all neurons,
independent from the expressed EphB2-C1 variant (Figure 6.16).
In contrast, older neurons displayed numerous static clusters prior to stimulation. In addition,
these more mature neurons did not show a strong homogeneous distributed fluorescence be-
fore stimulation as observed with young neuronal cultures. However, mature neuronal cul-
tures displayed a much higher number of moving vesicles along both dendrites and axons.
Similar to the young cultures, addition of the preclustered ephrinB2-Fc resulted in fast cluster
formation and brighter fluorescence on the plasma membrane. In contrast to young neu-
ronal cultures, stimulation induced a large number of smaller sized cluster. In addition, the
vesicular trafficking slowed and sometimes even stopped (Figure 6.17). Moreover, neither the
kinase-inactive nor the C-terminal truncated version of the fluorescently tagged EphB2 recep-
tor showed other effects in transfected neuronal cultures (Figure 6.16-17).
In addition, the velocities of trafficking vesicles in more mature hippocampal neurons express-
ing one variant of EphB2-C1 receptors were calculated using the so-called “track points tool”
of the Metamorph software. The average velocity of vesicles was 0.88 µm/sec in dendrites
and 2.90 µm/sec in axons. These velocities are in the range of reported velocities of fast ax-
onal transport (4.6 µm/sec, Kandel et al. (2000)) and of trafficking vesicles in dendrites (0.77
µm/sec, Guillaud et al. (2003)).
In addition, a series of hippocampal cultures of other ages were transfected with the EphB2-C1
variants. Time lapse imaging of these neuronal cultures never showed additional effects (data
not shown). In summary, independently from the expressed EphB2-C1 variant and the age of
the culture, fluorescently tagged EphB2 receptors were highly dynamic and were transported
in vesicles along dendrites and axons in transfected hippocampal cultures. These fast mov-
ing fluorescent vesicles were detectable in all transfected neurons, whereas young transfected
neurons displayed less trafficking vesicles compared to the older cultures. Young hippocam-
pal cultures showed some stable EphB2 clusters and trafficking vesicles along the neurites,
older cultures display many static clusters and many trafficking vesicles. Independently from
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Figure 6.17. Comparison of unstimulated versus ephrinB2-stimulated more mature neurons (DIV8+2/3) ex-
pressing one variant of EphB2-C1-EYFP during live-cell imaging. Dissociated hippocampal cultures were trans-
fected at DIV8 with expression constructs encoding either EphB2-C1-EYFP (left column; supplementary informa-
tion on CD-Rom, movie 4), EphB2-C1-KD-EYFP (middle column; supplementary information on CD-Rom, movie
5) or EphB2-∆C-EYFP (right column; supplementary information on CD-Rom, movie 6). After 2-3DIV, transfected
neurons were imaged by time lapse microscopy at 1 frame/min. The upper and middle panel show phase con-
trast and fluorescence images 20 min before stimulation (-20’), respectively. After 20 min, preclustered ephrinB2-Fc
was added. The lower panel shows fluorescent images 30 min after stimulation (30’). Note the accumulation of
bright fluorescent clusters in these images. Time points of imaging are indicated in upper right corners. Scale bar
= 10 µm.
the age of the neurons, the number of moving vesicles decreased, sometimes even stopped, af-
ter adding preclustered ephrinB ligands (Figure 6.18). This suggests that the moving vesicles
were most likely recruited to the plasma membrane. This would also explain the increased
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overall fluorescence intensity of the plasma membrane after adding preclustered ligands.
The immunostaining results and the observed effects of the live-cell imaging suggest that
EphB2 receptors are mainly localized (i) on the surface of neurons and (ii) in cytoplasmic vesi-
cles trafficking along neuronal protrusions.
Figure 6.18. Summary of the effects observed during live-time imaging of young and more mature hippocam-
pal neurons expressing one variant of the different EphB2-C1 receptors. Young hippocampal cultures expressing
one variant of EphB2-C1 showed trafficking vesicles along the neuron and some stable large EphB2 clusters upon
ephrinB2-Fc stimulation. In contrast to young cultures, more mature hippocampal cultures display many traffick-
ing vesicles along dendrites and axons and many static clusters after ephrinB2 stimulation. The trafficking of the
vesicles slowed down, sometimes even stopped, after stimulation with preclustered ephrinB-Fc.
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6.3. Generation and analysis of transgenic mice expressing one
variant of EphB2-C1-EYFP under the control of the
Thy-1.2 expression cassette
In order to observe the dynamics and localization of fluorescently tagged EphB2 receptors
in the hippocampus in vivo, a second approach was taken and EphB2-C1-EYFP transgenic
mice were generated. An advantage of using an in vivo approach avoids the time-consuming
calcium phosphate transfection method. This method worked well in relatively young neu-
rons as described previously; however, transfection of very mature neurons is very challeng-
ing, due to the low transfection efficiencies, which dramatically decrease with neuronal age.
EphB2-C1-EYFP transgenic mice would therefore give the possibility to study in more detail
very old EphB2-C1-EYFP expressing neurons in vivo and in vitro.
For this the full-length, kinase-deficient and C-terminal truncated EphB2-C1-EYFP were placed
under the control of the Thy-1.2 expression cassette. This expression cassette was chosen be-
cause of its unique expression properties: (i) The neuron-specific elements from the thy-1.2
gene drives strong constitutive expression of transgenes specifically in neurons. Outside the
nervous system, only weak expression of the transgene has been reported in the lung (Caroni,
1997). (ii) Transgenic mice expressing multiple spectral variants of EGFP under the control of
the Thy-1.2 expression cassette (thy1-ExFP) that has been previously generated by Feng et al.
(2000) revealed that in some lines only occasional isolated neurons were labelled in different
subregions of the brain. With regard to imaging, sparsely labeled neurons allow clear iden-
tification of single neurons and their associated dendritic spines and to study the dynamics
and localization of EphB2-C1-EYFP variants at these structures. From the thy1-ExFP trans-
genic mice it is known that each of these independently generated transgenic lines express the
transgene in a unique, heritable expression pattern (Feng et al., 2000). The offspring of each
transgenic founder must therefore be analyzed for the expression of each of the fluorescent
EphB2 versions concering its distribution within the brain region of interest – the hippocam-
pus – and the population and density of affected cells there.
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6.3.1. Patterns of transgene expression
41 independent transgenic lines were generated: 22 for the full-length (line A-N, P-W), 8 for
the kinase-dead (line Ka-Kh) and 11 for the truncated version (line Da-Dk) of the EphB2-C1-
EYFP receptor. The full-length EphB2-C1 transgenic lines were consecutively named in alpha-
betical order. In case of the kinase-deficient and the truncated EphB2 version a K (abbreviation
for Kinase-dead) or a D (abbreviation for Delta-C) was added, respectively.
6.3.1.1. Full-length EphB2-C1-EYFP (line A-N, P-W)
21 founders of the 22 independent transgenic lines expressing full-length EphB2-C1-EYFP
driven by the Thy1.2 expression cassette gave offspring. Only 18 lines showed fluorescence
in the brain, of which three lines yielded low expression levels and were excluded from fur-
ther analysis. Compared to one of the thy1-YFP transgenic mice (line YFP-2Jrs) from Joshua
R. Sanes, which express only the cytoplasmic EYFP protein under the control of the Thy1.2
expression cassette (Feng et al., 2000), the fluorescence was weak in these 15 remaining trans-
genic lines. The six lines with the strongest fluorescent signal (A, E, J, M, R and W) were
selected and analyzed in more detail (Figure 6.19).
The transgenic lines A, E and J yielded a comparable expression pattern. The fluorescently
tagged EphB2-C1 receptors were present in the perforant fiber pathway, the mossy fiber path-
ways and in pyramidal cells of the CA1 region. In contrast, pyramidal cells of the CA3 region
showed only a faint or no expression of the full-length EphB2-EYFP receptor. Remarkably, the
mossy fiber axons of the granule cell of these three lines showed a strong fluorescence.
The line M and W also yielded a fluorescent signal in the perforant fiber pathway. In contrast,
these lines displayed no or only a faint fluorescence in the mossy fiber axons of the granule
cell and only a weak homogeneous fluorescence in the CA1 region (Figure 6.19, compare G-H
& K-L with A-F). Interestingly, neurons of CA3 region in the hippocampus of the transgenic
line M showed a stronger signal than in the CA1 region (Figure 6.19, G-H & K-L with A-F).
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Moreover, lines A and J displayed the brightest signal of immunostaining and fluorescence
among the six transgenic mouse lines.
Remarkably, in only one line – the R line – labeling was largely confined to single neurons (Fig-
ure 6.19I-J and 6.20). Unfortunately, however, the fluorescent signal in this line was too weak
for imaging in slices (Figure 6.19J) and only after an anti-EYFP immunostaining the sparse ex-
pression of EphB2-C1-EYFP receptors became clearly visible in all regions of the hippocampus
(Figure 6.20A-D). In addition, other regions, such as the cortex, also showed isolated EphB2-
C1-EYFP expressing neurons after immunostaining against EYFP (Figure 6.20E-F).
6.3.1.2. Kinase-dead EphB2-C1-EYFP (line Ka-Kh)
Six founders of the eight independent transgenic lines Ka-Kh expressing the kinase-dead
EphB2-C1-EYFP under the control of the regulatory elements of Thy1.2 gave offspring. Adults
from each line were analyzed, from which five founder mouse lines were fluorescent. The four
lines with the brightest fluorescent signal were further analyzed in more detail (Figure 6.21).
None of these lines yielded a sparse expression pattern of the fluorescently tagged kinase-
deficient EphB-C1 receptor. All lines displayed a homogeneous expression pattern. All re-
gions of the hippocampus were labeled in the transgenic line Ke (Figure 6.21C-D). The two
lines Kf and Kh showed, apart from the homogeneous distribution of the transgenic protein
in the DG and CA1 region of the hippocampus that granule cells of the DG sent bright fluo-
rescent mossy fibers to the pyramidal cells in CA3 region (Figure 6.21E-H). Interestingly, the
transgenic mouse line Kc possessed additional fluorescent pyramidal cell of the CA3 region
(Figure 6.21A-B and I-J).
Figure 6.19. Transgene expression in the hippocampal formation of adult thy1-EphB2-C1-EYFP mice. Analy-
sis of six independent transgenic lines of adult mice expressing EphB2-C1-EYFP under the control of the Thy-1.2
expression cassette (line A (A-B), line E (C-D), line J (E-F), line M (G-H), line R (I-J) and line W (K-L)) and for com-
parison of the thy1-YFP mouse (line YFP-2Jrs (M)). (A-L) Images of each line were taken from the same cryosection
of a fixed transgenic brain. The exposure time of each section was always 2 sec for the EYFP-fluorescence (right
column, EYFP (2 sec)); and in case of the anti-EYFP immunostaining the exposure time is displayed in the up-
per right corner of each image (left column, anti-EYFP). (M) The exposure time of the section of the thy1-YFP
transgenic mouse was 0.3 sec. 5-times magnification.
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6.3.1.3. C-terminal truncated EphB2-C1-EYFP (line Da-Dk)
Among the eleven founders (lines Da-Dk) expressing the C-terminal truncated EphB2-C1-
EYFP receptor under the control of the Thy1.2 expression cassette, six lines gave offspring.
Analysing the offspring of these six transgenic mouse lines revealed that three lines were flu-
orescent, but only the lines Df and Dj yielded an intense fluorescent signal (Figure 6.22). In
both lines neurons of the DG and the CA1 region were labeled homogeneously. Remarkably,
in images of the Df line a sharp border in fluorescence was clearly visible between the CA3
region and the CA1 region of the hippocampus. This boundary was also visible in images of
Figure 6.20. Sparse expression of EphB2-C1-EYFP in the adult transgenic mouse line R. Analysis of the inde-
pendent transgenic line R of an adult mouse brain expressing EphB2-C1-EYFP under the control of the Thy-1.2
expression cassette (line R (A-F)). Images were taken from anti-EYFP immunostained cryosections (A-F) of a fixed
brain. (A) shows the hippocampus. (B-D) Higher magnification of the hippocampus showing the CA3 (B) and
CA1 regions (C) and the dentate gyrus (DG) (D) of (A). (E-F) Different magnifications of the cortical region. Mag-
nifications: 5-times (A), 10-times (B-E) and 63-times (F).
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the Dj line, however, not as clear as in the Df line (Figure 6.22A-D, white arrowheads). There-
fore, in contrast to the Df line, neurons of the transgenic mouse line Dj expressed low levels of
transgenic proteins in the CA3 region of the hippocampus. In addition, only in the Df mouse
line axons of the mossy fiber pathway displayed an intense fluorescent signal. This signal in
the axons was not detectable in the Dj line.
In summary, all analyzed transgenic mouse lines, apart from line R, showed a homogeneous
distribution of the transgenic protein mainly in the DG and CA1 region of the hippocam-
pus independent from whether the transgenic mouse expressed either a full-length, a kinase-
deficient or a C-terminally truncated fluorescently tagged EphB2 receptor. Surprisingly, the
fluorescent intensity of the transgenic protein was not very high in all transgenic lines. Only
one line yielded a sparse expression of full-length EphB2-C1-EYFP in neurons, but with weak
120
6.3. Generation and analysis of transgenic mice
Figure 6.21. Expression pattern of kinase-deficient EphB2-C1-EYFP in the hippocampal formation of adult
transgenic mice. Analysis of four independent transgenic lines of adult mice expressing kinase-deficient EphB2-
C1-EYFP under the control of the Thy-1.2 expression cassette (line Kc (A-B, I-J), line Ke (C-D), line Kf (E-F) and
line Kh (G-H)). Images of each line were taken from the same cryosection of a fixed brain from the adult trans-
genic mouse. The exposure time of each section was always 2 sec for the EYFP-fluorescence (right column, EYFP
(2 sec)); and in the case of the anti-EYFP immunostaining the exposure time is displayed in the upper right corner
of each image (left column, anti-EYFP). Magnification: 5-times (A-H) and 10-times (I-J).
121
6. Results
fluorescence.
After realizing that in almost all lines the fluorescent signal was too homogeneous for imag-
ing in brain slices, primary hippocampal cultures were prepared from the lines with a bright
fluorescent signal (line A and J). The aim was to investigate whether these cultures could be
useful for time lapse microscopy, but unfortunately the intensity of the fluorescence was still
too weak for live-cell imaging (data not shown).
Figure 6.22. Expression pattern of C-terminal truncated EphB2-C1-EYFP in the hippocampal formation of adult
transgenic mice. Analysis of two independent transgenic lines of adult mice expressing C-terminal truncated
EphB2-C1-EYFP under the control of the Thy-1.2 expression cassette (line Df (A-B) and line Dj (C-D)). Images of
each line were taken from the same cryosection of a fixed adult transgenic brain. The exposure time of each section
was always 2 sec for the EYFP-fluorescence (right column, EYFP (2 sec)). The exposure time of the immunostained
sections is displayed in the upper right corner of each image (left column, anti-EYFP). White arrowheads indicate
the transition from the CA3 region to the CA1 region. 5-times magnification.
To determine if the sparse expression pattern of the transgenic mouse line R could yield
enough fluorescence for imaging by confocal microscopy, so-called organotypic Gähwiler cul-
tures were made. After two to four weeks in culture, hippocampal slice cultures were imaged,
but again, the fluorescent signals were not bright enough for confocal live-cell microscopy
(data not shown). Therefore, we did not pursue the original aim of imaging the behaviour of
EphB2 proteins in individual neurons, of an intact slice, in these transgenic mice.
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6.3.2. In situ hybridization data of different transgenic thy1-EphB2-C1 mice
The analysis of the different transgenic mice expressing one variant of EphB2-C1-EYFP under
the control of the Thy1.2 expression cassette revealed that almost all lines showed a homo-
geneous expression of the transgenic proteins in the DG and CA1 region of the hippocam-
pus. It has been shown that the EphB2 receptor is important in hippocampal LTP (Grunwald
et al., 2001). To determine if the overexpression of truncated EphB2 proteins may result in an
dominant-negative effect on LTP, we decided to measure LTP in these transgenic mice. An
important control was to check the extent of correlation between the transgene expression
patterns and their respective mRNA levels. In situ hybridization experiments were therefore
performed.
Figure 6.23. Comparison of in situ hybridization data with the fluorescent signal of hippocampal section of
different transgenic lines. Hippocampal sections of adult transgenic mice expressing either full-length (line R (A,
E), line A (B, F)), kinase-dead (line Kf (C, G)) or C-terminal truncated EphB2-C1-EYFP receptors (line Df (D, H))
were used for in situ hybridization analysis using a digoxigenin-labeled antisense probe against EYFP (indicated
as YFP (upper panel)). For each line, images were taken from anti-digoxigenin immunostained (upper panel, in
situ) and fixed-only hippocampal sections (lower panel, EYFP (5 sec)) derived from the same transgenic brain.
The exposure time of fluorescent sections was 5 seconds.
The in situ hybridization data of the transgenic mice were obtained using a newly generated
transgene-specific probe, namely the digoxigenin-labeled antisense probe against the EYFP
coding sequence. Three different transgenic mouse lines expressing either full-length (line A),
kinase-dead (line Kf) or C-terminal truncated EphB2-C1-EYFP receptors (line Df) driven by
Thy-1.2 expression cassette were selected based on (i) similar homogeneous (transgene) ex-
pression pattern and (ii) a comparable fluorescent intensity. Adult mice of these transgenic
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lines were analyzed. In addition, the transgenic thy1-EphB2-C1 mouse line R displaying the
isolated transgene expression in the hippocampus was also examined. To compare the fluo-
rescent signal with the in situ hybridization data of the same brain, one hemisphere was used
for each experiment (Figure 6.23).
The in situ hybridization analysis confirmed the expression pattern of transgenic EphB2-C1
proteins of fixed anti-GFP immunostained sections (Figure 6.19-22): a weak expression pattern
in the hippocampus was consistent with a weak mRNA level of the transgene and vice versa.
The EphB2-C1-EYFP mRNA of the transgenic line R was barely detectable in the hippocam-
pus, consistent with the sparse expression of the transgene (Figure 6.23A, E). The lines A, Kf
and Df yielded mRNA levels confined to CA1 region and DG. The lines A and Kf displayed a
weak transgene expression in the CA3 region, almost absent in line Df (Figure 6.23B-D, F-H).
In addition, the line Df showed a very strong expression of the truncated EphB2-C1 receptor
in the CA1 region (Figure 6.23D, H).
The binding specifity of the antisense EYFP probe, which was generated from a newly cloned
construct, was demonstrated by using the thy1-YFP transgenic mouse line YFP-2Jrs (Figure
6.24A-B). Hippocampal sections of this line nicely showed the isolated transgene expression
in fixed-only sections and even sparse mRNA positive neurons were visible in the in situ hy-
Figure 6.24. In situ hybridization analysis of hippocampal sections of thy1-YFP transgenic mice and a wild type
(wt) animal. In situ hybridization analyses (upper panel, in situ) of hippocampal sections of the adult thy1-YFP
transgenic mouse line YFP-2Jrs (A-B) and a wild type mouse (C) using the indicated digoxigenin-labeled antisense
probes. Images of the fluorescent signal (lower panel, EYFP) of fixed hippocampal sections of different old thy1-
YFP transgenic mice (line YFP-2Jrs) (old (D), young (E)). The exposure time of the fluorescent sections is displayed
in the lower right corner of these images.
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bridization analysis of these sections (Figure 6.24, compare A with D, B with E). An additional
control for the in situ hybridization procedure was the antisense EphA4 probe, that nicely
revealed the previously described mRNA levels from EphA4 in the hippocampus (Figure
6.24C)(Grunwald et al., 2001). In summary, the mRNA levels of the transgene corresponded
with the expression patterns of the fluorescently tagged EphB2-C1 variants in all four trans-
genic mouse lines.
6.3.3. Overexpression of EphB2-C1 or EphB2-∆C in transgenic mice does not
affect CA3-CA1 hippocampal LTP
With respect to the synapse between CA3 and CA1 neurons, ephrinB2 and ephrinB3 are ex-
pressed mainly in postsynaptic CA1 neurons, while the relevant Eph receptors - EphB2 and
EphA4 - are expressed both pre- and postsynaptically in the adult hippocampus (Grunwald
et al., 2001, 2004). In addition, it has been shown by our group that these proteins – EphB2,
EphA4, ephrinB2 and ephrinB3 – are required for hippocampal CA3-CA1 long-term plastic-
ity (Grunwald et al., 2001, 2004), thereby supporting the hypothesis that Eph receptors and
ephrins are directly involved in synaptic plasticity of mature synapses.
The in situ hybridization data and the analysis of the EYFP-fluorescence of hippocampal sec-
tions of the transgenic mouse line Df revealed a very strong signal of transgenic mRNA and
protein, respectively (Figure 6.23D, H). This mouse line overexpresses the C-terminal trun-
cated EphB2-C1 receptor at the postsynaptic site of CA1 neurons, thereby possibly interfering
with hippocampal plasticity. Assuming that transgenic EphB2 receptors interact with wild
type EphB2 proteins at the postsynaptic site of the cell, then the overexpression of truncated
EphB2 receptors could have a dominant-negative effect by blocking endogenous EphB2 re-
ceptor signalling (heterodimers), thereby causing an effect in LTP. Another possibility causing
also a dominant-negative effect could be that the overexpressed truncated EphB2 proteins
take away ephrinB ligands, thereby preventing endogenous EphB2 forward signalling. A
third possibility is that this overexpression results in a dominant-active effect by the interac-
tion of truncated EphB receptors with the endogenous ephrinBs, thereby increasing the acti-
vation of ephrinB reverse signalling and affecting LTP. To assess, whether the overexpression
of the C-terminal truncated or the full-length EphB2-C1-EYFP could alter the availability of
ephrinBs at the CA3-CA1 synapse, LTP was measured in acute hippocampal slices from trans-
genic mice (line Df and A) and littermate controls after thetaburst stimulation (TBS). The TB
stimulus is known to be efficient in inducing long-lasting LTP (Bliss and Collingridge, 1993).
125
6. Results
Figure 6.25. LTP was not affected in hippocamapl neurons overexpressing full-length or C-terminal truncated
EphB2-C1 in adult transgenic mice. LTP was induced by stimulation of presynaptic CA3 neurons with thetaburst
stimulation (TBS, black arrow) in acute hippocampal slices. Transgenic mice expressing EphB2-∆C-EYFP (line
Df, (A)) or full-length EphB2-C1-EYFP (line A, (B)) under the control of the Thy-1.2 expression cassette showed
no reduction in early- or late-phase CA3-CA1 LTP compared to littermate controls. Until 180 min after TBS the
fEPSP from control and thy1-EphB2-∆C-EYFP (A) or thy1-EphB2-C1-EYFP (B) slices were not significantly different.
n=number of slices from 3 (A) or 2 (B) mice per animal group. Error bars: SEM.
After recording a stable baseline, a TBS was given to the presynaptic CA3 neurons and LTP
was recorded from CA1 neurons for up to three hours after stimulation. All electrophysio-
logical experiments were performed by Martin Korte and Volker Staiger in the laboratory of
Tobias Bonhoeffer at the Max-Planck Institute of Neurobiology (Martinsried, Germany). All
recordings were performed in a strictly blind fashion and the genotypes of the mice were only
revealed after final data analysis.
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Figure 6.25 shows the summary graphs for all LTP recordings. Hippocampal slices of thy1-
EphB2-C1-EYFP (full-length EphB2-C1), thy1-EphB2-∆C-EYFP (C-terminal truncated EphB2-
C1) and littermate wild type mice showed normal post tetanic potentiation (Figure 6.25). All
groups showed clear E- and L-LTP after TBS stimulation with no obvious difference between
genotypes.
6.4. Trans(endo)cytosis of EphB2-C1 receptors in primary
hippocampal neuronal cultures
Recently our group could show that cell-to-cell contact between EphB- and ephrinB-expressing
HeLa cells leads to bi-directional endocytosis, thereby terminating adhesion and enabling cells
to detach and separate from each other (Zimmer et al., 2003). In addition, growth cones of very
young immature primary neurons of mouse forebrain can take up ephrinB or EphB after stim-
ulation with soluble preclustered ectodomains of ephrinB ligands or EphB receptors fused to
Fc fragments and after contact with ligand- or receptor-expressing cell lines (Zimmer et al.,
2003).
So far, it is not known (i) if older mature neurons also engage in endocytic events of ephrinB-
EphB complexes and if they do so, (ii) what is the cell counterpart in the brain, is it a neuron or
a glial cells. Therefore, we decided to investigate whether there is ephrinB- or EphB-triggered
transcytosis in mature hippocampal cultures.
6.4.1. Reverse transcytosis of EphB2-C1 receptors in mature primary
hippocampal cultures
The aim of the following studies was to investigate whether EphBs and ephrinBs undergo
transcytosis in mature neuronal cultures without any “artificial” stimulation, such as soluble
preclustered fusion bodies of ephrin/Eph ectodomains with Fc fragments or ligand/receptor-
expressing cell lines. To assess this, 14-day-old primary hippocampal cultures were trans-
fected with expression constructs coding for EphB2-C1-EYFP. Two days later, transfected neu-
ronal growth cones were imaged for transcytosis by time lapse microscopy. Figure 6.26B-E
shows a sequence of four images taken during a time period of six minutes, showing a neu-
ronal process with its growth cone engaging with other cells in the high-density culture, such
as neurons and glial cells. During the first two minutes, a filopodium-like protrusion of the
EphB2-C1 expressing neuron showed a small fluorescent cluster of EphB2 on its tip. In sub-
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Figure 6.26. Reverse transcytosis of EphB2-C1-EYFP in a primary neuronal culture during live-cell imaging after
neuron-to-cell contact. (supplementary information on CD-Rom, movie 8) A high-density mature 14-day-old
primary hippocampal culture was transfected with expression constructs coding for fluorescently tagged EphB2-
C1-EYFP receptors. Two days later, transfected neurons were imaged by time lapse microscopy at 1 frame/min.
(A) Large image shows merge of phase contrast image in red and the EphB2-C1 fluorescence of a transfected
neurite and its growth cone in green before the transcytosis. Dashed box indicates the area of transcytosis. Dashed
lines and lighter areas indicate outline of glial cells (asterisks). Diamond indicates glia-free area. (B-E) Fluorescent
images from the area indicated by the dashed box in A. Within six minutes a fluorescent cluster is moving away
from the middle filopodium-like extension into a neighbouring cell, most-likely a glial cell, after cell-to-cell contact
(fluorescent cluster indicated by arrow). Time points of imaging are indicated in upper right corners. Scale bar =
20 µm.
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sequent images, this cluster was taken up by another cell, presumably a glial cell and was
retrogradely transported (Figure 6.26D-E, arrows). Figure 6.26 displays only six minutes of
the total 70 minutes of live-cell imaging (supplementary information on CD-Rom, movie 8).
A closer look at the movie reveals several interesting events: First, there are several occur-
rences of transcytosis in the area shown in the figure, especially in the growth cone and in its
close proximity. Second, the growth cone and other parts of the neuronal process are partially
growing on glial cells (Figure 6.26A, asterisks and dashed lines). These cells are easily recog-
nizable during live-cell imaging because (i) glial cells always display faster cell movement, (ii)
their cytoplasm appears different from the neuronal and (iii) they have a flat spread morphol-
ogy and grow very often underneath the neurons (Figure 6.26A, dashed lines). Third, tran-
scytosis was observed close to areas rich in glial cells. Fourth, filopodia of growth cones and
neurites that were not in contact with glial cells only displayed slow movement of filopodia
with no obvious transcytosis events (Figure 6.26A, diamond). In contrast, filopodia growing
close to or on top of glial cells, very often displayed highly dynamic filopodia accompanied,
very often with transcytosis. The neuron-to-cell transcytosis events were also often followed
by retraction or even disappearance of filopodia (see also figure 6.28). Last, continuous tran-
scytosis was clearly visible during time lapse imaging of the area shown in figure 6.26B-E; in
this case, it appeared that after the contact between the neuronal filopodia and the most-likely
glial cell, the glia started to retract, thereby pulling away the filopodia-like protrusion. Very
often transcytosis was followed (i) by disconnection of the interacting partners, thus resulting
in a retraction or loss of filopodia or (ii) by internalization of the clusters from filopodia still
connected to the presumably glial cell.
Figure 6.27 shows another example of transcytosis in mature hippocampal high-density cul-
tures. The white arrows indicate the area of transcytosis with an most-likely astrocyte grow-
ing underneath the neuronal process (Figure 6.27, dashed line). In the five successive images
taken in a time period of eight minutes the translocation of a fluorescent EphB2 cluster from
the tip of the neuronal protrusion was visible. The pink arrow indicates another transcytosis
event in close proximity to the same glial cell (supplementary information on CD-Rom, movie
9). The corresponding movie shows several events of transcytosis mainly from two neuronal
protrusions (Figure 6.27, arrows). In general the reverse transcytosis events were very fast
(within minutes) and were often followed by fast retraction of neuronal protrusions. Fur-
thermore, after cell-to-cell contact EphB2 clusters were internalized from the tip of neuronal
protrusions by neighbouring cells and retrogradely transported. The data indicate that the
neighbouring cell may be a glial cell or more likely an astrocyte (data not shown). These re-
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sults show that transcytosis is possible at sites of neuron-to-cell contacts without an “artificial”
stimulation in neuronal cultures.
Figure 6.27. Reverse transcytosis of EphB2-C1-EYFP into adjacent cells of a mature primary hippocampal cul-
ture during live-cell imaging after neuron-to-cell contact. (supplementary information on CD-Rom, movie 9)
Similar experiment as shown in figure 6.26. Mature primary high density hippocampal culture was transfected
at DIV14 with EphB2-C1-EYFP expression constructs. Two days later, a transfected neuron was imaged by time
lapse microscopy at 1 frame per min. (A) Merge of phase contrast image in red and the EphB2-C1 fluorescence in
green at time point 0 min. (B-F) Fluorescent images from the area indicated by the dashed box in A, showing the
beginning of a transcytosis with the fast translocation of the fluorescent cluster away from the neuronal protrusion
within 8 min (indicated by white arrows). Dashed line and lighter area indicate outline of the glial cell (asterisks).
Time points of imaging are indicated in upper right corners. Scale bar = 10 µm.
6.4.2. Reverse transcytosis of EphB2-C1-EYFP proteins followed by persistent
retraction of the neuronal protrusion
Figure 6.28 shows a sequence of images taken during a time period of ten minutes of an
EphB2-C1 transfected high density culture as described earlier. However, in contrast to movie
9 (Figure 6.29), this case the transcytosis was followed by a retraction and persistent disap-
pearance of the neuronal protrusion (see also supplementary information on CD-Rom, movie
8). Again, as mentioned before, the Eph2-C1 expressing neurons only showed events of tran-
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scytosis in areas rich in glial cells, indicating again that the transcytosis event is mainly taking
place between a neuron and a glial cell (Figure 6.28, dashed lines). The pink arrow indicates
other transcytosis events (supplementary information on CD-Rom, movie 10).
Figure 6.28. Reverse transcytosis of EphB2-C1-EYFP followed by retraction of a neuronal protrusion from the
dendritic shaft. (supplementary information on CD-Rom, movie 10) A mature primary high-density hippocampal
culture was transfected at DIV13 with expression constructs coding for fluorescently tagged EphB2-C1-EYFP. Two
days later, the transfected neuron was imaged by time lapse microscopy at 1 frame/min. (A) Merge of phase
contrast image in red and the EphB2-C1 fluorescence in green before the transcytosis. Dashed box indicates area
of transcytosis. (B-G) Fluorescent images from the area indicated by the dashed box in A. Fluorescent cluster is
moving away from the retracting neuronal protrusion (indicated by arrows). Dashed line and lighter areas indicate
outline of glial cells (asterisks). Diamonds indicate glia-free areas. Time points of imaging are indicated in upper
right corners. Scale bar = 10 µm.
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6.4.3. Transcytosis is not a general phenomenon among the Eph and ephrin
classes of protein families
Recent data by our group demonstrated that trans-endocytosis can be bi-directional (Zimmer
et al., 2003). To address if ephrinB is transcytosed in mature hippocampal cultures, neuronal
cultures were transfected at DIV13-14 with expression constructs coding for N-terminal fluo-
rescently tagged ephrinB1 or ephrinB2. This modification has been shown not to interfere with
receptor binding or transcytosis (Brückner et al., 1999; Zimmer et al., 2003). Two days later,
Figure 6.29. Quantification of percentage of transcytosis in transfected neuronal high-density cultures. Mature
primary hippocampal high-density cultures were transfected at DIV13-15 with expression constructs coding for
either EphB2-C1-EYFP, EYFP-ephrinB1, EYFP-ephrinB2, EGFP-∆N-TrkB or myrEYFP. Two days later, transfected
neurons were imaged by time lapse microscopy at 1 frame/min. Each movie was analyzed for transcytosis and
counted as negative (no) if no transcytosis was detectable. Movies were counted as positive (yes) if the beginning
of the internalization and the fast retrograde translocation of fluorescent clusters were clearly visible. Graph
display n=numbers of time lapse recordings used for the analysis.
transfected neuronal cultures were imaged as described before. Each movie was analyzed
for transcytosis events and counted as negative (Figure 6.29, no) if no transcytosis event was
detectable. Movies were counted as positive (Figure 6.29, yes) if the beginning of the internal-
ization and the fast retrograde translocation of fluorescent clusters were clearly visible. The
classification “maybe” was used for ambiguous transcytosis events, e.g. when transcytosis
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had seemingly started but then suddenly stopped during retrograde transport. Surprisingly,
in only 1 out of 15 cases (= 6.7 %) ephrinB was internalized in a forward manner by glial
cells. In contrast, 11 from 18 cases (= 61.1%) showed a clear reverse transcytosis of fluorescent
EphB2 clusters, in 5 cases (= 27.8%) no internalization into adjacent cells was detectable and 2
cases (= 11.1%) could not be clearly identified.
To determine if the EphB2 reverse transcytosis is a specific event driven by the exogenous
expression of EphB receptors, cultures were transfected with expression constructs coding for
either another transmembrane receptor (= the N-terminal truncated EGFP-TrkB receptor) or a
membrane targeted version of EYFP (myrEYFP). 84.6% of neurons overexpressing the trans-
membrane EGFP-∆N-TrkB receptor showed no internalization of fluorescent TrkB clusters,
7.7% a clear internalization and 7.7% a possible transcytosis. Internalization of fluorescent
clusters was never observed when myrEYFP-expressing neurons encountered glial cells. The
percentage of transcytosis events for the differently transfected primary hippocampal neurons
are summarized in figure 6.29.
In summary, these data suggest that the neuron-to-cell contact of an EphB2-C1 expressing ma-
ture neuron and a neighbouring cell, possibly a glial cells, triggers the reverse transcytosis of
full-length EphB2 clusters.
6.4.4. Reverse transcytosis of EphB2-C1 in mature primary hippocampal
low-density cultures
To have a closer look at the neuron-to-cell interaction during transcytosis, low-density cul-
tures for live-cell imaging were established. Low-density cultures consist of only 14 to
1
5 of the
cell number of high-density cultures; allowing the imaging of single neurons with their single
contacts to adjacent cells.
To determine reverse transcytosis in neurons of low-density cultures, mature primary hip-
pocampal cultures were transfected at DIV15 with EphB2-C1-EYFP expression constructs and
two days later imaged, acquiring sequentially pairs of fluorescence and phase contrast images
at a frequency of 1 frame per minute. In contrast to high-density cultures, the contact between
an EphB2-C1 expressing neuronal process and a glial cell was clearly visible in the time lapse
recording (Figure 6.30). The glial process was in contact with a filopodium-like protrusion
from the axon of the transfected neuron. From the beginning to the end of the time lapse
series a fluorescent EphB2 cluster was visible in the glial process (Figure 6.30, white arrows).
This cluster was not static and was moving throughout the entire imaging sequence. In the
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Figure 6.30. Reverse transcytosis of EphB2-C1-EYFP from an axonal filopodium into a glial process is followed
by withdrawal of glia. (supplementary information on CD-Rom, movie 11) A mature primary low-density hip-
pocampal culture was transfected at DIV15 with expression constructs coding for EphB2-C1-EYFP. Two days later,
culture was imaged, sequentially acquiring sets of fluorescence and phase contrast images at a frequency of 1
frame per min. Selected pairs of fluorescence and phase contrast images are shown in the left column (a-f)
and right column (A-F), respectively. Note that after the fast reverse transcytosis of a fluorescent EphB2 clus-
ter (indicated by red arrows a-c, A-C) into a possible astrocytic process, the glial cells detaches and withdraws
(E-F). Time points of imaging are indicated in lower right corners of the fluorescent images. Scale bar = 10 µm.
first 3 minutes it moved towards the neuron (data not shown; supplementary information on
CD-Rom, movie 11), then for several minutes it remained in close proximity to the filopodial
tip (Figure 6.30a-c) and then moved once again towards the glia (similar to a tug-of-war com-
petition between neuronal and glial cell)(Figure 6.30d-f). At the point when the cluster was
in the closest proximity to the filopodium a second faint cluster was detectable (Figure 6.20a,
red arrow). This EphB2 cluster was reverse transcytosed into the glial process and quickly
retrogradely transported during the next two minutes along the process (Figure 6.30b-c, red
arrows). After the transcytosis event (Figure 6.30a-c, red arrows) the glial process started to
detach (Figure 6.30E) and withdraw (Figure 6.30F), thereby taking away the above mentioned
cluster (Figure 6.30e-f, white arrows).
These results demonstrate that the full-length EphB2 receptor expressed in a filopodium of
a neuron may be taken up by a glial process through ephrinB reverse endocytosis. Reverse
transcytosis of EphB2-C1 into a glial process can sometimes be followed by detachment and
withdrawal of the glial cell.
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Movie 1-3: Comparison of unstimulated versus ephrinB2-stimulated young neurons ex-
pressing one variant of EphB2-C1-EYFP during live-cell imaging. 2-day-old primary hip-
pocampal cultures were transfected with expression constructs encoding either EphB2-C1-
EYFP (Movie 1), EphB2-C1-KD-EYFP (Movie 2) or EphB2-∆C-EYFP (Movie 3). After 1DIV,
transfected neurons were imaged by time lapse microscopy taking a fluorescent image at 1
frame per minute. After 10-14 min, preclustered ephrinB2-Fc was added (indicated by a white
circle in the upper right corner). Note the fast accumulation of bright and large fluorescent
clusters after stimulation with ephrinB2.
Movie 4-6: Comparison of unstimulated versus ephrinB2-stimulated neurons (DIV8+2/3)
expressing one variant of EphB2-C1-EYFP during live-cell imaging. Dissociated hippocam-
pal cultures were transfected at DIV8 with expression constructs encoding either EphB2-C1-
EYFP (Movie 4), EphB2-C1-KD-EYFP (Movie 5) or EphB2-∆C-EYFP (Movie 6). After 2-3DIV,
transfected neurons were imaged by time lapse microscopy taking a fluorescent image at 1
frame per minute. Preclustered ephrinB2-Fc was added after 20-27 min (indicated by a white
circle in the upper right corner). Note the quick accumulation of bright fluorescent clusters
and the slowing down of the moving vesicles after stimulation with ephrinB2.
Movie 7: Trafficking of fluorescent vesicles in an EphB2-C1-KD-EYFP expressing neuron. 8-
day-old primary hippocampal cultures were transfected with expression constructs encoding
EphB2-C1-KD-EYFP. After 2DIV, a transfected neuron was imaged by time lapse microscopy
taking a fluorescent image at 1 frame per 3 seconds. The velocity of vesicles was calculated
using the Metamorph 6.2 software (Track point tool).
Movie 8: Transcytosis of fluorescently tagged EphB2-C1-EYFP in a primary hippocampal
neuronal culture. A 14-day-old primary hippocampal culture was transfected with expres-
sion constructs encoding EphB2-C1-EYFP. After 2DIV, the transfected neuron was imaged by
time lapse microscopy taking a fluorescent image (left panel) and a bright field image (right
panel) at 1 frame per minute. Figure 6.26 shows only plane 27 to 33 of the total 70 planes.
Time points of imaging are indicated in the lower right corner.
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Movie 9: Transcytosis of fluorescently tagged EphB2-C1-EYFP in a primary hippocampal
neuronal culture. A 14-day-old primary hippocampal culture was transfected with expres-
sion constructs encoding EphB2-C1-EYFP. Two days later, the transfected neuron was imaged
by time lapse microscopy taking a fluorescent image (left panel) and a bright field image (right
panel) at 1 frame per minute. Figure 6.27 shows only plane 20 to 26 of the total 60 planes. Time
points of imaging are indicated in the lower right corner.
Movie 10: Transcytosis of fluorescently tagged EphB2-C1-EYFP in a primary hippocampal
neuronal culture. A 13-day-old primary hippocampal culture was transfected with expres-
sion constructs encoding EphB2-C1-EYFP. After 2DIV, the transfected neuron was imaged by
time lapse microscopy taking a fluorescent image (left panel) and a bright field image (right
panel) at 1 frame per minute. Figure 6.28 shows only plane 6 to 10. Time points of imaging
are indicated in the lower right corner.
Movie 11: Transcytosis of fluorescently tagged EphB2-C1-EYFP in a primary hippocam-
pal low-density culture. A 15-day-old primary hippocampal low-density cultures was trans-
fected with expression constructs encoding EphB2-C1-EYFP. After 2DIV, the transfected neu-
ron was imaged by time lapse microscopy taking a fluorescent image (upper panel) and a
bright field image (lower panel) at 1 frame per minute (Figure 6.30). Time points of imaging
are indicated in the lower right corner of the upper movie.
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7. Discussion
My results of the transcytosis experiments will be considered at first. They will be followed
by an assessment of the EphB2-ExFP receptors generation and their functionality. Finally, the
findings of the thy1-EphB2-C1-EYFP transgenic mice of the present study will be discussed.
7.1. Transcytosis of EphB2 in mature neuronal cultures
7.1.1. Overexpression of full-length EphB2-C1-EYFP receptors lead to
transcytosis in primary hippocampal cultures
The bi-directional trans-endocytosis of ephrinB-EphB complexes has recently been described
as a new mechanism of how the initial high affinity interactions of two transmembrane
molecules can be turned into a repulsive response. In cell lines, such as HeLa cells and Swiss
3T3 fibroblasts, this kind of transcytosis leads to cell retraction and detachment (Marston et al.,
2003; Zimmer et al., 2003). In addition, stimulation experiments of growth cones of primary
immature neuronal cultures with (i) preclustered fusion bodies of B-type ephrin/Eph recep-
tor ectodomains with Fc fragments or (ii) HeLa cells transiently expressing EphB2-C1, could
demonstrate that EphB-ephrinB complex internalization is functionally important for axon
withdrawal during growth cone collapse (Mann et al., 2003; Zimmer et al., 2003). The data of
the study presented here first addressed the phenomenon of transcytosis of EphB or ephrinB
clusters in mature hippocampal cultures, deriving with three important observations: (i) ma-
ture hippocampal cultures are capable of performing Eph-ephrin transcytosis events, (ii) tran-
sient expression of EphB2 (but not of ephrinB) triggers uptake of EphB receptors from neurites
and growth cones into neighbouring cells. (iii) These cells are most likely glial cells.
Is transcytosis from the neuron into the interacting cell taking place after cell-to-cell con-
tact in mature hippocampal cultures?
In mature hippocampal cultures, neurons have filopodia-like protrusions on the tip of growth
cones and on long neurite shafts. These filopodium-like protrusion form contacts with other
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neuronal and non-neuronal cells of the brain. In this study, I could show that these contacts
in mature neurons overexpressing fluorescently tagged EphB2 receptors (EphB2-C1) could in-
duce reverse transcytosis of EphB2 clusters from these neurons into neighbouring cells. Since
the EYFP-tag is in the cytoplasmic domain of the EphB2-C1 protein, the presence of fluores-
cent clusters in neighbouring cells strongly indicate that the entire EphB2-C1 molecule was
internalized into the encountered cell and not cleaved from the cell surface. So far, it was only
demonstrated that immature neurons can uptake ephrinB/EphB from overexpressing HeLa
cells after cell-to-cell contact (Zimmer et al., 2003). The endocytosis of the Eph/ephrin com-
plexes in the opposite direction – from the neuron into the neighbouring cell – however, was
not observed under these conditions. My finding that transcytosis is taking place in mature
hippocampal neurons fits well with the observations done in cell lines and immature neurons
at their growth cones: Endocytosis of ephrinB-EphB complexes can occur in a bi-directional
fashion in cell lines overexpressing EphB/ephrinB (Zimmer et al., 2003; Parker et al., 2004),
whereas prolonged cell-to-cell contact may favour EphB2 forward endocytosis by receptor-
expressing cells (Marston et al., 2003; Zimmer et al., 2003). Non-transfected growth cones of
a very immature primary mouse forebrain culture showed little EphB2 forward but rather
pronounced ephrinB reverse transcytosis into the growth cone after cell-to-cell contact with
ephrinB1 and EphB2 transiently expressed in HeLa cells, respectively (Zimmer et al., 2003).
Similar results were obtained with young non-transfected primary neurons from embryonic
Xenopus retina when stimulated with soluble EphB2-Fc or ephrinB1-Fc fusion proteins (Mann
et al., 2003). The relative contribution of ephrinB reverse versus EphB forward endocytosis
may largely depend on the cellular context, experimental design and expression levels of Eph
receptors and their ligands. It has been shown that uni-directional reverse endocytosis alone
efficiently switches adhesion to detachment by removal of the ephrin-Eph complexes from the
surface (Zimmer et al., 2003).
The experiments presented in this thesis cannot exclude that EphB forward transcytosis into
the neuron takes place after an EphB2-C1 expressing neuron encountered another cell of the
mature hippocampal culture. In contrast to the growth cones of immature cultures, an in-
ternalization from the glial cell into the neuron could not be detected with this experimental
design. A future challenge will be to determine bi-directional transcytosis in hippocampal
cultures. A potential experiment could be live cell imaging of contacts between e.g. EphB2-
C1-EYFP expressing neurons and ECFP-ephrinB expressing glial cells revealing the possible
occurrence of EphB2-mediated forward endocytosis into neurons of primary hippocampal
cultures.
140
7.1. Transcytosis of EphB2 receptors in primary hippocampal cultures
Findings by Spacek and Harris (2004) in the CA1 region of the mature rat hippocampus in-
dicate that there is more transcytosis taking place from neuronal protrusions into astrocytic
processes as vice versa. My results also suggest a preferential transcytosis from neuronal pro-
trusions into most likely glial cells. However, in the mature hippocampus Spacek and Har-
ris (2004) could also observe neuron-to-neuron internalization: double-membrane structures
(spinules) emerged from spine heads (62%) were invaginated into axons (v90%) rather then
astrocytic processes (v8%). So far, I could not reliable detect such kind of neuron-to-neuron
transcytosis in EphB2-C1 overexpressing hippocampal cultures because the neuronal identity
of the uptaking cell could not be confirmed.
Is there ephrinB triggered reverse transcytosis from the neuron into the neighbouring cell?
My experiments showed that transient expression of EphB2 but not ephrinB1/B2 in neurons
triggers transcytosis events into the interacting neighbouring cell after cell-to-cell contact. If
primary hippocampal neurons transiently express EphB2 receptors, clusters of EphB2 were
preferentially transcytosed into neighbouring cells. Surprisingly, neurons transfected with
plasmids coding for the ligand – ephrinB1 or ephrinB2 – did not clearly induce transcytosis.
A possible explanation of this observation could be that the ligands for the EphB2 receptor –
ephrinBs and ephrinA5 – are endogenously expressed in the uptaking cell, whereas all Eph
receptors of ephrinB1/B2 are absent or only weakly expressed. These results implicate that
mainly ephrin-mediated reverse transcytosis is taking place between neurons and neighbour-
ing cells. The identity of the uptaking cell has not been verified yet, but the shape and the
behaviour of these cells during live cell imaging strongly suggests that they are glial cells as
will be discussed later.
Which cell types express Eph receptors and their ligands in the mature hippocampus?
Neuron-to-cell interaction mediated by EphB2s and their ligands leads to transcytosis into the
neighbouring cell, potentially a glial cell. In neurons, EphB2 mRNA has been detected at high
levels in all regions of the hippocampus, while ephrinB2/B3 mRNAs were absent or barely
detectable in the CA3 region of the hippocampus. EphrinB1 mRNA was also barely detectable
in the CA1 region, in contrast to the dentate gyrus. EphrinB2 mRNA was mostly confined to
CA1 and weakly present in the dentate gyrus (Grunwald et al., 2001). The overall expression
of EphB2 in the hippocampus could indicate that transcytosis might potentially be a general
phenomenon within the hippocampal formation.
Little is known about the expression patterns of ephrin ligands and Eph receptors in glial
141
7. Discussion
cells. A previous study reported that ephrinA3 displayed the highest hippocampal expres-
sion among ephrinAs and is expressed in astrocytic processes of the adult hippocampus (Mu-
rai et al., 2003). Another study reported that EphA4 expression in astrocytes was upregulated
after spinal cord injury, which inhibits neurite outgrowth in wild type mice (Goldshmit et al.,
2004). In addition, data by Conover et al. (2000) identified the presence of ligands of the EphB
receptors, such as ephrinB2 and ephrinB3, in astrocytes that ensheath chains of migrating neu-
roblasts in the adult subventricular zone. Also it has been shown that the ephrinA5 ligand is
expressed by astrocytes (Winslow et al., 1995). I tried several immunostainings with antibod-
ies against different B- and A-types of ephrins and Eph receptors on cultured glial cells seeded
on coverslips. So far, the majority of these immunostainings looked unspecific, as revealed by
control experiments using the secondary antibodies alone (data not shown). However, two
immunostainings looked specific and indicate the expression of ephrinB2 and EphA4 in glial
cells. Nevertheless, further experiments have to be done to identify the expression patterns
of endogenous Eph receptors and their ligands in glial cell in the hippocampal cultures used
in this study. To overcome the problems encountered in the immunostainings with primary
antibodies, I intend to carry out further immunostainings with fusion proteins of Fc fragments
with ectodomains of Eph receptors (Eph-Fc) or ephrin ligands (ephrin-Fc).
What is the identity of the cells that endocytose EphB2 receptors?
As described before, I observed transcytosis between EphB2-C1 expressing neurons and in-
teracting cells. Based on shape, motility and structure, these interacting cells were identified
as glial cells, most likely astrocytes.
Nearly one-half of the cells in the human brain are astrocytes (Ullian et al., 2004). In contrast
to oligodendrocytes, astrocytes have been described to contribute in regulating spine mor-
phology (Murai et al., 2003), modulating levels of synaptic activity as well as influencing the
number of functional synapses (Newman, 2003; Yang et al., 2003) and synaptogenesis in hip-
pocampal neurons (Hama et al., 2004; Ullian et al., 2004). In addition, recent data showed
that in the CA1 region of the mature rat hippocampus astrocytes can perform transcytosis or
macropinocytosis through double-membrane invaginations emerging from dendrites or ax-
ons (so-called spinules). Whereas, thin spines showed more transcytosis in form of spinules
into astrocytic processes than mushroom spines (Spacek and Harris, 2004). In addition, it has
been shown that fragments of EGFP-labeled plasma membrane from the surface of ephrinB-
bearing human umbilical-vein endothelial cells (HUVECs) were removed by adjacent EphB-
expressing cells (Marston et al., 2003), suggesting the formation of multivesicular bodies (=
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double-membrane structures).
Because of the close association of astrocytes with neurons, the high number of astrocytes in
the CNS (Haydon, 2001) and the findings of spinules in astrocytes, it seems to be very likely
that reverse transcytosis of EphB receptors can occur between neurons and astrocytes. To con-
firm the hypothesis that only a specific subtype of glia is involved in neuron-glia transcytosis
in the mature hippocampal cultures, immunostainings for a specific marker of astrocytes (e.g.
the calcium-binding protein, S-100β) or oligodendrocytes (e.g. enzyme CNPase) in low den-
sity cultures after imaging will be useful (Ghosh and Koenig, 1977; Matthias et al., 2003).
Is the EphB transcytosis event coupled to a change in cell behaviour?
It has previously been shown that contact-triggered EphB activation in HUVECs can stimu-
late the formation of membrane protrusions, such as lamellipodia and filopodia, exclusively
in EphB4-expressing and not in ephrinB-expressing cells (Marston et al., 2003). These events
seem to initiate the cells to retract from one another, concomitantly with the endocytosis of
the activated EphB receptors and their bound, full-length ephrinB ligands (Marston et al.,
2003). Interestingly, the bi-directional transcytosis of ephrinB-EphB complexes can trigger dif-
ferent cellular responses: ephrinB1-overexpressing HeLa cells endocytose efficiently but do
not retract, whereas forward endocytosis into cells transiently expressing EphB2 receptors is
followed by a lamellipodial retraction response after cell-to-cell contact (Zimmer et al., 2003).
Both the Eph-receptor internalization and the subsequent cell retraction events are dependent
on actin polymerization in cell lines, which in turn is dependent on Rac signalling within
the receptor-expressing cells (Marston et al., 2003). In addition, transcytosis is proposed to
destabilize cell contacts and might therefore at least partially contribute to Eph-ephrin reg-
ulated cell repulsion (Marston et al., 2003). However, growth cone detachment of immature
primary forebrain neurons was impaired after contact with HeLa cells transiently expressing
C-terminal truncated EphB2, suggesting that uni-directional ephrinB reverse endocytosis is
less efficient (Zimmer et al., 2003).
The data of the present study show that in mature neuronal cultures reverse transcytosis of
EphB2-C1 clusters into the cell interacting with the neuron was mainly followed by the detach-
ment and retraction of the filopodia-like protrusion of mature growth cones and of neurites.
As mentioned before, with my experimental setup it was not possible to detect bi-directional
transcytosis, only the uni-directional transcytosis from the neuron into the neighbouring in-
teracting cell. The above described findings from cell lines suggest that after an EphB2-C1
expressing neuron encounters another ligand-expressing cell, activated ephrinB-EphB clus-
143
7. Discussion
ters are bi-directional – forward and reverse – endocytosed into the neuron and also from
the neuron into the other cell (possibly a glial cell), respectively. This would allow the adhe-
sive ligand-receptor interaction to destabilize and enable the cells to detach and the neuronal
filopodium-like protrusion to retract, probably involving an actin redistribution mediated by
phosphorylated EphB2 proteins.
Dendritic filopodia are discussed to serve as precursors to spines (Dailey and Smith, 1996;
Ziv and Smith, 1996). In contrast to spines, filopodia are long, thin structures and display a
very dynamic nature. These features indicate an exploratory function of filopodia and only
those that successfully capture an axonal terminal became stabilized by transforming into
spines (Yuste and Bonhoeffer, 2004). Beside the typical morphological features and the differ-
ent dynamic nature of filopodia and spines, there is no specific marker that can distinguish
filopodia from spines (Yuste and Bonhoeffer, 2004). In addition, EphB receptors can be found
in both filapodia and spines. These similarities raise the question if these different dendritic
protrusions also display similar cell behaviour, such as repulsion potentially leading to loss
of synapses. As the main cytoskeletal element, filamentous actin is highly enriched in spines
and filopodia and is necessary for their shape and the motility (Dailey and Smith, 1996; Ethell
and Yamaguchi, 1999; Scott and Luo, 2001; Bonhoeffer and Yuste, 2002). The small GTPase
Rac1 is important for the formation and maintenance of dendritic spines in cultured pyra-
midal neurons (Nakayama et al., 2000). It has also been shown that hippocampal neurons
in triple EphB1, EphB2, EphB3-deficient mice fail to form spines in vitro and develop abnor-
mal immature spines in vivo. The actin filament accumulation in spines is disrupted in the
triple EphB-deficient hippocampal neurons indicating that the EphBs are responsible for tar-
geting of actin to spines (Henkemeyer et al., 2003). In addition, synaptic EphB receptors have
been linked to protrusive responses to ephrinB stimulation. Here activated EphB2 receptors
mediate the formation of new actin-rich dendritic spines through Cdc42 and Rac1 activated
by their respective exchange factors intersectin and kalirin (Irie and Yamaguchi, 2002; Penzes
et al., 2003).
What is the functional relevance of EphB-ephrin transcytosis in cells of the brain?
In contrast to cell lines, in young cortical neurons reverse endocytosis of EphB2 leads to fast
detachment and growth cones collapse after contact with HeLa cell transiently expressing
EphB2-C1 (Zimmer et al., 2003). Furthermore, growth cones of cultured embryonic Xenopus
retinal neurons stimulated with unclustered EphB2 ectodomain fusion bodies triggered fast
(5-10 min) transient collapse responses concomitant with endocytosed EphB2-Fc molecules.
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This suggests that endocytosis provides a fast mechanism for switching off signalling in re-
verse direction (Mann et al., 2003). In contrast, stimulation with clustered ephrinB1-Fc causes
only slow (30-60 min) growth cone collapses and no endocytosis of ephrinB1-Fc molecules
into growth cones, suggesting that forward signalling does not involve endocytosis of clus-
tered ephrinB1-Fc. Thus reverse EphB-ephrinB complex internalization is functionally impor-
tant for axon withdrawal during growth cone collapse (Mann et al., 2003; Zimmer et al., 2003).
Anyway, it remains to be solved whether the slow withdrawal of glial cells after contact with
the dendritic protrusion of the EphB2-C1 expressing neuron in low density cultures as ob-
served in my studies is a specific effect downstream of EphB-ephrinB complex internalization,
or not. Interestingly, in high density cultures some glial cells also showed repulsive responses
following reverse transcytosis of fluorescent EphB2 clusters (Movies 8-9, supplementary in-
formation on CD-Rom). However, due to the high numbers of cell contacts the overall cell
movement was diminished in these cultures and probably only glial protrusion withdrew
and not the whole glial cell.
Is intracellular signalling of EphB receptors and their ligands important for transcytosis?
It has been shown that the cytoplasmic tails of ephrinB and EphB2 are required for bi-
directional endocytosis in cell lines. If one interaction partner is truncated bi-directional tran-
scytosis is always shifted toward uni-directional endocytosis into the cells overexpressing the
full-length protein (Zimmer et al., 2003). Additionally, axon detachment of immature cortical
neurons from C-terminally truncated EphB2-C1 expressing HeLa cells is delayed compared to
full-length EphB2-C1 expressing HeLA cells. This implies that uni-directional ephrinB reverse
endocytosis is less efficient and additional EphB2 forward endocytosis is required for proper
axon detachment (Zimmer et al., 2003).
As expected from these published data, weakening the EphB2 receptor’s ability to signal by
C-terminal truncation or blocking the kinase activity in neurons should not impair the ephrinB
reverse transcytosis of the neighbouring glial cells. In contrast, it should have a blocking effect
on the EphB2-mediated forward endocytosis into neurons. One the other hand, the expres-
sion of C-terminal truncated ephrinB in glial cells should block their transcytosis ability and
the EphB-mediated forward transcytosis of neurons should not be effected.
Live cell imaging of transfected C-terminally truncated EphB2-C1-EYFP neurons or ephrinB-
ECFP glias may shed more light on the importance of the cytoplasmic tails of B-type ephrins
and Ephs in neuron-glia transcytosis.
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Can the other subfamily of Eph receptors (EphAs) trigger transcytosis?
This study showed that EphB receptors transiently expressed on neuronal protrusions were
internalized into the neighbouring cells after cell-to-cell contact. Like the EphA in situ hy-
bridization data indicates, EphA4 is expressed at remarkably high levels in all region of the
adult mouse hippocampus (Figure 6.24C and Grunwald et al. (2001)), especially at postsynap-
tic sites in the CA1 area (Murai et al., 2003). As mentioned before, ephrinA3 – an EphA4 ligand
– is expressed on astrocytic processes of the adult hippocampus (Murai et al., 2003). Therefore,
it would be interesting to determine, whether A-type Eph receptor can be trans-cytosed into
neighbouring cells of the primary hippocampal cultures. To address this, (i) stimulation of
cultured astrocytes with preclustered EphA-Fc (or ephrinA-Fc), followed by a surface versus
total immunostaining of EphA-Fc (or ephrinA-Fc) and (ii) live time imaging with fluorescently
tagged EphAs (or ephrinAs) expressed in primary hippocampal cultures could give further
insights in neuron-to-glia transcytosis.
7.1.2. What could be the in vivo relevance of Eph receptor transcytosis by glial
cells?
Surface availability of receptors and termination of signal transduction
Endocytosis of receptor-ligand complexes is a common feature in signal transduction of recep-
tor tyrosine kinases. It is thought to be involved in regulating the surface availability of recep-
tors as well as to be one of the mechanisms to attenuate signal transduction. Internalization
of transmembrane proteins into intracellular vesicles often leads to lysosomal degradation or
their recycling to the cell membranes (Presley et al., 1997; Walker-Daniels et al., 2002; Conner
and Schmid, 2003; Marmor and Yarden, 2004).
However, a growing body of evidence also suggests that endocytosed membrane may be im-
portant for intracellular signalling. Receptors may continue to signal after endocytosis as it
was shown for internalized EGF and neurotrophin (TrkA) receptors (Kurten, 2003; Weible and
Hendry, 2003). EphB2 may therefore also continue signalling: Consistent with this idea is that
(i) internalized EphB2 clusters are tyrosine phosphorylated and (ii) EphB receptor forward
signalling is independent of rapid protein synthesis and degradation, indicating receptor re-
cycling (Mann et al., 2003; Marston et al., 2003). Comparable to the Trk receptors, endocytic
vesicles of ephrin-EphB can possibly be seen as parcels of activated plasmalemma that can
propagate transducing signalling locally and to distant parts of the neuron by retrograde
transport (Poo, 2001). Remarkably, in the hippocampal cultures used in my experiments (an-
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terograde and retrograde) long-range trafficking EphB2-C1 vesicles was also be seen in neu-
rons expressing EphB2-C1.
Pruning of axons in the developing brain
There is accumulating evidence that the interaction between neurons and glial cells are is im-
portant for axonal pruning. Transcytosis, which most likely involves the neuron-to-glial cell
interaction might also play a central role in the axon pruning process.
Axon pruning is an important process during the development of the nervous system and
is involved in establishment and maintenance of functional neuronal circuits. Studies from
Drosophila mushroom bodies (MBs) and the vertebrate neuromuscular junctions (NMJs) pro-
vide fresh insights into the mechanisms of synapse elimination (Awasaki and Ito, 2004; Bishop
et al., 2004; Watts et al., 2004). For example, data by Awasaki and Ito (2004) demonstrate that
transient disruption of glial function arrests axon pruning, suggesting an instructive role for
glia in developmental axon pruning.
There are three important findings pointing towards a role of transcytosis involved during
axon pruning: First, during synapse elimination in the developing mammalian NMJ most
of the withdrawing axons shed fragments rich in normal synaptic organelles, so-called axo-
somes, into surrounding glial cells, presumably terminal Schwann cells. Axosomes may be
assimilated in the cytoplasm of Schwann cell (Bishop et al., 2004). However, it is not known, if
Schwann cells actively dismantle axons or whether they play a passive scavenger role in this
process. Second, in the Drosophila larvae MBs, γ neurons initially extend axons branches into
both the dorsal and medial MB lobes, which are surrounded by several glial cells (Lee et al.,
1999; Watts et al., 2004). During metamorphosis, axon branches degenerate prior to the for-
mation of adult connections. This process is coincident with an increase of the number of glial
cells surrounding the dorsal and medial lobe. Changes in glia cell number is coincident with
blebbing of axons and fragmentation of dendrites. Finally, Watts et al. (2004) could show that
the material which is engulfed by glial cells, originates from the degenerating axons under-
going developmental axon pruning rather than debris from apoptotic cells. Taken together,
these findings provide the framework for further investigations into the mechanisms under-
lying axon-to-glia interactions during developmental axon pruning.
Shaping of synapses in the mature brain
Astrocytes have long been known to phagocytose degenerating axonal boutons (Ronnevi,
1978; Seil, 1997) or whole apoptotic neurons (Freeman et al., 2003). Recently, ultra structural
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examination of synapses in the mature rat hippocampus revealed that axons and dendrites
extend small protrusions into neighbouring neurons and glial cell. Some of these so-called
spinules appear to finally end as double-membrane inclusions in the recipient cell, very often
astrocytes, due to trans-endocytose or macropinocytose, which does not resemble traditional
astrocytic phagocytosis of degenerating or apoptotic neurons, because of the absence of very
dark and condensed cytoplasm (Spacek and Harris, 2004). Thin spines show more transcy-
tosis into astrocytic processes than mushroom spines, suggesting a shaping of interactions
between newly formed synapses and their perisynaptic glia during synaptic plasticity in the
immature and the mature brain (Spacek and Harris, 2004).
The present study shows that in vitro after cell-to-cell contact EphB2 receptors on neuronal pro-
trusions were transcytosed from the EphB2-C1 overexpressing neuron into the neighbouring
cell, most likely a glial cell. Considering that glial cells completely surround synapses, neuron-
glia transcytosis could also be potentially involved in the synapse elimination after LTD in the
mature brain. It is not known so far, if ephrinB-EphB mediated transcytosis between glial cells
and neurons actually takes place at freshly formed or mature tripartite synapses and what is
its role in the regulation of receptor trafficking and synaptic plasticity. Transcytosis should
therefore be analyzed in more detail at synapses.
7.2. Generation and analysis of the different fluorescently tagged
EphB2 receptors
To better understand the role of EphB2 receptors and to study their trafficking dynamics, in-
sertion and clustering in neurons during cellular interaction, such as synapse formation and
synaptic plasticity, the EphB2 receptor was fluorescently tagged at one of the three different
positions: (i) at the N-terminus (EphB2-N), (ii) adjacent to the juxtamembrane region (EphB2-
C1) or (iii) between the kinase and the SAM domain (EphB2-C2). Transfected Hek293 cells
expressing one of the three different EphB2 fusion proteins showed intense fluorescence at
the membrane. Compared to ExFP-expressing cells the fluorescently tagged EphB2 receptors
were less intensive in fluorescence, but still bright enough for live cell imaging. However,
the fluorescence of the EphB2 receptors was comparable to other known N-terminal fusion
proteins of ExFP and transmembrane receptors, such as EGFP-ephrinB1 or EGFP-∆N-TrkB.
Therefore, the insertion of the ExFP between two domains of the EphB2 receptor (EphB2-C1,
EphB2-C2) behave as commonly used N-terminal and C-terminal ExFP fusion proteins. In ad-
dition, biochemical studies revealed that all three versions of these differently tagged EphB2-
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ExFP proteins are tyrosine phosphorylated when expressed in Hek293 cells. Compared to
the wild type and the two other fluorescently tagged EphB2 receptors, the EphB2-C2 fusion
protein showed less tyrosine phosphorylation, indicating that the ExFP insertion between the
kinase and the SAM domain seems to affect proper phosphorylation of this EphB2 receptor.
One explanation could be that the insertion of the ExFP ”domain“ changes the protein struc-
ture of EphB2, possibly interfering with the usually close proximity of the juxtaposed kinase
domains after ligand binding, thereby affecting the trans-phosphorylation of tyrosine residues
in the activation segment of the tyrosine kinase domain (Hubbard, 2004). Another explanation
could be that the insertion of the fluorescent protein changes the conformation of the receptor
in a way that the inactive form is preferred. All three types of fluorescently tagged EphB2
receptors had a similar behaviour in their interaction with known partners, such as NR1 and
GRIP2, in cotransfected HEK293 cells.
Surprisingly, the cluster behaviour of the three different EphB2-ExFP fusion proteins was dif-
ferent upon stimulation with preclustered ephrinB ligands in transfected hippocampal neu-
rons. Only the EphB2-C1 fusion protein displayed proper cluster formation in immature neu-
rons upon stimulation with ephrinB while only few clusters if any clusters were detectable
in EphB2-N or EphB2-C2 expressing neurons. This indicates that the insertion of the fluores-
cent protein at the N-terminus or between the kinase and the SAM domain impaired cluster
formation. We assumed that the N-terminal fusion of ExFP followed by a linker region to
EphB2 would not interfere with the ligand binding because the N-terminal fusion of EGFP
with ephrinB1 does not interfere with cluster formation upon EphB2 stimulation (Brückner
et al., 1999). However, the N-terminal ExFP fusion to EphB2 resulted in a clearly function-
ally impaired protein, similar to the EphB2-C2 proteins. The ExFP insertion between these
two functional domains – the kinase and the SAM domain – may inhibit cluster formation,
most likely because of the interference with the SAM domain which is known to participate
in protein-protein interactions.
In contrast to mature neurons, young immature hippocampal EphB2-C1 expressing neurons
revealed a more even distribution of EphB2-C1 and only few fluorescent clusters were visible
without stimulation. Application of preclustered ephrinB-Fc specifically induced a dramatic
increase in cluster size and number in immature and mature cultures. Remarkably, very old
neurons (3-4 weeks old) showed a high number of fixed clusters even without exogenous
stimulation. In contrast to immature neurons, mature neurons display a higher degree of ar-
borization and a high number of contacts with other neurons, suggesting that these contacts
provided ephrinB ligands, which induced EphB2-C1 cluster formation in transfected neurons.
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Consistent with this idea, endogenous EphB2 receptors and their ligands have been found to
be expressed at the synapse (Torres et al., 1998; Buchert et al., 1999; Dalva et al., 2000; Grun-
wald et al., 2004) and in 23-day old hippocampal cultures many EphB2-C1 clusters were local-
ized at spine heads in transfected neurons. In addition, EphB2-C1 receptors were also located
on the surface of filopodia and other dendritic protrusions in younger neurons (1-2 weeks
old).
I also considered the possibility that neuronal electric activity drives EphB clusters or their
vesicles to the plasma membrane or even more specific in filopodia, the discussed precursors
of spines (Yuste and Bonhoeffer, 2004). To assess this, young and old hippocampal cultures
transiently expressing EphB2-C1-EYFP were briefly depolarized by applying a solution con-
taining KCl [50 mM] or glutamate [50 µM]. These depolarizing stimuli never induced an in-
crease in EphB2-C1-EYFP fluorescence in dendritic protrusions, dendrites or axons (data not
shown). In addition, the fluorescent vesicles never showed an obvious effect in their traffick-
ing behaviour during and after stimulation, suggesting that electric activity does not have an
effect in the vesicle trafficking and localization of EphB2-C1-EYFP receptors (data not shown).
Immunostainings against a dendritic marker revealed that the fluorescent EphB2-C1 receptors
were localized in the axon, in the dendritic tree, as well as in the cell body of the transfected
hippocampal neuron. The EphB2-C1 proteins were therefore not subcellularly sorted to the
dendrite or the axon, when expressed in neurons. Interestingly, beside the postsynaptic lo-
calization of EphB there is evidence that these receptors are also present at the presynaptic
terminal of neurons (Buchert et al., 1999; Grunwald et al., 2004).
My results show, that besides the membrane inserted EphB2-C1 receptors a big intracellular
pool of these fluorescent receptors are trafficking in vesicles along the dendrites and axons,
especially in thick dendritic branches. The number of trafficking vesicles increases with the
age of the cultures, suggesting that there is possible correlation between receptor trafficking
and the organization of postsynaptic membrane. Most likely, these trafficking vesicles carry
either endocytosed receptors from the cell surface to degradative compartments or newly syn-
thesized EphB2-C1 proteins on their way to the plasma membrane. Indeed, transfected hip-
pocampal neurons revealed anterograde and retrograde trafficking vesicles during live cell
imaging. Application of preclustered ligands induced a fast recruitment of EphB2-C1 recep-
tors to the cell surface within minutes, thereby fluorescently highlighting the neuronal cell
membrane. Simultaneously fast cluster formation became visible. Independently from the
age of the neurons, the number of moving vesicles decreased, sometimes even stopped after
adding the preclustered ligand.
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The overexpression of full-length, kinase-deficient or C-terminal truncated EphB2-C1 recep-
tors never showed any obvious effect on cell morphology, vesicle trafficking or protein distri-
bution during live cell imaging or in fixed cultures. A lack of defects may be due to different
cell culture densities. In comparison to other studies, our cultures were almost 6× and even up
to 10× less dense for the fixed-only cultures and for the time lapse imaging, respectively. Pre-
sumably, the overexpression of kinase-active, kinase-deficient or C-terminal truncated EphB2-
C1 causes only little differences in the number of fluorescent clusters, therefore it would be
necessary to quantify cluster formation, this still has to be done. For this quantification of
membrane inserted (before permeabilization) versus total (after permeabilization) EphB2-C1
clusters should be counted, otherwise it would not be possible to distinguish trafficking vesi-
cles from fixed clusters.
7.3. Transgenic mice expressing one variant of EphB2-C1 driven
by the Thy-1.2 expression cassette
7.3.1. Patterns of transgene expression and their fluorescent intensities
Transgenic mice expressing either the full-length, the kinase-deficient or the C-terminal trun-
cated EphB2-C1-EYFP under the control of the neuron-specific elements from the thy-1.2 gene
were generated. The aim was to observe the dynamics and localization of fluorescently tagged
EphB2 receptors in the hippocampus in vivo. We generated 41 independent transgenic lines: 22
for the full-length (line A-N, P-W), 8 for the kinase-dead (line Ka-Kh) and 11 for the truncated
version (line Da-Dk) of the EphB2-C1 receptor. Among the 41 founders 33 gave offspring: 21
for the full-length (wt), 6 for the kinase-deficient (KD) and 6 for the truncated (∆C) version of
the EphB2 receptor. Analysis of the offspring revealed that 23 transgenic lines showed fluo-
rescence in the brain, 5 lines yielded very low expression levels and were therefore excluded
from the analysis. The remaining 18 lines were analyzed in more details. Surprisingly, apart
from one transgenic line (line R) all analyzed lines showed a homogeneous labeling mainly
in the DG and the CA1 region of the hippocampus. The overall fluorescence of these trans-
genic lines made imaging of single neurons, or even spines almost impossible. As mentioned
previously, only one line – line R – yielded a sparse expression pattern of the fluorescently
tagged full-length EphB2-C1 receptor, but unfortunately the fluorescent signal was too weak
for imaging by confocal microscopy in hippocampal slices.
In neurons transiently expressing the EphB2-C1 proteins (or other ExFP-tagged transmem-
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brane proteins) the fluorescent intensity was less as compared with neurons transiently ex-
pressing the “pure” cytoplasmic ExFP proteins, indicating that the fusion of the ExFP protein
with these kind of proteins impaired fluorescence intensity of the ExFP. In neurons transiently
expressing these ExFP-tagged EphB2 proteins the fluorescent signal was still bright enough
for live cell imaging. It is known that dependent from the introduced copy number of the
expression construct and the strength of the promoter the transient expression can lead to
the production of recombinated protein of sometimes more then 50% of the total produced
proteins in the eukaryotic cell. In cultured neurons the transient expression of the different
EphB2-C1-EYFP versions under the control of the Thy-1.2 expression cassette displayed com-
parable fluorescence intensities as under the control of the strong cytomegalovirus (CMV)
promoter (data not shown). Therefore, the Thy-1.2 expression cassette should drive compa-
rable expression levels of the different EphB2-C1-EYFP versions. Taken together, this could
possibly indicate that the copy number of the transgene in the different variants of the thy1-
EphB2-C1-ExFP transgenic mice caused either homogeneous distribution of the transgene as
observed in 17 lines or the isolated expression pattern as observed in a single line. Whereas,
a very low copy number of the transgene led to the sparse transgenic expression and a sta-
ble integration of more copies caused a homogeneous expression of the transgene in some
regions. In addition, a very low copy number of the transgene could also explain the weak
fluorescence intensity of the transgenic protein in the mouse line R.
In addition, it was known from transgenic mice expressing multiple spectral variants of EGFP
driven by the Thy-1.2 expression cassette that: first, the expression pattern of the thy1-ExFP
lines differs greatly among lines. This line-to-line variations in thy1-ExFP transgene expres-
sion indicates that the variation reflects differences in chromosomal integration site and/or
copy number. And second, that at least 10-15 founders from the same construct must be gen-
erated to obtain one line with a sparse expression pattern (Table 1 of Feng et al., 2000 and
Caroni, 1997; personal communication with P. Caroni). In our approach, however, from 33
fertile founders we only had one line with a sparse expression pattern in the hippocampus.
This also indicates that possibly too many copies of the transgene were integrated into the
genome, causing a homogeneous expression pattern in the brain.
Expression of ExFP proteins in transgenic Thy-1.2 lines clearly labels neurons and these trans-
genic mice became a general useful tool for imaging neurons in vitro and in vivo (Feng et al.,
2000; Trachtenberg et al., 2002; Bishop et al., 2004; Nägerl et al., 2004). However, the inten-
sity of the different EphB2-C1-EYFP proteins of our thy1 transgenic mice lines was overall
very weak. Even hippocampal cultures of embryos of heterozygote and homozygote mouse
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lines with the brightest fluorescent intensity revealed signals that were too weak for live cell
imaging. We therefore decided not to follow this direction any further.
7.3.2. Overexpression of full-length or C-terminal truncated EphB2-C1-EYFP
receptor does not affect synaptic plasticity
The LTP analysis of hippocampal slices of transgenic mice expressing full-length (line A) or
the C-terminal truncated EphB2-C1-EYFP (line Df) at the CA3-CA1 synapse showed no effect
on LTP. Assuming that the transgenic proteins were expressed at the right place – the post-
synaptic site of the CA1 neuron – then the additional expression of truncated or full-length
EphB2-C1 receptors did not influence the synaptic transmission of these transgenic mice. This
might suggest that there is no cis interaction of ephrinBs and EphBs at the postsynaptic site.
Another possibility could be that in our approach the mouse strain background was not the
most suitable. Mouse strain backgrounds can effect LTP analysis, e.g. no stable baseline, LTP
can not be induced or is not lasting long (personal communication with M. Korte). To reduce
genetic heterogeneity usually F4 offspring of the backcrossed knockout or transgenic mice
were used for LTP analysis. Our transgenic mice were generated in a FVB strain and progeny
of the first backcross (F1) with C57/Black6 females was used for LTP analysis. LTPs could
be induced in these mice, but they showed a relatively low level of LTP in comparison to
other mouse strains. Possibly, a weak effect on LTP by the transgene could not be detectable
with this approach. Another more simpler explanation could be that the transgenic proteins
were not at the correct place in the synapse, because the in situ hybridization data and the
immunostainings against ExFP of fixed and permeablized slices only indicated the general
localization of the mRNAs and the EphB2-C1 protein in the neuron, respectively. Whether the
different EphB2-C1 transgenic proteins are inserted into the neuronal cell membrane and can
be found at the synapse as well as in transient expressing primary hippocampal cultures was
not analyzed. In situ hybridization analysis of hippocampal sections of these heterozygous
transgenic mice showed a very strong signal in the CA1 region of the hippocampus in case of
the C-terminal truncated EphB2-C1 receptor (line Df), indicating a very strong overexpression
of the transgenic protein in these neurons. However, we can not rule out the possibility that
too little truncated EphB2-C1 protein in these heterozygous transgenic mice was expressed in
the synapse or at the cell membrane to block endogenous EphB2 receptors.
Another explanation based on the freshest finding in the Eph/ephrin field by our group could
be a recently demonstrated postsynaptic role for ephrinBs in hippocampal plasticity, whereas
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ephrinB2 and ephrinB3 are required for CA3-CA1 hippocampal LTP (Grunwald et al., 2004).
With respect to the CA3-CA1 synapse, ephrinB2 and ephrinB3 are expressed mainly in post-
synaptic CA1 neurons, while the relevant Eph receptors – EphB2 and EphA4 – are expressed
both pre- and postsynaptically in the adult hippocampus (Grunwald et al., 2001, 2004). Impor-
tantly, both EphB2 and EphA4 receptors show signalling-independent requirement in long-
term plasticity (Grunwald et al., 2001; Henderson et al., 2001; Grunwald et al., 2004), sug-
gesting reverse signalling by postsynaptic ephrinBs. Assuming that the ephrinBs are the key
player in synaptic plasticity of mature synapses and they do not interact with EphB receptors
in cis, then the overexpression of EphB2 at the postsynaptic site of the CA1 neuron would
have no effect in synaptic plasticity.
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